Human Developmental Neurotoxicology
edited by
David C. Bellinger Children’s Hospital Boston Harvard Medical School Ha...
152 downloads
1928 Views
5MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
Human Developmental Neurotoxicology
edited by
David C. Bellinger Children’s Hospital Boston Harvard Medical School Harvard School of Public Health Boston, Massachusetts, U.S.A.
New York London
Taylor & Francis is an imprint of the Taylor & Francis Group, an informa business
Published in 2006 by Taylor & Francis Group 270 Madison Avenue New York, NY 10016 © 2006 by Taylor & Francis Group, LLC No claim to original U.S. Government works Printed in the United States of America on acid-free paper 10 9 8 7 6 5 4 3 2 1 International Standard Book Number-10: 0-8247-2988-9 (Hardcover) International Standard Book Number-13: 978-0-8247-2988-2 (Hardcover) Library of Congress Card Number 2005046676 This book contains information obtained from authentic and highly regarded sources. Reprinted material is quoted with permission, and sources are indicated. A wide variety of references are listed. Reasonable efforts have been made to publish reliable data and information, but the author and the publisher cannot assume responsibility for the validity of all materials or for the consequences of their use. No part of this book may be reprinted, reproduced, transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying, microfilming, and recording, or in any information storage or retrieval system, without written permission from the publishers. For permission to photocopy or use material electronically from this work, please access www.copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC) 222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that provides licenses and registration for a variety of users. For organizations that have been granted a photocopy license by the CCC, a separate system of payment has been arranged. Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. Library of Congress Cataloging-in-Publication Data Human developmental neurotoxicity / edited by David C. Bellinger. p. ; cm. Includes bibliographical references and index. ISBN-13: 978-0-8247-2988-2 (alk. paper) ISBN-10: 0-8247-2988-9 (alk. paper) 1. Neurotoxicology. 2. Nervous system--Diseases. 3. Fetus--Diseases--Complications. 4. Infants (Newborn)--Effect of drugs on. 5. Neurotoxic agents. I. Bellinger, David. [DNLM: 1. Neurotoxicity Syndromes--etiology. 2. Child Development--drug effects. 3. Embryonic and Fetal Development--drug effects. WL 140 C63992 2006] RG627.C65 2006 618.3'2071--dc22
Taylor & Francis Group is the Academic Division of Informa plc.
2005046676
Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com
Preface
Know anything? I don’t even suspect anything! —Yogi Berra, when, following a particularly dismal performance on a test, a teacher asked, “Yogi, don’t you know anything?” As we know, There are known knowns. There are things we know we know. We also know There are known unknowns. That is to say We know there are some things We do not know. But there are also unknown unknowns, The ones we don’t know We don’t know. —Donald H. Rumsfeld, U.S. Secretary of Defense, news briefing, Feb. 12, 2002
Those who investigate the impacts of chemical exposures on children’s neurodevelopment are not quite in the same dire epistemological straits as Yogi Berra. We at least suspect quite a lot of things. Rumsfeld’s musings, although resembling a Zen koan in their obtuseness, are, nevertheless, more apt. Some questions have answers that most (although rarely all) observers would endorse. For example, if asked, “Is children’s neurodevelopment adversely affected at levels of lead exposure that are not high enough to cause an overt encephalopathy?” most investigators would probably answer affirmatively. In Rumsfeld’s system for classifying knowledge, this would be a “known known.” An increase in the specificity with which a question is phrased will, however, often result in responses that are more variable, both in content and the respondent’s level of certainty, suggesting that the issue in question would be better classified as a “known unknown.” “What is the functional form of the dose-response relationship?”, “To what extent do the expressions of nervous system toxicity depend on the age at which exposure occurs?” and “What is the natural history of lead-associated neurodevelopmental deficits under different degrees of postnatal environmental enrichment?” are examples of such questions. And then there are the “unknown unknowns.” These bear on issues that we won’t even think to ask questions about until we learn enough to appreciate the existence of a mystery that, heretofore, lay unrecognized. These are not issues solely of academic interest. In the past two decades, children’s abilities to process information, to reason, to learn, and to achieve a positive psychosocial adjustment have emerged as critical endpoints in risk assessments of chemical exposures. It is recognized that children with even subtle impairments of these skills, who cannot function near the peak of their potential, will not fare as well as those who do in a technological marketplace that places high value on analytic and communication skills and the ability to adapt quickly and effectively to shifting demands and opportunities. It is iii
iv
Preface
no longer adequate to make public health decisions based on risk assessments that use as critical endpoints frank neurological disease or mental retardation (to say nothing of endpoints such as the LD50–the dose at which 50% of animals in the “exposed” group die). Exposure standards will be insufficiently protective if based on using approaches that do not acknowledge the potential importance, both to the individual and to society, of “sub-clinical” effects, that is adverse impacts that are not severe enough to meet diagnostic criteria for a disease or that do not correspond to a pattern that is sufficiently common to have been canonized as a “diagnosis.” The increasing recognition of “subtle” effects of neurotoxicant exposures and their acceptance as worthy of concern has resulted in a steady evolution over the past 30 years in the study methodologies applied in human developmental neurotoxicology studies. Case series describing the severe neurological deficits of children who developed Congenital Minamata Disease after prenatal exposure to methyl mercury or who presented with a fulminant lead encephalopathy were sufficient to convince us of the serious neurotoxicities caused by high dose exposure to these metals. Studies that were more analytic, using a case-control design, became necessary when the goal was to determine whether the prevalence of clinically-defined childhood morbidities, for example diagnoses such as learning disabilities or attention deficit hyperactivity disorder, differed between children who were considered “exposed” or “unexposed” to some chemical. The effect measures applied in case-control studies were typically the odds ratio and relative risk, expressing the extent to which the morbidity was more likely to be present among children in the “exposed’ than the “unexposed” group. When concern began to shift to possible subclinical impairments, it was necessary to mount cohort studies, in which participants were selected on the basis of exposure status rather than outcome status, and outcomes were often represented dimensionally rather than as diagnoses that were noted as being simply present or absent. Prospective studies were recognized as preferable to cross-sectional studies because they permitted an investigator to establish the temporal precedence of exposure vis a vis outcome, to characterize the natural history of exposure-outcome associations, and to identify age-dependent variations in susceptibility. In contrast to the odds ratio or relative risk statistics calculated in case-control studies, the effect measures calculated in cohort studies were more often the rate of change in the dimensional outcome per unit increase in an exposure index, providing new options for modeling dose-response and dose-effect relationships and developing points of departure for risk assessments. Other recent trends in the evolution of human developmental neurotoxicology research are notable. At the same time that the endpoints considered important to society were broadened to include sub-clinical as well as clinical impairments within a particular health domain, the range of health domains of interest as possible targets of neurotoxicant exposures has also broadened. For a variety of reasons, neurotoxicological studies traditionally focused on cognitive morbidities, defined rather narrowly and often consisting solely of IQ, as the critical endpoints. Beginning in the 1980s, however, attention was drawn in the general pediatric literature to what was called “the new morbidity,” referring to behavioral disorders and maladaptive psychosocial function. A concern with such disorders is increasingly reflected in neurotoxicological studies, with diagnoses such as juvenile delinquency, attention deficit hyperactivity disorder, and autism spectrum disorder serving as the endpoints of interest. Another trend is increasing sophistication of the methods used to address the critical issue of confounding bias by characterizing more accurately and comprehensively the panoply of factors that, apart from the chemical exposure of interest, can affect a child’s health. Determining how a chemical exposure fits into the complex web of influences on child development, its effects perhaps being exacerbated by some of these other influences and mitigated by others, also
Preface
v
became an important part of the evaluation of study hypotheses. These trends resulted in studies that have become increasingly complex and multidisciplinary, requiring, at least, the collaboration of toxicologists, developmental psychologists, epidemiologists, biostatisticians, and analytical chemists. The contributions of psychiatrists, sociologists and cultural anthropologists will be increasingly important as the range of endpoints of interest continues to broaden and the child development models used to evaluate chemical effects become richer in depth and complexity. The purpose of this book is to describe the state-of-the-art in the design, conduct, and interpretation of human developmental neurotoxicology studies. Authors were asked to do more, however, than to describe current knowledge and methods in their fields of research. They were asked to address the question, “How can we do better?” and encouraged to identify the advances that need to be made in order to allow investigators to clarify the “known unknowns” and to identify the “unknown unknowns” that will be the foci of future research. Chapters in section one focus on specific environmental chemical exposures, including mercury, PCBs, lead, and solvents. Although the first three are among the chemicals that have been most intensively studied, many knowledge gaps remain, continuing to inspire debate and to render the risk assessment process contentious. Because of the current world-wide concern about mercury toxicity, two chapters are devoted to this metal. Although there is some overlap in the topics covered, the chapters provide complementary perspectives on the conduct and interpretation of mercury studies as well as on their public health implications. The chapters in section two focus on the developmental neurotoxicities associated with intentional exposures to chemicals or chemical mixtures. Some of these are medications administered therapeutically, such as anti-epileptic and chemotherapeutic drugs, while others are drugs used recreationally, including tobacco, alcohol, and cocaine. The potential adverse effects of exposures to recreational drugs generally receive much more attention than do the potential adverse effects of exposures to therapeutic drugs, perhaps due, at least in part, to differences in the risk-benefit calculus appropriate to these two classes of exposures. Exposure to therapeutic drugs occurs as a result of a decision that the avoidance of a health risk associated with a medical condition outweighs the risks associated with their use, which might be substantial (i.e., “side effects”). In contrast, use of recreational drugs, particularly during pregnancy, would not be expected to provide any health benefit to the fetus or child, which could make the risk of even subtle “side effects” on a child enough to tip the balance in favor of avoiding the exposure. Chapters in section three focus on critical issues in the assessment of exposure and outcome. Separate chapters focus on the special considerations germane to the assessment of exposures to accumulative chemicals, such as many metals, and to the assessment of exposures to chemicals with relatively short biological residence times, such as organophosphate pesticides. Another chapter focuses on special issues that pertain to characterizing voluntary exposures, such as marijuana and cocaine. The chapters focusing on outcome assessment address considerations in assembling, modifying, and validating a battery of tests, the emerging role for neuroimaging modalities in assessing neurotoxicity, and the special challenges faced in studying the contributions of childhood neurotoxicant exposures to the development of adult neurologic disease. Chapters in section four provide perspectives on several aspects of the analysis and interpretation of developmental neurotoxicity studies. These include the strategies used to identify potential confounding variables to include in regression models and the potential utility of analytic strategies such as structural equation modeling in characterizing the relationships among exposures, outcomes, confounders, and mediators. Another chapter
vi
Preface
shows how our understanding of exposure-outcome associations can be enriched by taking into account the broader social environment within a child that is developing and building multi-level models of complex inter-relationships. Two other chapters address issues pertaining to study interpretation, one focusing on how consideration of the experimental animal literature on a chemical’s developmental neurotoxicity can inform both the choice of methods used in human studies, and the inferences drawn about behavioral mechanisms and, ultimately, about causality. A chapter that focuses on the effects of chemical exposures on thyroid hormone signaling pathways illustrates the daunting distance we have to go to bridge the yawning chasm that separates the observations made in epidemiologic studies of developmental neurotoxicity and an understanding of the biological mechanisms generating those observations. The chapters in section five place the contributions of developmental neurotoxicity research in a broader context. Two chapters provide the perspectives of groups who could be characterized as “consumers” of such studies, namely those who use the data clinically to manage patients exposed to neurotoxic chemicals, and those who use the data as the basis for formulating public policy. They help us to understand ways in which this research can be designed, conducted, analyzed in ways that will make the data more useful to those who apply the findings. The final chapters alert us to the hazards that can arise in doing research that threatens industrial interests or that enriches investigators who place themselves in positions of conflict of interest. These caveats remind us of the quite profound effects that developmental neurotoxicity research have on people’s health and livelihoods, and the special responsibilities we assume in undertaking such work. David C. Bellinger
Contents Preface : : : : iii Contributors : : : : xv SECTION ONE: ENVIRONMENTAL CHEMICALS 1. Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 Bernard Weiss Mercury as an Environmental Poison : : : : 1 Anticipation of the Current Debate : : : : 3 Minamata and Iraq : : : : 3 The Current Scene : : : : 6 Other Complications : : : : 8 The Risk Equation and Effect Modification : : : : 9 Inorganic Mercury : : : : 11 Delayed Toxicity : : : : 13 Postnatal Exposures in Humans : : : : 16 Unresolved Issues : : : : 18 References : : : : 19 2. Developmental Neurotoxicity Associated with Dietary Exposure to Methylmercury from Seafood and Freshwater Fish . . . . . . . . . . 25 Philippe Grandjean, Sylvaine Cordier, and Tord Kjellstro¨m Introduction : : : : 25 Prospective Study Designs and Settings : : : : 26 Cross-Sectional Studies : : : : 29 Exposure Assessment : : : : 32 Outcome Variables : : : : 34 Confounding Variables : : : : 36 Public Health Relevance : : : : 38 References : : : : 40
vii
viii
Contents
3. Effects of Developmental PCB Exposure on Neuropsychological Function in Epidemiological Studies: Issues and Research Needs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 Deborah C. Rice Identification of Types of Behavioral Deficits Produced by PCB Exposure : : : : 44 Choice of Congeners and Tissue Compartment as Determinants of Exposure : : : : 49 Determination of Effects of Multiple Chemicals in Addition to PCBs : : : : 51 Contribution of Postnatal Effects to Neurotoxicity : : : : 54 Determination of the Relationship between Exposure and Effect : : : : 57 Thyroid Hormones as a Potential Mediator of Neurotoxic Effects : : : : 58 Summary and Overall Conclusions : : : : 58 References : : : : 60 4. Lead Neurotoxicity in Children: Knowledge Gaps and Research Needs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67 David C. Bellinger Introduction : : : : 67 Selection of Exposure Biomarkers and Sources of Misclassification Errors : : : : 68 Selection of Critical Outcomes : : : : 71 Functional Form of the Concentration–Response/ Concentration–Effect Relationship : : : : 73 Reversibility : : : : 74 Effect Modification : : : : 75 Conclusion : : : : 77 References : : : : 77 5. Effects of Organic Solvents on Reproductive Outcome and Offspring Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83 Christine Till, Gideon Koren, and Joanne Rovet Basic Principles : : : : 83 Organic Solvents in the Central Nervous System : : : : 87 Fetal Vulnerability to Organic Solvents : : : : 88 Reproductive and Developmental Effects in Animals Following Prenatal Exposure to Organic Solvents : : : : 89 Reproductive and Developmental Effects Following Occupational Exposure to Organic Solvents : : : : 90 Organic Solvent Inhalant Abuse : : : : 96 Problems Studying Reproductive Hazards in Human Studies : : : : 97
Contents
ix
Summary and Recommendations : : : : 98 References : : : : 99 SECTION TWO: MEDICINAL AND RECREATIONAL SUBSTANCE USE 6. The Structural and Functional Teratology of Antiepileptic Medications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103 Jane Adams, Jennifer Anne Lantz Gavin, and Patricia A. Janulewicz Fundamentals of Teratology and Neurobehavioral Teratology : : : : 103 Research in the Early Years: The Role of Epilepsy as a Disease Contributing to Adverse Outcomes of Pregnancy : : : : 106 The Effects of Polytherapy Versus Monotherapy Treatments : : : : 107 The Teratogenic Effects of Monotherapy with Phenytoin, Phenobarbital, Carbamazepine, and Valproic Acid : : : : 116 Individualized Predictors of Susceptibility to Adverse Outcome that Can be Assessed During Pregnancy or at Birth : : : : 124 Future Research Needs : : : : 125 References : : : : 126 7. Chemotherapy Agents for Treatment of Acute Lymphoblastic Leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 131 Christine Mrakotsky and Deborah P. Waber Introduction : : : : 131 Pathophysiology and Prevalence of ALL : : : : 132 Evolution of Treatment Protocols : : : : 132 Chemotherapy Agents: Efficacy and Toxicity : : : : 133 Neuropsychological Sequelae of Treatment for ALL with Chemotherapy Only : : : : 135 Methodological Considerations, Limitations, Outstanding Issues and Data Needs : : : : 139 Conclusion : : : : 142 References : : : : 143 8. Prenatal Tobacco and Postnatal Environmental Tobacco Smoke Exposure and Children’s Cognitive and Behavioral Functioning . . . . . . . . . . . . . . . . . . . . . . . . . . . . Michael Weitzman, Todd A. Florin, and Megan Kavanaugh Introduction : : : : 149 Characteristics of Women Associated with Maternal Smoking : : : : 150 Potential Pathway for Adverse Effects : : : : 151
149
x
Contents
Neurocognitive and Behavioral Outcomes Associated with Maternal Smoking : : : : 153 Research Implications : : : : 158 Summary : : : : 159 References : : : : 160 9. Lessons Learned: Fetal Alcohol Spectrum Disorders . . . . . . . . . . 169 Christie L. McGee, Susanna L. Fryer, and Sarah N. Mattson Introduction : : : : 169 Methodology : : : : 170 Review of Neuropsychological Literature : : : : 173 Long-Term Consequences : : : : 181 Conclusions : : : : 185 References : : : : 186 10. Neurodevelopmental Sequelae of Prenatal Cocaine Exposure . . . . 193 Linda C. Mayes and Marjukka Pajulo Models of Neurobehavioral Teratology : : : : 193 Prenatal Cocaine Exposure : : : : 197 Human Model of Prenatal Exposure : : : : 208 The Interaction of Prenatal Cocaine Exposure and a Drug-Dependent Environment : : : : 211 Summary : : : : 216 References : : : : 218 SECTION THREE: EXPOSURE AND OUTCOME ASSESSMENTS 11. Immutable Elements—Variable Effects: Exposure Assessment for Neurotoxic Metals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 231 Alan H. Stern Introduction : : : : 231 General Considerations for Metals : : : : 231 General Approaches to Exposure Assessment for Developmental Neurotoxic Metals : : : : 233 Application of Pharmacokinetic Models : : : : 237 Mercury as a Case Study : : : : 239 References : : : : 248 12. Studying the Relation Between Pesticide Exposure and Human Development . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 253 Dana B. Barr, Asa Bradman, Natalie Freeman, Robin M. Whyatt, Richard Y. Wang, Luke Naeher, and Brenda Eskenazi Introduction : : : : 253 Toxicology : : : : 256 Human Studies on the Neurotoxic Effects of Pesticides in Children : : : : 258
Contents
xi
Factors Affecting Fetal, Infant, and Early Childhood Exposure : : : : 266 Assessing Exposure to Neurotoxic Pesticides : : : : 269 Recommendations for Future Studies : : : : 275 References : : : : 276 13. Assessing In Utero Exposure to Cannabis and Cocaine . . . . . . . . 287 Gale A. Richardson, Marilyn A. Huestis, and Nancy L. Day Introduction : : : : 287 Prevalence : : : : 287 Self-Report Methods : : : : 288 Biological Measures : : : : 291 Comparisons of Self-Report and Biological Markers : : : : 296 Conclusions and Recommendations : : : : 297 References : : : : 298 14. Neurobehavioral Test Batteries for Children Diane S. Rohlman and W. Kent Anger Identifying the Problem : : : : 303 Planning the Research Study : : : : 304 Methods Development : : : : 309 Quality Control : : : : 311 An Example: Developing a Test Battery for Preschool Children : : : : 312 Analyzing the Results : : : : 315 Conclusions : : : : 316 References : : : : 316
. . . . . . . . . . . . . . . . 303
15. Role of Neuroimaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 321 Patricia A. Janulewicz, Roberta F. White, and Carole Palumbo Neuroimaging Techniques : : : : 322 Imaging in Developmental Neurotoxicology Research : : : : 325 Faroese Imaging Study : : : : 327 Discussion : : : : 332 References : : : : 332 16. Early Life Environmental Exposures and Neurologic Outcomes in Adults . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 341 Marc G. Weisskopf, Robert O. Wright, and Howard Hu Introduction : : : : 341 Critical Periods in Brain Development : : : : 342 Are Early Life Exposures Related to Adult Neurologic Outcomes? : : : : 344 Difficulties in Studying the Effect of Early Life Exposures on Adult Neurologic Outcomes : : : : 347 How Can the Effect of Early Life Exposures on Adult Neurologic Outcomes Best be Studied? : : : : 351
xii
Contents
Summary : : : : 353 References : : : : 353 SECTION FOUR: ANALYSIS AND INTERPRETATION 17. The Critical Concept of Control in Human Neurobehavioral Toxicology Studies: We Can, and Must, Do Better . . . . . . . . . . . . 361 Paul Stewart Introduction : : : : 361 Additional (Theoretical) Criteria for Covariates : : : : 372 References : : : : 376 18. Environmental Risk Assessment with Structural Equation Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 379 Esben Budtz-Jørgensen Summary : : : : 379 Introduction : : : : 379 The Faroese Mercury Study : : : : 380 The Standard Approach to Effect Estimation : : : : 381 Structural Equation Models : : : : 382 Estimation of Exposure Measurement Error : : : : 383 Effect Estimation in Structural Equation Models : : : : 385 The Benchmark Approach to Setting Safety Standards : : : : 387 Standard Application of the Benchmark Approach : : : : 388 Sophisticated Benchmark Analysis : : : : 389 Discussion : : : : 390 References : : : : 391 19. Incorporating the Social-Ecological Perspective into Studies of Developmental Neurotoxicity . . . . . . . . . . . . . . . . . . . . . . . . . . 393 Virgina A. Rauh, Frederica Perera, and Jennifer F. Culhane Introduction : : : : 393 The Confluence of Social and Chemical Risks : : : : 394 Interactions Between Social and Chemical Risks : : : : 402 References : : : : 407 20. Assessing the Neurobehavioral Effects of Early Toxicant Exposure: A Perspective from Animal Research . . . . . . . . . . . . . 415 Barbara J. Strupp and Stephane A. Beaudin Introduction : : : : 415 Considerations in Task Selection and Design : : : : 416 Some Cautionary Notes : : : : 433 Summary : : : : 436 References : : : : 438
Contents
xiii
21. The Developmental Neurotoxicology of Chemicals Disrupting Thyroid Hormone Signaling . . . . . . . . . . . . . . . . . . . . 447 R. Thomas Zoeller The EDSTAC Final Recommendation for Screening Anti-thyroid Activities : : : : 447 The HPT Negative Feedback System : : : : 449 Mechanism of Thyroid Hormone Action : : : : 449 Thyroid Hormone Exerts Time- and Dose-Dependent Effects on Brain Development : : : : 451 Polychlorinated Biphenyls (PCBs) : : : : 452 Conclusion : : : : 454 References : : : : 455
SECTION FIVE: DEVELOPMENTAL NEUROTOXICITY: CLINICAL PRACTICE, RISK ASSESSMENT ETHICS 22. Public Health Perspectives on Developmental Neurotoxicology . . 463 Jennifer S. Mammen and Lynn R. Goldman Public Health Burden of Developmental Disabilities/Learning Disabilities in Children : : : : 463 Assessment of Risk of Potential Developmental Neurotoxic Agents : : : : 464 Tracking Developmental Disabilities : : : : 476 Policy Issues : : : : 476 Conclusions : : : : 479 References : : : : 479 23. Research to Clinical Practice: A Pediatric Environmental Health Perspective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 483 April A. Harper and Michael W. Shannon Introduction : : : : 483 The Role of Scientific Research in Clinical Practice : : : : 484 Specific Research Needs : : : : 485 Conclusion : : : : 493 References : : : : 494 24. Evaluating Neurotoxic Effects: Epidemiological, Epistemic, and Economic Issues . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 499 Herbert L. Needleman Introduction : : : : 499 The Growth of Understanding of Childhood Lead Toxicity : : : : 500 The Conundrum of Causality : : : : 500 Science, Universities, and the Market Place : : : : 504 Summary : : : : 506 References : : : : 506
xiv
Contents
25. Knowledge, Norms, and the Politics of Risk: Ethical Issues in Policy-Relevant Science . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 509 Virginia Ashby Sharpe Introduction : : : : 509 The Normative Context of Policy-Relevant Science : : : : 510 New Mandates in Policy-Relevant Science : : : : 514 Corporate Construction of Risk and Conflicts of Interest : : : : 516 Conflict-of-Interest Disclosure and the Right-to-Know : : : : 517 Community-Based Research : : : : 519 Conclusion : : : : 520 References : : : : 521 Index : : : : 525
Contributors
Jane Adams Department of Psychology, University of Massachusetts Boston, Boston, Massachusetts, U.S.A. W. Kent Anger Center for Research on Occupational and Environmental Toxicology, Oregon Health and Science University, Portland, Oregon, U.S.A. Dana B. Barr National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, U.S.A. Stephane A. Beaudin New York, U.S.A.
Division of Nutritional Sciences, Cornell University, Ithaca,
David C. Bellinger Department of Neurology, Children’s Hospital Boston, Harvard Medical School and Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A. Asa Bradman Center for Children’s Environmental Health, School of Public Health, University of California, Berkeley, California, U.S.A. Esben Budtz-Jørgensen Department of Biostatistics, University of Copenhagen, Copenhagen and Institute of Public Health, University of Southern Denmark, Odense, Denmark and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, U.S.A. Sylvaine Cordier Rennes, France
National Institute for Health and Medical Research (INSERM),
Jennifer F. Culhane Department of Obstetrics and Gynecology, Drexel University College of Medicine, Philadelphia, Pennsylvania, U.S.A. Nancy L. Day Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, U.S.A. Brenda Eskenazi Center for Children’s Environmental Health, School of Public Health, University of California, Berkeley, California, U.S.A. xv
xvi
Contributors
Todd A. Florin American Academy of Pediatrics, Center for Child Health Research and Department of Pediatrics, The University of Rochester School of Medicine and Dentistry, Rochester and Department of Pediatrics, New York University School of Medicine, New York, New York, U.S.A. Natalie Freeman Center for Environmental and Human Toxicology, College of Veterinary Medicine and College of Public Health and Health Professions, University of Florida, Gainesville, Florida, U.S.A. Susanna L. Fryer Center for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, California, U.S.A. Jennifer Anne Lantz Gavin Department of Psychology, University of Massachusetts Boston, Boston, Massachusetts, U.S.A. Lynn R. Goldman Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, U.S.A. Philippe Grandjean Department of Environmental Medicine, University of Southern Denmark, Odense, Denmark and Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A. April A. Harper Division of General Pediatrics, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, U.S.A. Howard Hu Department of Environmental Health, Harvard School of Public Health and The Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A. Marilyn A. Huestis Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, U.S.A. Patricia A. Janulewicz Department of Environmental Health, Boston University School of Public Health and Department of Psychology, University of Massachusetts, Boston, Massachusetts, U.S.A. Megan Kavanaugh American Academy of Pediatrics, Center for Child Health Research and Department of Pediatrics, The University of Rochester School of Medicine and Dentistry, Rochester and Department of Pediatrics, New York University School of Medicine, New York, New York, U.S.A. Tord Kjellstro¨m National Institute of Public Health, Stockholm, Sweden and Australian National University, Canberra, Australian Capital Territory, Australia and Wellington School of Medicine and Health Sciences, Wellington, New Zealand Gideon Koren Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, Toronto, Ontario, Canada
Contributors
xvii
Jennifer S. Mammen Environmental Health Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, U.S.A. Sarah N. Mattson Center for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, California, U.S.A. Linda C. Mayes
Yale Child Study Center, New Haven, Connecticut, U.S.A.
Christie L. McGee Center for Behavioral Teratology, Department of Psychology, San Diego State University, San Diego, California, U.S.A. Christine Mrakotsky Department of Psychiatry, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, U.S.A. Luke Naeher U.S.A.
College of Public Health, University of Georgia, Athens, Georgia,
Herbert L. Needleman Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, U.S.A. Marjukka Pajulo Department of Child Psychiatry, University of Tampere, Tampere, Finland and Yale Child Study Center, New Haven, Connecticut, U.S.A. Carole Palumbo Department of Neurology, Boston University School of Medicine, Aphasia Research Center, VA Boston Healthcare System, Boston, Massachusetts, U.S.A. Frederica Perera Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, U.S.A. Virginia A. Rauh Heilbrum Department for Population and Family Health, Mailman School of Public Health, Columbia University, New York, New York, U.S.A. Deborah C. Rice Environmental and Occupational Health Program, Maine Center for Disease Control and Prevention, Augusta and Center for Integrative and Applied Toxicology, University of Southern Maine, Portland, Maine, U.S.A. Gale A. Richardson Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, U.S.A. Diane S. Rohlman Center for Research on Occupational and Environmental Toxicology, Oregon Health and Science University, Portland, Oregon, U.S.A. Joanne Rovet Ontario, Canada
Department of Pediatrics, The Hospital for Sick Children, Toronto,
Michael W. Shannon Division of Emergency Medicine, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, U.S.A. Virginia Ashby Sharpe Center for Clinical Bioethics, Georgetown University Medical Center, Washington, D.C., U.S.A.
xviii
Contributors
Alan H. Stern Division of Environmental and Occupational Health, University of Medicine and Dentistry of New Jersey, School of Public Health, Piscataway, New Jersey, U.S.A. Paul Stewart Department of Psychology, State University of New York at Oswego, Oswego, New York, U.S.A. Barbara J. Strupp Division of Nutritional Sciences and Department of Psychology, Cornell University, Ithaca, New York, U.S.A. Christine Till
Toronto Rehabilitation Institute, Toronto, Ontario, Canada
Deborah P. Waber Department of Psychiatry, Children’s Hospital Boston, Harvard Medical School, Boston, Massachusetts, U.S.A. Richard Y. Wang National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia, U.S.A. Bernard Weiss Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York, U.S.A. Marc G. Weisskopf Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A. Michael Weitzman American Academy of Pediatrics, Center for Child Health Research and Department of Pediatrics, The University of Rochester School of Medicine and Dentistry, Rochester and Department of Pediatrics, New York University School of Medicine, New York, New York, U.S.A. Roberta F. White Department of Environmental Health, Boston University School of Public Health, Boston, Massachusetts, U.S.A. Robin M. Whyatt Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, New York, U.S.A. Robert O. Wright Department of Pediatrics, Children’s Hospital and The Channing Laboratory, Brigham and Women’s Hospital, Harvard Medical School and Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A. R. Thomas Zoeller Biology Department, University of Massachusetts-Amherst, Amherst, Massachusetts, U.S.A.
SECTION ONE: ENVIRONMENTAL CHEMICALS
1
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma Bernard Weiss Department of Environmental Medicine, University of Rochester, School of Medicine and Dentistry, Rochester, New York, U.S.A.
MERCURY AS AN ENVIRONMENTAL POISON The New York Times of August 26, 1991, carried a headline on its first page that reverberates with debates that are even more strident today: “Despite Era of Concern for the Earth, Mercury is Re-emerging as a Peril.” It pointed to the deepening concern over contamination by mercury of aquatic life and how it had aroused governmental agencies charged with environmental protection and public health to take preventive and regulatory action. It described the origins of the catastrophe in Minamata, Japan, a fishing village whose inhabitants suffered an epidemic of methylmercury poisoning from contaminated fish. It told of the conflicts faced by sport and subsistence fishermen about the safety of consuming their catch, and of the confusion and wariness on the part of fish consumers. The intensity of the debate has not waned. Instead, it has even widened in scope to include forms of mercury other than the methyl form found in aquatic species. It now includes the vaccine preservative Thimerosal, indicted as a risk factor for autism because it is 50% ethylmercury which, like methylmercury, is a potent neurotoxicant. It also includes dental amalgams, an argument carried on for 150 years but becoming more forceful because of the availability of alternatives. Advocacy groups and individuals have raised alarms because chewing releases mercury vapor from fillings that then is inhaled. Why is mercury the focus of such intense discussion at this time? It is not just the evidence of its potency as a toxicant, which Hunter (1), in his treatise on occupational medicine, described in his review of the “ancient metals.” It more likely is a symptom of our distrust of the information made available to us in the realm of food and chemical safety. We have been deceived or misled about chemical hazards on so many occasions at the same time we’ve received reassurances that our concerns are unfounded that we raise a shield of skepticism. We often have seen how commercial or political interests distort the truth, and have witnessed so many disastrous episodes that it requires a suspension of hardened cynicism to believe in reassurances. Methylmercury is the principal subject addressed here, but in the environment it is entangled with other forms of mercury and other neurotoxic entities. Of all mercury species, methylmercury, however, is the one with the broadest implications for public 1
2
Weiss
health. It is found primarily in a major food source, fish, so it affects populations worldwide. It became a model for behavioral teratology as a definitive example of an environmental neurotoxicant, and it contains lessons useful to the study of other agents with the potential to interfere with neurobehavioral development (2). Methylmercury also illustrates the problems posed to regulatory agencies and their need to translate into exposure standards questions such as the shape of dose-response functions and the inherent limitations of epidemiology. In most instances, the translation is a challenge because most of the toxicity information takes the form of high-dose experiments in animals and, except for mass poisonings, low-level environmental exposures in humans, requiring a succession of tentative extrapolations to harmonize these disparities. Like other agents discussed in this volume, methylmercury exemplifies how an appropriate definition of low-level exposure is a constantly moving target. From some perspectives, discussions of neurotoxicity attributable to environmental chemicals involve a marginal problem compared, say, to the serious disabilities of the fetal alcohol syndrome (FAS). Comparability is not the issue, however. Even FAS can be seen as a minor problem compared to the lives erased by guns, child abuse, and auto accidents. It is the inexorable accumulation of many different risks that is so appalling. Exposure to environmental toxicants, although incurring far less dramatic effects than FAS, is more widely distributed in the population, and their effects, because they are so insidious, are easily overlooked. A small effect on IQ, such as an effect size of 0.33 (one-fifth of a standard deviation or 3 IQ points, producing a mean score of 97 rather than 100) assigns 3.2% of the population to the category “retarded” rather than 2.3%. Figure 1 depicts such a condition. It is the kind of situation that animates how we view the neurobehavioral risks of lead and PCBs as well. That is, their adverse effects are
Proportion
0.03
0.02
0.01
0.00
Proportion
0.03
0.02
0.01
0.00 40
60
80
100 IQ
120
140
160
Figure 1 Upper chart shows an IQ distribution with a mean of 100 and SD of 15. The dark area represents the 2.3% of the population below 70. The light area represents those with IQs below 100 and above 70. The lower chart depicts an IQ distribution with a mean of 97. Here, 3.2% of the population falls below 70. IQ of 100 is shown on both charts as the vertical line.
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
3
expressed primarily as shifts in the distribution of population scores rather than, as with clinical assessments, deficits in individuals. This is the core issue for methylmercury, too.
ANTICIPATION OF THE CURRENT DEBATE In 1968, we held the first of over 20 Rochester Conferences on Environmental Toxicity (3). By that time, Swedish scientists had alerted the world that the catastrophe of methylmercury poisoning at Minamata, Japan, represented not a local problem but rather one with global dimensions. They had demonstrated that environmental discharges of all forms of mercury (metallic, inorganic divalent, phenylmercury) can all be converted by natural processes in aquatic settings to the highly toxic methylmercury form (4). They had been alerted to the existence of a methylmercury problem in Sweden’s waters by a decline in sea bird populations, in species such as ospreys, that depended on fish for sustenance. Their findings recapitulated the questions that had been posed by Rachel Carson (5) about pesticides when she observed diminished bird populations. By analyzing the mercury content of bird feathers in museums and comparing them to contemporary levels, they demonstrated the sharp rises coincident with the introduction of organic mercury fungicides into Swedish agriculture. (Feathers, like growing hair, reflect methylmercury concentrations in the blood). They also showed how the process of bioconcentration could magnify toxic exposures: pike in Swedish waterways bore flesh levels of methylmercury as much as 3000 times greater than the ambient water concentration due to increases at successive trophic levels as predators consumed contaminated prey. At the 1968 meeting, Robert Risebrough, of the University of California, Berkeley, asked the following question: Why should mercury be a problem in the northern countries rather than in the more temperate areas?
Fredrik Berglund of the National Institute of Public Health, Sweden, replied: I think one reason that this problem does not exist in the United States with mercury is that the levels are not known.I feel, personally, that the problem also exists here as it does in other parts of the world but it is not recognized.
Recognition soon came, with the discovery, in 1970, of methylmercury contamination in the Great Lakes, stemming mainly from the discharge of metallic mercury by chlor-alkali plants. These plants use large pools of liquid mercury as electrodes to convert brine into chlorine and sodium hydroxide. The current methylmercury agenda, with its emphasis on prenatal exposure, was set the following year with a mass chemical poisoning in Iraq (6). This history parallels the concurrent development of neurobehavioral toxicology as a science.
MINAMATA AND IRAQ Two mass chemical disasters awakened us to the threats posed to developing brains by methylmercury. One occurred in Japan, the other in Iraq. Progessive stages in the evolution of neurobehavioral toxicology can be traced by how those two mass poisonings helped spawn a discipline that pulled toxicology from its traditional reliance on lethality and pathology towards criteria such as IQ scores and performance on behavioral tests.
4
Weiss
What the Japanese later called Minamata Disease arose from methylmercury contamination of Minamata Bay, which adjoins a fishing village in the southernmost Japanese island of Kyushu. A change in catalyst use in the production of acetaldehyde by the Chisso factory on the shores of the bay resulted in the discharge of mercury into the bay, where it contaminated the fish and shellfish consumed by the villagers, especially fishermen and their families. The tragedy of Minamata has been told many times and in many ways, but perhaps none as effectively as in the photo essay by Eugene and Aileen Smith (7). It depicted with one unnerving episode the price Japan had paid for industrialization carried out with little concern for its environmental consequences. Minamata disease, after a lengthy period of puzzlement about its etiology, was eventually discovered to be due to methylmercury exposure. Its signs, in adults, had been known for decades because of accidents. They are listed in Table 1. The victims of that tragedy extend beyond the group whose manifestations were easily identified. A much larger group most surely bears scars that are not as easily or directly ascribed to methylmercury because their legacy came in the form of functional deficits that required close study with appropriate tests and comparisons at a time when quantitative measures of exposure were not available. The drama of that episode, however, has tended to blur an important environmental lesson. Like some other environmental contaminants, methylmercury delivered its toxicological message insidiously. Figure 2 charts the rising incidence of Minamata Disease over a three-years period. Cases appeared sporadically. Dr. Hajime Hosokawa, a physician employed by Chisso, courageously proposed that a link existed between the factory and the continuing appearance of cases. His hypothesis was dismissed by Chisso management, but he based his argument on an almost intuitive epidemiology and, perhaps, drew from a famous experiment with cats described by Eto et al. (8). By 1958, almost no cat could be found in the Minamata district. Even as far back as 1952, they had begun to display convulsions, ataxia, and what the inhabitants termed “dancing disease.” Because of this history, a cat experiment was designed to test the conclusion, declared by a study group from Kumamoto University, that organic mercury was responsible for the outbreak. Ten cats were fed food mixed with industrial waste produced in the Chisso plant. The results were not made public, but Eto et al. (8) found the specimens and conducted pathological and chemical assays. Typical lesions of methylmercury poisoning were observed in the central nervous system tissue, and were associated with markedly elevated mercury levels (9). Table 1
Signs and Symptoms of Methylmercury Poisoning in Adults
Sensory Paresthesia (numbness and tingling) Pain in limbs Visual disturbances (field constriction) Hearing disturbances Asterognosis (discrimination by touch) Motor Disturbances of gait Weakness, leg unsteadiness, falling Thick, slurred speed (dysarthria) Tremor Other Headaches, rashes, “mental disturbance”
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
5
Onset of Minamata Disease by Month 60 Number of Cases
50 40 30 20
"Mystery Dlsease" report by Dr. Hosokawa
10 0 12/53
6/54
12/ 54
6/ 55
cumulative
12 / 55
6/ 56
12 / 56
new cases
Data courtesy of H. Satoh and C. Watanabe
Figure 2 Accumulation of cases of Minamata disease between December 1953 and December 1956.
Figure 2 reflects a property of methylmercury toxicity that helped obscure the connection between fish and shellfish consumption and Minamata disease: the period of silent toxicity between exposure and onset of effect. Although 95% of ingested methylmercury is absorbed, delayed toxicity, or displacement in time between exposure and its consequences, makes it difficult to discern a relationship, a gap that can deceive investigators about etiology or lead to disasters that could have been averted or diminished if acted on earlier. This property of methylmercury is discussed later. Minamata also provided the first suggestions of fetal vulnerability. Pregnant women who evinced no signs of poisoning themselves gave birth to offspring with severe neurological deficits who later received the diagnosis of Fetal or Congenital Minamata Disease. These prenatally-exposed children were characterized by severe neurological impairments that included ataxia, neuromotor disability, seizures, hearing loss, microcephaly and cognitive impairment (10). Some of these individuals, now in their 50s, are maintained in a special unit attached to the Minamata Disease Research Institute, which was formed and is supported by the Japanese government. In a bizarre repetition of Minamata about 10 years later, another Japanese town, Niigata, also experienced an epidemic of methylmercury poisoning (11). Again, it arose from a factory that manufactured acetaldehyde and that, in the process, discharged inorganic and methylmercury into a waterway, in this instance, the Agano river. The authors report that 690 adults have been certified as victims of methylmercury poisoning. They also report that even many of those exposed prenatally, whose mothers’ hair levels may have exceeded 50 ppm, a level now considered excessive, show little evidence of adverse effects. These measurements have not been verified by current analytical methods, however. The second mass poisoning, and the one best documented, occurred in Iraq in the winter of 1971–72. A severe drought in the summer of 1971 impelled the Iraqi government to purchase 80,000 tons of seed wheat for planting in 1972. It also requested that the wheat be treated with a methylmercury fungicide, a request made in error. Hungry farmers in rural Iraq, rather than planting the wheat, baked it into bread. During a three-month period that winter, as many as 5000 victims may have died with as many as 50,000 suffering severe illness.
6
Weiss
Because Thomas W. Clarkson at the University of Rochester had recently reported on a sulfhydryl-binding resin that accelerated the clearance of methylmercury from the body, he was contacted by the Iraqi Ministry of Health to secure the resin. The ultimate outcome of that request was establishment of a laboratory in Baghdad and a survey of the exposed population in the countryside (12). It led to the use of hair as a biomarker of exposure history and, of supreme importance, a clear demonstration of the exquisite sensitivity of the fetal brain. Children whose mothers had been pregnant during the outbreak were examined at about 30 months of age to assess developmental milestones such as walking, a difficult task because of undocumented birth dates coupled with the need to conduct examinations in the field. Nevertheless, those data suggested that maternal body burdens in the range of those seen in fish-consuming populations might pose a risk to neurobehavioral development (13) and eventually stimulated several prospective studies in such populations. Interpretation of the results of those studies provides the basis for the current debates about the neurodevelopmental risks of methylmercury. Minamata and Iraq aroused enormous anxieties about their implications for child development (14). Both episodes identified the human fetal brain as the most vulnerable target of methylmercury neurotoxicity, an expectation confirmed by studies in animal models (15,16). Such models have provided the main basis for exploring the mechanisms underlying the pathological features observed in human brains. These were described by Choi et al. (17), who examined the brains of two full term newborn human infants in Iraq who were exposed to methylmercury early in pregnancy due to maternal ingestion of methylmercury–contaminated bread. The brains contained high levels of mercury. Disturbed development was marked by incomplete or abnormal migration of neurons to the cerebellar and cerebral cortices, and deranged cortical organization. Numerous heterotopic neurons were seen in the white matter of cerebrum and cerebellum. The characteristic laminar pattern of the cerebral cortex was distorted in many regions. Such a pattern of damage is unlike the focal neuronal damage observed in poisoned adults and children exposed postnatally. Studies in mice by Sager et al. (18) and Rodier et al. (19) indicate that mitosis is blocked by methylmercury exposure during metaphase. The mechanism appears to be disruption of microtubules in the mitotic spindle. Mitotic arrest can prove devastating to the developing brain, especially before birth, when the bulk of neurons are formed. Choi (20), also in mice, noted abnormal patterns of neuronal migration and cortical cytoarchitecture, another feature of methylmercury neuropathology.
THE CURRENT SCENE In practice, the only source of methylmercury exposure is food from aquatic and marine environments. Because these represent crucial food sources, and a dominant one for protein in some populations, methylmercury ascended to a problem of global dimensions. Although several smaller epidemiological studies have been undertaken (21–27), two large, longitudinal cohort studies occupy the center of the risk debate. One, undertaken by investigators from the University of Rochester, was situated in the Republic of the Seychelles, an island group in the Indian Ocean. Another, conducted by investigators from the University of Southern Denmark, in Odense, was situated in the Faroe Islands in the North Atlantic. Both research groups chose to study the relationship between prenatal exposure to methylmercury and a variety of neurodevelopmental measures. In the Seychelles project, methylmercury concentration in maternal hair was chosen as the biomarker, a choice
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
7
governed by data demonstrating a close correlation between blood levels and levels in growing hair and by ease of storage for transportation and later assays. Because scalp hair grows about 1.1 cm per month, a 12 cm hair strand can recapitulate a one-year exposure history, a vital factor in tracing the outbreak of poisoning in Iraq (6). McDowell et al. (28) point out another advantage of hair assays; namely, because they are noninvasive, they elicit much better response rates from population subgroups such as children that usually resist blood sampling. The hair:blood ratio roughly averages 250:1, but with substantial variation (29,30) and higher ratios in children. The question of how hair levels relate to brain levels will be discussed later. Based on the autopsy material from the Seychelles (31), maternal hair and infant brain levels are closely correlated. The Faroes investigators selected cord blood, which reflects exposure during the later stages of pregnancy, as their main index of exposure, but additional analyses showed a high correlation with hair levels. Maternal hair levels averaged 6.9 ppm in the Seychelles and 4.27 in the Faroes. In the U.S., recent NHANES data showed a geometric mean of 0.12 ppm in children, and 0.20 ppm in women (32). Frequent fish consumers, compared with non-consumers, showed geometric mean hair mercury levels for women of 0.38 versus 0.11 ppm and levels for children of 0.16 versus 0.08 ppm. In the Seychelles, mothers reported eating a mean of 12 fish meals weekly. In the Faroes, adults reported mean daily consumption of 72 grams of fish, 12 grams of whale muscle, and 7 grams of whale blubber. The differences in consumption patterns are significant; the methylmercury source in the Seychelles is ocean fish, while in the Faroes it is primarily pilot whales. The differences create an interpretive dilemma, as discussed later, because these whales are heavily contaminated with other neurotoxicants such as PCBs and a variety of other organohalogens. The Seychelles cohort, consisting of 779 mother-infant pairs enrolled in 1989–1990, has so far been assessed at 6.5, 19, 29, 66, and 107 months of age by a variety of neuropsychological tests appropriate for the cohort’s stage of development (33). For example, at 19 months of age, the main assay consisted of the Bayley Scales of Infant Development. At 107 months of age, the investigators were able to deploy a broad variety of instruments ranging from those assessing motor function (e.g., grooved pegboard) to those assessing cognitive function (e.g., Boston Naming Test) to those assessing conduct (e.g., Child Behavior Checklist). From all of these assessments, based on multiple regression analyses that included potential confounders, only a handful of scattered endpoints revealed any correlation with mercury exposure indices. And, of these, some showed a positive relationship between exposure level and performance, but the relationship depended on age. The Faroes cohort was also assessed with a battery of tests that included neurophysiological (e.g., visual and auditory evoked potentials) as well as neuropsychological (e.g., motor function, cognitive function, subjective state) instruments. The study was initiated with the collection of maternal hair and cord blood levels from 1022 singleton births. At about 7 years of age, 917 of the children were recruited to undergo testing (34). Multiple regression analyses, adjusted for confounders, comprised the main statistical technique. Neither the neurophysiological endpoints nor clinical examinations showed a relationship with methylmercury exposure. In contrast to the Seychelles results, analyses of the neuropsychological indices demonstrated significant negative associations with prenatal methylmercury measures in all five domains chosen for assessment: motor, attention, visuospatial, language, and memory. The different conclusions derived from the Seychelles and Faroes studies remain puzzling but, also, contentious. A National Academy of Sciences committee, charged with
8
Weiss
establishing a risk assessment of methylmercury in seafood, chose the Faroes data as its basis because it offered a clear outcome (35). Specifically, it relied upon the Boston Naming Test as the index measure. It then applied Benchmark Dose (BMD) modeling to derive an exposure level associated with a specified risk value. For such calculations, a Benchmark Response (BMR) is chosen; for example, a value of 5%, which means an increased risk of an abnormal response of 5%. A BMD is then calculated by fitting a mathematical model to the dose-response function, and, on the basis of that function, deriving the dose of the agent that would be predicted to produce, for a BMR of 5%, an excess risk of that magnitude. Because of statistical uncertainty about the central estimate BMD, a lower 95% confidence limit (BMDL) for the BMD is also computed. The committee determined a BMDL of 58 ppb in cord blood (equal approximately to 12 ppm in hair) as the appropriate exposure level from which to derive risk values. The value of 58 ppb was extrapolated to an equivalent intake of 1.1 mg/kg of methylmercury per day. In setting exposure standards, it is common to divide a value such as the BMDL by one or more uncertainty factors to provide a margin of protection. Dividing that value by uncertainty factors summing to about 10 yields a Reference Dose (RfD) (equivalent to an acceptable daily intake) of 0.1 mg/kg per day. The EPA defines a RfD as an exposure level that is without adverse effects over a 70 years lifespan. This RfD translates into a weekly consumption of one 198 g (7 oz) can of tuna for an adult. BMD models have also been applied to the Seychelles data set (36). As the authors note, such models can prove useful even when a statistically significant dose-related trend is absent. On the basis of an increase of 0.1 in the probability of an adverse response (the BMR), maternal hair BMDLs calculated from the Seychelles data ranged from about 19 to about 30 ppm. These values are not markedly different from the Faroes BMDL, nor from BMDLs based upon a New Zealand cohort (23,24) or the data from Iraq (37). The Faroes BMDL values can roughly be translated into brain levels. In nonhuman primates, the blood-brain ratio is approximately 3–10:1 (38–41). In the Seychelles cohort, comparing maternal blood with infant brains secured at autopsy yielded ratios between 5.1 and 6.7 (31). Based on these values, we would expect brain levels at the BMDL to roughly approximate 300 ppb. Infant brains from the Seychelles were examined by Lapham et al. (42). They found no evidence of neuropathology, assessed by criteria similar to those of Choi et al. (17); these brains all exhibited levels of mercury less than 300 ppb, however, while discernible anatomical abnormalities (by conventional pathological techniques) are seen in experimental animals at levels of 1000 ppb and above (43).
OTHER COMPLICATIONS The underlying question for the risk assessment of methylmercury is converting exposure magnitude into risk, which is then translated into the form of the dose-response function. Response takes the form of scores on one or more neuropsychological tests. Dose takes the form of methylmercury in blood or hair. Methylmercury is a biomarker of seafood consumption. (The term seafood is used generically to refer to fish, crustaceans, sea mammals, and other forms of aquatic life eaten by humans and coming from both marine and freshwater sources). In general, those who consume more of these foods exhibit higher levels of methylmercury. Investigators pursuing the question of methylmercury risks, like toxicologists in general, traditionally assume a monotonic dose-response function; that is, that higher exposure levels correspond to greater adverse effects. The dose-response relationship for any particular agent and endpoint may assume a different shape due either
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
9
to the nature of the biological response or because of interactions or confounding with other factors (cf., 44). Instead, it might assume a U-shaped function, as suggested in some data from the Seychelles project (45), especially in populations where fish rather than other aquatic species comprise major portions of the diet. Adverse developmental outcomes, that is, could be associated with both low and high levels of methylmercury, and optimal outcomes might be associated with intermediate values, as described below. U-shaped functions are common in nutrition. For example, manganese is required by neonates for normal skeletal and inner ear development and as components of critical enzymes (46). Elevated manganese exposures in neonatal rats, however, can also induce neurochemical and behavioral abnormalities (47). Vitamins share the same kind of U-shaped dose-response properties and, like manganese, reflect different endpoints in the two arms of the U. In the methylmercury example, lower levels might reflect diminished intake of important nutrients such polyunsaturated long chain fatty acids (PUFAs). The n-3 (omega-3) fatty acids, such as docosahexanoic acid (DHA), are abundant in fish. Higher levels of methylmercury would overcome such beneficial properties and induce toxicity. This phenomenon may underlie the finding of an inverse relationship between maternal hair mercury levels and scores of male offspring at 66 and 107 months of age on the Conners Rating Scales, which are used as measures of ADHD (45). These results do not contradict the recognized threats to brain development posed by higher levels of methylmercury exposure; they merely suggest that the neurotoxic risks associated with low levels of exposure may be concealed by the benefits of fish consumption for which methylmercury serves as an exposure marker. Choline levels are also high in fish. Zeisel (48) reviewed the evidence suggesting an essential role for choline in human neurodevelopment and cognitive functioning. Studies in rats have demonstrated that supplementation with choline during embryonic development or immediately following birth can result in improved memory performance, which is maintained throughout life (49). Whether supplementation or deprivation later in postnatal development could affect complex cognitive, sensory, motor or behavioral functions is unclear. Common developmental disorders including ADHD, dyslexia, dyspraxia and autistic spectrum disorders (ASD) may also involve functional deficiencies or imbalances in n-3 and n-6 fatty acids (50). But the Seychellois diet is high in these fatty acids, and the levels of PUFAs in blood in Seychellois women is six times higher than in U.S. women. THE RISK EQUATION AND EFFECT MODIFICATION Few epidemiological studies examining exposure to environmental neurotoxicants can without ambiguity dissociate themselves from the multitude of other toxic risks encountered during development nor, in some cases, such as pesticides, from the question of potential public health benefits. For some environmental contaminants, such as dioxin and lead, no benefits are attached to exposure. For pesticides, it could be argued that exposure must be weighed against the benefits of pest control and efficient agricultural production (51). For seafood, the dilemma is how to construct a risk assessment equation across several dimensions. We are faced with three axioms: 1. All fish, crustaceans, and sea mammals contain methylmercury in variable concentrations. 2. Fish, crustaceans, and sea mammals also contain nutrients, again in variable concentrations, such as n-3 fatty acids, choline, and iodide, that are essential for brain development.
10
Weiss
3. Many fish, crustaceans, and sea mammals are also contaminated with a variety of toxic contaminants other than methylmercury; for example, cadmium, PCBs, polybrominated diethyl ethers (PBDEs) dioxins, DDT and its metabolites, other organochlorine pesticides, and a variety of polycyclic aromatic hydrocarbons such as benzo[a]pyrene. Disentangling the individual contributions of such contaminants, all of which can exert adverse effects on brain function and development, is a daunting, if not impossible challenge, especially because of the potential for additive or synergistic combinations. The mixture problem, a legacy of the extent to which we have thoughtlessly contaminated the environment, is hardly confined to seafood, and pervades every facet of current toxicology. Achieving an appropriate balance of risks and benefits for seafood presents an unusual dilemma that needs further exploration. The third axiom above noted that other common contaminants, as discussed in other chapters in this book, offer hazards of their own. Methylmercury is found primarily in muscle tissue. Organohalogens are concentrated in fatty tissue. Fish that are low in methylmercury and high in n-3 fatty acids, such as salmon and herring, because of their high fat content, also tend to contain higher concentrations of the organohalogens. The consumer, as a result, is compelled to choose between toxicants in selecting different varieties of seafood. Farm-raised salmon, for example, may be contaminated by levels of PCBs exceeding those recommended by agencies such as the U.S. EPA (52). These authors also noted wide regional differences in the degree of contamination. Fish raised in farms in Scotland and the Faroes contained the highest concentrations of PCBs, while those raised in Chile contained the least. The high lipid solubility of PCBs and other organohalogens presents a special problem for brain development. The fetal and neonatal brain is 60% lipid, and it consumes a high proportion (70%) of the energy drawn from the mother. Its energy consumption is one reason it is so vulnerable. Fetal and infant brain development are highly dependent on the availability of two long-chain polyunsaturated fatty acids, docosahexanocic acid (DHA) and arachidonic acid (AA). Seafoods provide these nutrients in relative abundance compared to terrestrial sources (53). These authors argue, in fact, that the evolution of the hominid brain depended on the availability of these fatty acids, which were provided in fish consumed by littoral communities. The organohalogen connection, for which PCB levels provide an exposure index, creates interpretive complications. Fangstrom et al. (54), in their analyses of PCBs in pregnant Faroese women, observed high concentrations of PCBs in serum, “possibly the highest so far reported in a population” and attributed these values primarily to the consumption of pilot whale blubber. Some neurotoxic effects of PCB exposure were uncovered in the 7 years assessment (34). The later stratified analyses conducted by Grandjean et al. (55) suggested that neurotoxicity stemming from PCB exposure may be detectable only at the higher levels of methylmercury, which suggests an additive or more complex model. Whether joint PCB and methylmercury exposure can be disentangled by statistical methods is unclear because we do not understand the mechanisms of interaction, or, indeed, if interaction is the proper term for this situation (56). A study of sport fish consumers residing in a community on the shore of Lake Ontario, designed primarily to explore the influence of prenatal PCB exposure on neurobehavioral development, has also unearthed a complex PCB-methylmercury relationship (57). It is, in essence, a mirror-image of Grandjean et al. (55). In this cohort, in offspring exhibiting the higher PCB levels, methylmercury concentrations in maternal
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
11
hair provided a significant predictor of performance on the McCarthy Scales of Children’s Abilities. In a somewhat parallel analysis of PCB-methylmercury interactions, Grandjean et al. (58) reported that breast feeding in the Faroes is associated with diminished growth, an outcome attributed to both methylmercury and PCBs. Put another way, the benefits of breast feeding for neuropsychological development and immune function in a community such as the Faroes have to be balanced against the risk of growth retardation. These PCB-methylmercury interactions can be viewed from the perspective of effect modification as well as from a mechanistic perspective. Bellinger (59) defines the term to describe a phenomenon in which the effects of one variable, such as dose, depend upon the levels of another variable, such as socioeconomic status. Bellinger pointed to the latter as a model, because of his finding that an effect of lead on IQ scores could be seen in children from low SES but not in high SES families. Analogously, in the Ontario and Faroe cohorts, an effect of PCBs (or methylmercury) in combination with methylmercury (or PCBs) depended on the level of the other agent.
INORGANIC MERCURY The risk assessment challenge of methylmercury in seafood is also compounded by simultaneous exposure to inorganic mercury from sources other than food. In the form of mercury vapor (Hg8), elemental mercury is a potent neurotoxicant. The complications for methylmercury risk assessment due to concurrent exposure to the vapor species arise from two sources. One is the potential developmental neurotoxicity of mercury vapor itself. The other is the possibility that the vapor and organic species share common mechanisms of toxicity. Because assays of mercury in blood often do not distinguish inorganic from organic species, much of the data in the literature cannot be used to compare their individual contributions to selected endpoints. Although mercury vapor is a venerable and potent adult neurotoxicant, its hazards for nervous system development are virtually unknown. The fetus may be exposed to both the methyl and vapor forms. While methylmercury is consumed in the diet, exposures to the vapor form may occur in the workplace, as a result of certain religious practices employing metallic mercury (60), through the use of mercury-containing cosmetics (61), or, the most common source, by mercury vapor emitted by dental amalgam restorations and inhaled by pregnant women. Both the organic and vapor forms of mercury are then transmitted to the fetus. Chewing is known to produce vapor, which is then inhaled by the mother and carried to the fetus. Information about the joint effects of these two mercury species is scant, but, on the basis of mechanistic considerations and sketchy animal data, warrants careful consideration. Berlin (62) argues forcefully that inorganic mercury could pose a threat to fetal brain development. He notes, based on in vitro experiments, that toxic effects are discernible at concentrations of 1–10 ng/g in tissue, which lie in the range measured in infants and fetuses from amalgam-bearing mothers. Further, he argues, anatomical and behavioral disorders are seen in rats and in monkeys exposed developmentally at fetal brain concentrations of 10–200 ng/g, which fall below the concentrations seen to produce such effects with methylmercury. In addition, he points to epidemiological studies indicating that occupational exposure to mercury vapor is associated with elevated risks of mental retardation and infants labelled as small for gestational age.
12
Weiss
Inorganic mercury levels in fetal tissue are significantly correlated with the number of maternal amalgam surfaces (63). And Bjornberg et al. (64) report that inorganic Hg in cord blood increased significantly with increasing number of maternal dental amalgam fillings. Not only are billions of individuals world-wide exposed to the emission of mercury vapor from amalgam restorations, but some pregnant women suffer an increase in dental problems such as caries and gingivitis, and become candidates for dental restorations (65). In some communities, dental care, including restorations, is promoted as part of prenatal care. Like methylmercury, inhaled mercury vapor is transported from mother to fetus, across the placenta, in much the same manner in which it crosses from the blood into the brain (66,67). Furthermore, we also know that maternal vapor exposure in humans is correlated with mercury blood levels in the fetus (68). Ionic mercury neither enters the brain nor penetrates the fetus. One source of concern about coexposure arises from morphological findings in primates exposed to inhaled mercury vapor (summarized in 69). Prenatal exposure resulted in brain growth retardation, sulcal abnormalities and increases in the number of heterotopic neurons in the cerebrum. In particular, the subpially localized heterotopic neurons with their disoriented apical dendrites indicated arrested cell migration. Similar changes of subpially localized cells have been noted in humans after exposure to methylmercury (17). Consequently, both empirical and mechanistic reasons suggest that combined exposure to methylmercury and inhaled mercury vapor might together produce effects more severe than those seen from exposure to either agent alone. These are based on the following considerations: (1) both agents produce prenatal damage, (2) both produce behavioral changes in animals at levels that are not overtly toxic, (3) arrested neuronal migration is detectable after both agents, and (4) both agents result in the release in the brain of the same toxic species of mercury, namely, mercuric mercury. Further, as with methylmercury, infants and children seem significantly more vulnerable than adults to mercury vapor toxicity. The syndrome of acrodynia (“painful limbs”), also known as “Pink Disease” because of the erythema and prolonged episodes of irritability and crying, began to make its appearance in medical journals early in this century (70). Its etiology was ascribed mainly to infectious diseases. Only in 1947 was it discovered to be a manifestation of mercury toxicity, when Warkany and Hubbard (71), at the University of Cincinnati, detected high levels of mercury in the urine of children with Pink Disease. The sources consisted of teething powders, which contained calomel (mercurous chloride), and some anti-helminthics. When calomel was withdrawn from teething powders in England, Pink Disease reports fell sharply except for instances probably arising from other exposure sources. Although inorganic mercury compounds were responsible for the early outbreaks, almost all of the contemporary reports of Pink Disease in the medical literature point to mercury vapor as the exposure source (72). Despite the fact that inhaled mercury vapor distributes to the fetal brain in humans (63) and monkeys (73), no investigations of subclinical developmental changes in children, like those conducted for in utero exposure to lead and methylmercury (74), have been published. A study of pregnant women in Sweden (75) found that 28% of the mercury in blood during early pregnancy proved to be inorganic while the rest was comprised of methylmercury. The inorganic component was mostly contributed by dental amalgams. And, as noted earlier, Bjornberg et al. (64), also showed a close relationship between number of maternal amalgams and inorganic mercury in cord blood, but a lower proportion of total mercury, perhaps because of changes in dental care. These values
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
13
should be viewed against the figures derived from the 1999–2000 NHANES survey, which indicated that about 8% of women had blood mercury concentrations higher than the U.S. EPA recommended RfD of 5.8 mg/L (76), which assumes that almost all the mercury in blood is contributed by the methyl form. In a more recent assessment, Mahaffey et al. (32), also based on the 1999–2000 NHANES survey, used measures of both total and inorganic mercury in blood to calculate the organic (methyl) component. They noted that, as the organic proportion rose with an increasing number of fish meals, the inorganic proportion dwindled, but that is to be expected if the vapor exposure remains fairly constant. This argument is not a valid dismissal of the potential contribution of mercury vapor to mercury-associated developmental neurotoxicity. In fact, it could be argued that, as organic mercury intake increases, the potential neurotoxicity of the vapor component becomes increasingly important. In fact, if animal data provide any guidance, the combined exposure may even be synergistic (77). One complication arising from these possibilities is that measures of cord blood mercury often measure only total mercury (27,30,78). Although total mercury is closely related to dietary intake of methylmercury, it is conceivable that the inorganic component may itself be correlated with later neuropsychological measures. Hair levels of mercury do not reflect vapor exposure, so that for most purposes it may be the preferred index. Speciation is also crucial for measuring transfer of mercury to the infant from breast milk. Oskarsson et al. (79) measured mercury concentrations in breast milk, blood, and hair samples, collected six weeks after delivery, from 30 Swedish women. Milk samples showed an average of 51% of total mercury in the form of inorganic mercury. In blood, similar to the findings of Vahter et al. (75), an average of only 26% was present in the inorganic form. Both total and inorganic mercury concentrations in blood and milk were significantly correlated with the number of amalgam restorations. Estimated methylmercury intake from fish and concentrations in breast milk were not related. The potential confounding of different mercury species both in the measurement of endpoints and in biomarker assays warrants precautions such as measuring mercury in maternal and infant urine; urinary mercury provides an index of vapor exposure and is correlated with the number of amalgam restorations.
DELAYED TOXICITY Latent, or delayed, toxicity appies to the phenomenon in which detectable expressions of adverse effects are displaced in time from an acute exposure or after exposure has ceased (80). It represents the core issue, not just for methylmercury, but for all neurodevelopmental toxicants. Cognitive difficulties, retarded language acquisition, and attention deficit disorders, for example, are identified only at a stage of maturation when the organism is expected to be functioning appropriately for that stage. The main challenge for developmental neurotoxicology is how to connect such manifestations to exposures occurring earlier in life. One impediment to securing such an anchor is the documented but rather limited plasticity of the developing brain. The prevailing doctrine used to be that young brains can recover even from the type of severe damage that disables adult brains. One source of this belief was the experiments of Margaret Kennard, who, in the 1930s and 1940s, compared the effects of brain lesions in infant monkeys with presumably similar lesions in adult monkeys and found far less functional disturbance in the infants than in the adults.
14
Weiss
Examined more carefully, however, the doctrine lacked sound support. Kennard, in fact, later reported that deficits in motor function not observed during infancy began to emerge as the lesioned monkeys matured (81). Similar findings were reported after pyramidal tract lesions. In rat studies, aberrant social behaviors in rats subjected to amygdala lesions during infancy appeared only when they reached puberty. The classical experiments of Goldman (82) provided compelling evidence for the phenomenon that has been called, “growing into” the lesion. Monkeys subjected to removal of dorsolateral cortex when infants did not differ from controls on a delayed alternation task at 15 months of age. At 2 years of age, the lesioned monkeys committed significantly more errors than the control monkeys even though they had practiced the task 9 mo earlier. One way to account for such observations is to presume that the behavioral deficits appear only at the time when the damaged region would typically begin to subserve the function being tested. Another way to interpret the phenomenon is to view it as the structure becoming “committed” to a specific range of functions as the organism matures. Prenatal exposure to relatively modest MeHg concentrations (e.g., !10 ppm in maternal hair) may influence only those higher order cognitive functions that develop with maturity. As a result, deficits may not begin to appear until the brain has developed to a stage at which it has “grown into” the lesions caused by earlier exposure. Johnson and Almli (83) describe the phenomenon as follows: “One of the most perplexing results found when brain damage is sustained during infancy is that many behavioral deficits do not become manifest until after considerable time has elapsed.Goldman.has suggested that delayed effects following brain damage sustained at an early age may be related to the degree of functional maturity of the brain region-behavior relationship under study.With maturation, as that brain region would normally become committed to the behavior in question, deficits in behavior of the brain-damaged animal become manifest.” The temporal patterning sequence seen by Gogtay et al. (84) in their MRI mapping study of cortical development reveals that higher-order association cortices mature only after lower-order somatosensory and visual cortices, the functions of which they integrate, are developed. Changes are taking place even into the late teens, so that earlier damage might not emerge, if the “growing into the lesion” phenomenon holds in this instance, until that stage and with tests based on complex cognitive function. The experimental data are supported by observations in humans. Lenneberg (85), on the basis of his experience with brain-injured children offered the following comment: “One may say that the child with a perinatal cerebral injury only gradually ‘grows into his symptoms,’ and that both lesions and symptoms have their own ramified consequences, often affecting distant structures years after the primary injury.” These venerable lesion studies are reviewed here to illustrate the principle that the brain is a dynamic entity and that it changes through the lifespan in often dramatic ways that are reflected in behavior. This principle needs to guide why the conclusions we have reached on the basis of our current information about methylmercury should also remain in a dynamic state, so to speak. Our appreciation of how the consequences of exposure may vary through the lifespan remains fairly primitive. Two animal studies are illuminating examples of this principle. Spyker (15) administered 4 or 8 mg/kg methylmercury to pregnant mice on gestational day 7, 9, or 12. She then maintained them for a lifetime. Most of the offspring displayed no overt signs of toxicity at weaning. At about 30 days of age, the treated offspring showed deviant behavior in open-field testing and in swimming behavior. As they matured, and especially as they approached senescence, they began to exhibit a multitude of disabilities: obesity,
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
15
kyphosis, muscular atrophy, difficulty in righting themselves, and an assortment of less obvious behavioral deficits. They also died sooner than control mice. Two studies in rats, Newland and Rasmussen (86) and Newland et al. (87), also demonstrated interactions with aging following developmental exposure to methylmercury. As they aged, the treated subjects began to display deviations from control performance on complex behavioral tasks. These were not grossly aberrant performances; the deficits occurred earlier during senescence (86), or were expressed as slower acquisition (87). Evidence from nonhuman primates also indicates that effects of low exposures to MeHg during postnatal development may not emerge until later in life. Such delayed neurotoxicity, appearing years after cessation of exposure, was suggested in reports from Minamata, and the publications cited above provide further evidence for such a phenomenon. These primate studies provide even more impressive evidence for delayed toxicity. In one study, Rice (88) exposed one group of monkeys to methylmercury beginning during gestation and continuing until 4 years of age). In tests of auditory function conducted at 11 and 19 years of age, the monkeys exhibited deficits in pure-tone thresholds, especially at the later age. Another group of monkeys received low daily doses of methylmercury from birth to 7 years of age. After a six-years hiatus, at 13 years of age, they began to display mild signs of somatosensory dysfunction in their home cages (40) consisting mainly of impaired dexterity and clumsiness in handling items of food. These observations were validated by tests of vibration sensitivity (89). The monkeys dosed during gestation and until 4 years of age also showed somatosensory deficits (90). Figure 3 depicts the situation graphically and compares it to the Minamata outbreak. There, latency periods as long as 15 years have been reported and described as “Minamata disease of late onset” (91).
Delayed onset in primates* start dosing
end dosing
onset effects
50µgHg /kg /day
0
3
6 9 years of age
12
15
Late onset of Minamata cases** End of acute Minamata outbreak
‘60
‘63
Reports of “new cases”
66 69 1960 - 1975
‘72
‘75
Figure 3 The late onset of methylmercury poisoning in nonhuman primates and in humans after exposure to methylmercury in Minamata.*Based on Rice (1996) in primates and **Igata (1991) in humans.
16
Weiss
These primate experiments, although revealing sensory and motor deficits resulting from developmental exposures, failed to demonstrate the kind of cognitive performance deficits assayed by certain forms of schedule-controlled operant behavior (92,93). Newland et al. (94), relying on another form of operant behavior, did demonstrate deficits associated with prenatal exposure. In this situation, the exposed animals showed retarded adaptation to shifts in reinforcement contingencies. Different monkey species as well as different dosing schedules may underlie the different findings.
POSTNATAL EXPOSURES IN HUMANS The primary question addressed by human developmental studies up to now is whether prenatal exposure to methylmercury is associated with adverse effects on behavioral function during childhood. The long-term impact of postnatal dietary exposure has largely been overlooked. Exposure doesn’t cease at birth, however. In populations in which fish comprises a significant part of the diet, it is consumed over a lifetime. We remain largely ignorant of the joint contribution to neurobehavioral outcomes of prenatal and postnatal exposure. The two largest epidemiological studies, one in the Faroe Islands (34), the other in the Seychelles (33), have provided data on pre-adolescent ages. A recent reanalysis of the Seychelles data (95) suggests the possibility that postnatal exposure may incur subtle adverse effects that only become apparent as children approach adolescence. Nonlinear multiple regression analyses of scores on the Child Behavior Checklist at 107 months of age showed a significant adverse association, on the Thought Problems subscale, with contemporary hair levels of methylmercury. Figure 4 shows a partial residual plot for depicting the association (pZ0.002). No effects are seen below approximately 8 ppm, but there is an increasing trend (adverse effect) above that level. Thought Problems
Smoothed Postnatal MeHg
0.4 0.3 0.2 0.1 0.0
0
5
10 15 Postnatal MeHg
20
25
Figure 4 Plot showing the relationship between scores on the Thought Problems subscale of the Child Behavior Checklist and postnatal methylmercury exposure as measured by hair levels at 107 months of age. The analysis was based on the application of semiparametric additive models. Above about 10 ppm the data points are fewer and the confidence intervals widen. The rug plot (vertical marks) along the bottom illustrates the distribution of postnatal exposure in this cohort. Source: From Ref. 95.
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
17
These results, indicating effects of postnatal exposure, to some extent parallel those of Murata et al. (96) with the Faroe Islands cohort on brainstem auditory evoked responses at 14 years of age. When tested at age 7 years, (34,97), the cohort exhibited delayed latencies associated with elevated prenatal exposures based on cord blood. The newer data, based on age 14 years, showed increased delays associated, as well, with current exposures as measured by the children’s hair levels of mercury. Subtle adverse consequences emerging during later childhood and adolescence, as also seen in experimental animals, should come as no surprise. Adolescence, like the perinatal period, is a tumultuous stage of development during which profound changes are occurring in brain function (84). Adams and colleagues (98) noted that “in addition to the dramatic neuroendocrinological and physical changes associated with adolescence.it is clear that the brain of the adolescent also undergoes striking transformations.Several brain regions undergo prominent remodeling.These regions include the prefrontal cortex.These data suggest that the adolescent period of brain development should be a time of particular vulnerability to insult.However, there has been surprisingly little investigation in either humans or animals of the vulnerability of the adolescent brain to developmental perturbation. Moreover, adverse impacts on neurocognitive and behavioral functions during such periods are likely to have protracted consequences for latter success.” This question deserves to be urgently pursued in methylmercury research. These recent data are especially relevant because, in fish-consuming populations, prenatal and postnatal exposures are entwined. However, prenatal and postnatal exposures seem to result in different patterns of brain damage, and, as a result, tend to produce different phenotypes. Prenatal exposure disrupts cell migration and differentiation throughout the developing brain in mice (19) and in humans (20). Such extensive damage would be expected to induce widespread impairment manifested as deficits in cognitive function, sensory function, motor function, information processing and language, memory, attention, and social communication. The syndrome of what Japanese investigators labeled Congenital Minamata Disease, which was marked overtly by neurological signs, included such global effects. In contrast, postnatal exposure, at least in adults, appears to be predominantly focal with most damage centered in areas deep in the sulci such as the calcarine fissure and the folds of the cerebellum in both nonhuman primates (99) and humans (9). It is this pattern of damage that accounts for the signs and symptoms associated with methylmercury poisoning (Table 1) before the sensitivity of the developing brain was appreciated. Aging The emphasis on early development has tended to obscure a larger issue: the consequences of lifetime exposure. The overwhelmingly predominant source of methylmercury is fish and other aquatic species. Fish consumption takes place through a lifetime and, during advanced age, the brain, as seen in animal studies, may begin to reflect the consequences of cumulative exposure. In fact, in its investigation of the catastrophe at Minamata, Japan, the Kumamoto University committee made the following statement (100): “.the problem about the relationship between a small amount of methylmercury pollution for a long period and its accumulation in the brain still remains obscure.Subclinical Minamata disease was sometimes revealed by detectable symptoms during the aging process.The subclinical Minamata disease.could be called a delayed type of Minamata disease in aged people.” A more quantitative assessment of this finding can be found in Kinjo et al. (101). They compared over one thousand Minamata disease patients aged 40 or over with
18
Weiss
controls matched by age and sex. A questionnaire interview surveyed subjective complaints and activities of daily living (ADL). The patients had significantly higher rates of all complaints than the controls, particularly in the categories of sensory disturbances such as paresthesias and motor difficulties such as tremor and weakness. Differences between patients and controls increased with age, and ADL disability in MD patients was aggravated by aging. The observations in Minamata emphasize how crucial it is, to more fully understand the risks stemming from developmental exposures, to study outcomes not only during the relatively early phases of the life cycle, but throughout the lifetime (87,102). The risks are ambiguous because early, low-level exposures may produce undetected, latent (103), or “silent” damage (104,105) that will be manifested only when functional capacities are challenged by other conditions, such as aging (106,107), drugs (108,109), or complex behavioral situations (86,87). The effects ascribed to aging underscore the principle that neurotoxicity may be manifested differently at different stages of the life cycle (88,92). Certainly, older humans handle drugs and toxicants differently from younger adults who handle them differently from children and neonates. Furthermore, the age question deserves a greater emphasis than it has received in the past. It is important to ask how such exposures might affect “aging” processes themselves (110). The pioneering experiments of Spyker (15) and Spyker et al. (111), the primate studies of Rice (90,92), and the aging models offered by Weiss and Simon (107) and Weiss et al. (106) show how these issues become closely intertwined when addressing the long-term consequences of exposures to toxic agents during early development.
UNRESOLVED ISSUES Despite the flood of research unleashed by the disasters in Minamata and Iraq, perplexing questions about the risks to neurobehavioral development posed by methylmercury persist. One stimulus for such questions is the source of exposure. Fish is an essential part of the diet for many populations, so exposure is inescapable. Even in populations where other protein sources are readily available, such as ours, fish remains an important food. Whatever risks are associated with fish consumption need to be weighed against its nutritional properties, some of which were discussed earlier. Moreover, methylmercury is hardly the only contaminant to be considered in evaluating the potential risks of fish consumption. Our grasp of how such risks combine is relatively primitive (56). Second, we must recognize that the selection of endpoints for assessing methylmercury neurotoxicity reveals incompatabilities between epidemiological and laboratory research. The human studies, in part because of their reliance on standardized tests—perhaps inescapably—have featured cognitive function. Animal studies indicate deficits in motor and sensory function to be the clearest outcomes of exposure, in parallel with poisonings in adult humans. The appropriate endpoints need to be pursued more intensively in developmentally-exposed humans. Finally, the issue that has been least adequately addressed is how to formulate risks based on lifetime exposure. We are especially deficient in our understanding of the combined effects of prenatal and postnatal exposure. Development is a continuous process, although sometimes treated as though it is separated into a series of individual journeys. Delayed or latent effects, and the contribution of aging, with its accompanying decline in compensatory processes, have not been incorporated into the risk equation.
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
19
REFERENCES 1. Hunter D. The Diseases of Occupations. Boston: Little, Brown, 1969. 2. Weiss B. Perspectives on methylmercury as a global health hazard. Neurotoxicology 1995; 16:577–578. 3. Miller MW, Berg GG, eds. Chemical Fallout. Springfield, IL: CC Thomas, 1969. 4. Jensen S, Jernelov A. Biological methylation of mercury in aquatic organisms. Nature 1969; 223:753–754. 5. Carson R. Silent Spring. Boston: Houghton Mifflin, 1962. 6. Bakir F, Damluji SF, Amin-Zaki L, et al. Methylmercury poisoning in Iraq. Science 1973; 181:230–241. 7. Smith WE, Smith AM. Minamata. Austin, TX: Rinehart and Winston, 1975. 8. Eto K, Yasutake A, Nakano A, Akagi H, Tokunaga H, Kojima T. Reappraisal of the historic 1959 cat experiment in Minamata by the Chisso Factory. Tohoku J Exp Med 2001; 194:197–203. 9. Eto K. Minamata disease. Neuropathology 2000; 20:S14–S19. 10. Harada Y. Congenital Minamata disease. In: Tsubaki R, Irukayama K, eds. Minamata disease: Methyl mercury poisoning in Minamata and Niigata. Tokyo, Japan: Kodansha, 1977:209–239. 11. Saito H, Sekikawa T, Taguchi J, et al. Prenatal and postnatal methyl mercury exposure in Niigata, Japan: adult outcomes. Seychelles Med Dent J 2004; 7:138–146. 12. Myers GJ, Davidson PW, Cox C, Shamlaye C, Cernichiari E, Clarkson TW. Twenty-seven years studying the human neurotoxicity of methylmercury exposure. Environ Res 2000; 83:275–285. 13. Cox C, Clarkson TW, Marsh DO, Amin-Zaki L, Tikriti S, Myers GG. Dose-response analysis of infants prenatally exposed to methyl mercury: an application of a single compartment model to single-strand hair analysis. Environ Res 1989; 49:318–332. 14. Davidson PW, Myers GJ, Weiss B. Mercury exposure and child development outcomes. Pediatrics 2004; 113:1023–1029. 15. Spyker JM. Behavioral teratology and toxicology. In: Weiss B, Laties VG, eds. Behavioral Toxicology. New York: Plenum Press, 1975:311–349. 16. Watanabe C, Satoh H. Evolution of our understanding of methylmercury as a health threat. Environ Health Perspect 1996; 104:367–379. 17. Choi BH, Lapham LW, Amin-Zaki L, Saleem T. Abnormal neuronal migration, deranged cerebral cortical organization. and diffuse white matter astrocytosis of fetal human brain: a major effect of methylmercury poisoning in utero. J Neuropathol Exp Neurol 1978; 37:719–733. 18. Sager PR, Aschner M, Rodier PM. Persistent, differential alterations in developing cerebellar cortex of male and female mice after methylmercury exposure. Brain Res 1984; 314:1–11. 19. Rodier PM, Aschner M, Sager PR. Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. Neurobehav Toxicol Teratol 1984; 6:379–385. 20. Choi BH. The effects of methylmercury on the developing brain. Prog Neurobiol 1989; 32:447–470. 21. Cordier S, Garel M, Mandereau L, Morcel H, Doineau P, Gosme-Seguret S, et al. Neurodevelopmental investigations among methylmercury-exposed children in French Guiana. Environ Res 2002; 89:1–11. 22. Dolbec J, Mergler D, Passos CJS, de Morais SS, Lebel J. Methylmercury exposure affects motor performance of a riverine population of the Tapajos river, Brazilian Amazon. Int Arch Occup Environ Health 2000; 73:195–203. 23. Kjellstrom T, Kennedy P, Wallis S, Mantell C. Physical and mental development of children with prenatal exposure to mercury from fish. Stage 1. Preliminary tests at age 4. Solna, Sweden: National Swedish Environmental Board Report No. 3080, 1986.
20
Weiss
24. Kjellstrom T, Kennedy P, Wallis S, et al. Physical and mental development of children with prenatal exposure to mercury from fish. Stage 2. Interviews and psychological tests at age 6.Solna, Sweden: National Swedish Environmental Board Report No. 3642, 1989. 25. Lebel J, Mergler D, Branches F, et al. Neurotoxic effects of low-level methylmercury contamination in the Amazonian Basin. Environ Res 1998; 79:20–32. 26. McKeown-Eyssen GE, Ruedy J, Neims A. Methyl mercury exposure in northern Quebec. II. Neurologic findings in children. Am J Epidemiol 1983; 118:470–479. 27. Ramirez GB, Pagulayan O, Akagi H, et al. Tagum study II: Follow-up study at two years of age after prenatal exposure to mercury. Pediatrics 2003; 111:e289–e295. 28. McDowell MA, Dillon CF, Osterloh J, et al. Hair mercury levels in U.S. children and women of childbearing age: reference range data from NHANES 1999–2000. Environ Health Perspect 2004; 112:1165–1171. 29. Rice DC. The US EPA reference dose for methylmercury: sources of uncertainty. Environ Res 2004; 95:406–413. 30. Stern AH, Smith AE. An assessment of the cord blood:maternal blood methylmercury ratio: implications for risk assessment. Environ Health Perspect 2003; 111:1465–1670. 31. Cernichiari E, Brewer R, Myers GJ, et al. Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology 1995; 16:705–710. 32. Mahaffey KR, Clickner RP, Bodurow CC. Blood organic mercury and dietary mercury intake: national health and nutrition examination survey, 1999 and 2000. Environ Health Perspect 2004; 112:562–570. 33. Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003; 361:1686–1692. 34. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-years-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19:417–428. 35. National Research Council. Committee on the Toxicological Effects of Methylmercury. Toxicological Effects of Methylmercury. Washington, DC: National Academy Press, 2000. 36. Crump KS, Van Landingham C, Shamlaye C, et al. Benchmark concentrations for methylmercury obtained from the Seychelles Child Development Study. Environ Health Perspect 2000; 108:257–263. 37. U.S. EPA. Mercury Report to Congress, Volume VI: Characterization of Human Health and Wildlife Risks from Anthropogenic Mercury Emissions in the United States. EPA452/R-97-001f. Washington, DC:U.S. Environmental Protection Agency, 1997. 38. Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, Burbacher T. Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury. Toxicol Appl Pharmacol 1994; 124:221–229. 39. Evans HL, Garman RH, Weiss B. Methylmercury: exposure duration and regional distribution as determinants of neurtoxicity in nonhuman primates. Toxicol Appl Pharmacol 1977; 41:15–33. 40. Rice DC. Brain and tissue levels of mercury after chronic methylmercury exposure in the monkey. Toxicol Environ Health 1989; 27:189–198. 41. Stinson CH, Shen DM, Burbacher TM, Mohamed MK, Mottet NK. Kinetics of methyl mercury in blood and brain during chronic exposure in the monkey Macaca fascicularis. Pharmacol Toxicol 1989; 65:223–230. 42. Lapham LW, Cernichiari E, Cox C, et al. An analysis of autopsy brain tissue from infants prenatally exposed to methymercury. Neurotoxicology 1995; 16:689–704. 43. Burbacher TM, Rodier PM, Weiss B. Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. Neurotoxicol Teratol 1990; 2:191–202. 44. Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Ann Rev Pharmacol Toxicol 2003; 43:175–197. 45. Davidson PW, Myers GJ, Cox C, et al. Effects of prenatal and postnatal methylmercury exposure from fish consumption on neurodevelopment: outcomes at 66 months of age in the Seychelles Child Development Study. JAMA 1998; 280:701–707.
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
21
46. Hurley LS. The roles of trace elements in foetal and neonatal development. Philos Trans R Soc Lond B Biol Sci 1981; 294:145–152. 47. Tran TT, Chowanadisai W, Crinella FM, Chicz-DeMet A, Lonnerdal B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 2002; 23:635–643. 48. Zeisel SH. Choline: needed for normal development of memory. J Am Coll Nutr 2000; 19:528S–531S. 49. Meck WH, Williams CL. Simultaneous temporal processing is sensitive to prenatal choline availability in mature and aged rats. Neuroreport 1997; 8:3045–3051. 50. Richardson AJ. Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum. Prostaglandins Leukot Essent Fatty Acids 2004; 70:383–390. 51. Weiss B, Amler S, Amler RW. Pesticides. Pediatrics 2004; 113:1030–1036. 52. Hites RA, Foran JA, Carpenter DO, Hamilton MC, Knuth BA, Schwager SJ. Global assessment of organic contaminants in farmed salmon. Science 2004; 303:226–229. 53. Broadhurst CL, Wang Y, Crawford MA, Cunnane SC, Parkington JE, Schmidt WF. Brainspecific lipids from marine, lacustrine, or terrestrial food resources: potential impact on early African Homo sapiens. Comp Biochem Physiol B Biochem Mol Biol 2002; 131:653–673. 54. Fangstrom B, Athanasiadou M, Grandjean P, Weihe P, Bergman A. Hydroxylated PCB metabolites and PCBs in serum from pregnant Faroese women. Environ Health Perspect 2002; 110:895–899. 55. Grandjean P, Weihe P, Burse VW, et al. Neurobehavioral deficits associated with PCB in 7-years-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol 2001; 23:305–317. 56. Newland MC. Neurobehavioral toxicity of methylmercury and PCBs: Effects-profile and sensitive populations. Environ Toxicol Pharmacol 2002; 12:119–128. 57. Stewart PW, Reihman J, Lonky EI, Darvill TJ, Pagano J. Cognitive development in preschool children prenatally exposed to PCBs and MeHg. Neurotoxicol Teratol 2003; 25:11–22. 58. Grandjean P, Budtz-Jorgensen E, Steuerwald U, et al. Attenuated growth of breast-fed children exposed to increased concentrations of methylmercury and polychlorinated biphenyls. FASEB J 2003; 17:699–701. 59. Bellinger DC. Effect modification in epidemiologic studies of low-level neurotoxicant exposures and health outcomes. Neurotoxicol Teratol 2000; 22:133–140. 60. Riley DM, Newby CA, Leal-Almeraz TO, Thomas VM. Assessing elemental mercury vapor exposure from cultural and religious practices. Environ Health Perspect 2001; 109:779–784. 61. U.S. Centers for Disease Control. Mercury poisoning associated with beauty cream–Texas, New Mexico, and California, 1995–1996. Morbidity Mortality Weekly 1996; 45:400–403. 62. Berlin M. Mercury in dental amalgam: a risk analysis. Seychelles Med Dent J 2004; 7:154–158. 63. Drasch G, Schupp I, Hofl H, Reinke R, Roider G. Mercury burden of human fetal and infant tissues. Eur J Pediat 1994; 153:607–610. 64. Bjornberg KA, Vahter M, Petersson-Grawe K, et al. Methyl mercury and inorganic mercury in Swedish pregnant women and in cord blood: influence of fish consumption. Environ Health Perspect 2003; 111:637–641. 65. Salvolini E, Di Giorgio R, Curatola A, Mazzanti L, Fratto G. Biochemical modifications of human whole saliva induced by pregnancy. Br J Obstet Gynaecol 1998; 105:656–660. 66. Clarkson TW. The pharmacology of mercury compounds. Ann Rev Pharmacol 1972; 12:375–406. 67. Clarkson TW, Friberg L, Hursh JB, Nylander M. The prediction of mercury intake from amalgams. In: Clarkson TW, Friberg L, Nordberg FG, Sager PR, eds. Biological Monitoring of Toxic Meals. New York: Plenum Press, 1988:246–260. 68. Clarkson TW. The three modern faces of mercury. Environ Health Perspect 2002; 110:11–23. 69. Goering PL, Galloway WD, Clarkson TW, Lorscheider FL, Berlin M, Rowland AS. Toxicity assessment of mercury vapor from dental amalgams. Fundam Appl Toxicol 1992; 19:319–329.
22
Weiss
70. Weiss B, Clarkson TW. Mercury toxicity in children. In: Chemical and Radiation Hazards to Children. Ross Pediatric Conferences, 1982:52–58. 71. Warkany J, Hubbard DM. Adverse mercurial reactions in the form of acrodynia and related conditions. Am J Dis Child 1951; 81:335–373. 72. Curtis HA, Ferguson SD, Kell RL, Samuel AH. Mercury as a health hazard. Arch Dis Child 1987; 62:293–295. 73. Warfvinge K. Mercury distribution in the neonatal and adult cerebellum after mercury vapor exposure of pregnant squirrel monkeys. Environ Res 2000; 83:93–101. 74. World Heath Organization. Environmental Health Criteria 101, Methylmercury. Geneva, Switzerland: World Health Organization, 1990. 75. Vahter M, Akesson A, Lind B, Bjors U, Schutz A, Berglund M. Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood. Environ Res 2000; 84:186–194. 76. Schober SE, Sinks TH, Jones RL, et al. Blood mercury levels in US children and women of childbearing age, 1999–2000. JAMA 2003; 289:1667–1674. 77. Fredriksson A, Dencker L, Archer T, Danielsson BR. Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats. Neurotoxicol Teratol 1996; 18:129–134. 78. Bilrha H, Roy R, Moreau B, Belles-Isles M, Dewailly E, Ayotte P. In vitro activation of cord blood mononuclear cells and cytokine production in a remote coastal population exposed to organochlorines and methylmercury. Environ Health Perspect 2003; 111:1952–1957. 79. Oskarsson A, Schultz A, Skerfving S, Hallen IP, Ohlin B, Lagerkvist BJ. Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women. Arch Environ Health 1996; 51:234–241. 80. Weiss B, Reuhl K. Delayed neurotoxicity: a silent toxicity. In: Chang LW, ed. Principles of Neurotoxicology. New York: Marcel Dekker, 1994:765–784. 81. Kennard MA. Cortical reorganization of motor function. Studies on series of monkeys of various ages from infancy to maturity. Arch Neurol Psychiat 1942; 48:227–240. 82. Goldman PS. An alternative to deelopmental plasticity: heterology of CNS structures in infants and and adults. In: Stein DG, Rosen JJ, Butters N, eds. Plasticity and Recovery of Function in the Central Nervous System. New York: Academic Press, 1974:149–174. 83. Johnson D, Almli CR. Age, brain damage, and performance. In: Finger S, ed. Recovery from brain damage. Research and theory. New York: Plenum Press, 1978:115–134. 84. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 2004; 10121:8174–8179. 85. Lenneberg EH. The effect of age on the outcome of cortical nervous system disease in children. In: Isaacson RI, ed. The Neuropsychology of Development. New York: Wiley, 1968. 86. Newland MC, Rasmussen EB. Aging unmasks adverse effects of gestational exposure to methylmercury in rats. Neurotoxicol Teratol 2000; 22:819–828. 87. Newland MC, Reile PA, Langston JL. Gestational exposure to methylmercury retards choice in transition in aging rats. Neurotoxicol Teratol 2004; 26:179–194. 88. Rice DC. Age-related increase in auditory impairment in monkeys exposed in utero plus postnatally to methylmercury. Toxicol Sci 1998; 44:191–196. 89. Rice DC, Gilbert SG. Effects of developmental methylmercury exposure or lifetime lead exposure on vibration sensitivity function in monkeys. Toxicol Appl Pharmacol 1995; 134:161–169. 90. Rice DC. Evidence for delayed neurotoxicity produced by methylmercury. Neurotoxicology 1996; 17:583–596. 91. Igata A. Epidemiological and clinical features of Minamata Disease. In: Suzuki T, Imura N, Clarkson TW, eds. Advances in Mercury Toxicology. New York: Plenum Press, 1991:439–457. 92. Rice DC. Effects of pre- plus postnatal exposure to methylmercury in the monkey on fixed interval and discrimination reversal performance. Neurotoxicology 1992; 13:443–452.
Methylmercury: A Model Neurotoxicant and Risk Assessment Dilemma
23
93. Gilbert SG, Burbacher TM, Rice DC. Effects of in utero methylmercury exposure on a spatial delayed alternation task in monkeys. Toxicol Appl Pharmacol 1993; 123:130–136. 94. Newland MC, Yezhou S, Logdberg B, Berlin M. Prolonged behavioral effects of in utero exposure to lead or methyl mercury–reduced sensitivity to changes in reinforcement contingencies during behavioral transitions and in steady state. Tox Appl Pharmacol 1994; 126:6–15. 95. Myers GJ, Davidson PW, Shamlaye CF, et al. The Seychelles Child Development Study of methylmercury from fish consumption: analysis of subscales from the Child Behavior Checklist at age 107 months in the main cohort. Seychelles Med Dent J 2004; 7:107–114. 96. Murata K, Weihe P, Budtz-Jorgensen E, Jorgensen PJ, Grandjean P. Delayed brainstem auditory evoked potential latencies in 14-years-old children exposed to methylmercury. J Pediatr 2004; 144:177–183. 97. Murata K, Weihe P, Renzoni A, et al. Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol 1999; 21:343–348. 98. Adams J, Barone S, Jr., LaMantia A, et al. Workshop to identify critical windows of exposure for children’s health: neurobehavioral work group summary. Environ Health Perspect 2000; 108:535–544. 99. Garman RH, Weiss B, Evans HL. Alkylmercurial encephalopathy in the monkey (Saimiri sciureus and Macaca arctoides): a histopathologic and autoradiographic study. Acta Neuropathologica 1975; 32:61–74. 100. Research Committee on Minamata Disease. Kumanoto, Japan: Kumamoto University, 1973. 101. Kinjo Y, Higashi H, Nakano A, Sakamoto M, Sakai R. Profile of subjective complaints and activities of daily living among current patients with Minamata disease after 3 decades. Environ Res 1993; 63:241–251. 102. Berlin CM, Kacew S. Environmental chemicals in human milk. In: Kacew S, Lambert GH, eds. Environmental Toxicology and Pharmacology of Human Development. Washington, DC: Taylor & Francis, 1997:67–93. 103. Isaacson RL. The myth of recovery from early brain damage. In: Ellis NR, ed. Aberrant Development in Infancy: Human and Animal Studies. Hillsdale, NJ: Erlbaum, 1975:1–25. 104. Grant CA. Pathology of experimental methylmercury intoxication: Some problems of exposure and response. In: Miller MW, Clarkson TW, eds. Mercury, Mercurials, and Mercaptans. Springfield, IL: Charles C. Thomas, 1973:294–312. 105. Reuhl KR, Chang LW. Effects of methylmercury on the development of the nervous system. Neurotoxicology 1979; 1:21–55. 106. Weiss B, Clarkson TW, Simon W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect 2002; 110:851–854. 107. Weiss B, Simon W. Quantitative Perspectives on the long-term toxicity of methylmercury and similar poisons. In: Weiss B, Laties VG, eds. Behavioral Toxicology. New York: Plenum, 1975:429–435. 108. Eccles CU, Annau Z. Prenatal methyl mercury exposure, II: Alterations in learning and psychotropic drug sensitivity in adult offspring. Neurobehav Toxicol Teratol 1982; 4:377–382. 109. Rasmussen EB, Newland MC. Developmental exposure to methylmercury alters behavioral sensitivity to D-amphetamine and pentobarbital in adult rats. Neurotoxicol Teratol 2001; 23:45–55. 110. Williams JR, Spencer PR, Stahl SM, et al. Interactions of aging and environmental agents: the toxicological perspective. In: Baker SR, Rogul M et al, eds. Environmental Toxicity and the Aging Processes. New York: Liss, 1987:81–135. 111. Spyker JM, Sparber SB, Goldberg AM. Subtle consequences of methylmercury exposure: behavioral deviations in offspring of treated mothers. Science 1972; 177:621–623.
2 Developmental Neurotoxicity Associated with Dietary Exposure to Methylmercury from Seafood and Freshwater Fish Philippe Grandjean Department of Environmental Medicine, University of Southern Denmark, Odense, Denmark and Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A.
Sylvaine Cordier National Institute for Health and Medical Research (INSERM), Rennes, France
Tord Kjellstro¨m National Institute of Public Health, Stockholm, Sweden and Australian National University, Canberra, Australian Capital Territory, Australia and Wellington School of Medicine and Health Sciences, Wellington, New Zealand
INTRODUCTION Methylmercury is a ubiquitous contaminant of seafood and freshwater fish (1). Human exposures to this toxicant have increased over time, due to anthropogenic mercury pollution, and because modern fishing technology allows catching large predatory species that accumulate methylmercury. Dramatic reminders of the neurotoxic potential of methylmercury occurred in the poisoning incidents in Minamata and Niigata, Japan, in the 1950s and 1960s and the subsequent contamination of bread in Iraq in 1971 from methylmercury-treated seed grains (1,2). Recent assessments of methylmercury neurotoxicity have been published by national and international bodies, e.g., the U.S. National Research Council (3), the U.S. Environmental Protection Agency (4), and the Joint FAO/WHO Expert Committee on Food Additives (5). While agreeing that the developing brain is the main target for methylmercury, the reports suggest that two of the largest prospective studies of developmental neurotoxicity have reached “different” conclusions. Indeed, one study seems to disagree with several others, but the neurotoxicology literature includes many examples of studies that are ‘non-positive’ without offering convincing evidence that neurotoxic effects were absent (6). 25
26
Grandjean et al.
Like other scientific inquiries, epidemiological studies will always render tentative knowledge, since no scientific process can provide absolute proof. However, the observational studies carried out so far to explore the low-level neurotoxicity of methylmercury offer strong evidence of the public health impact of exposures that are common in many populations that depend on marine food or freshwater fish. The present chapter will review the main issues in regard to the current risk assessment of methylmercury.
PROSPECTIVE STUDY DESIGNS AND SETTINGS In the absence of clinical controlled trials, prospective epidemiological studies provide evidence of the greatest importance. When choosing a setting, the researchers must try to maximize the statistical power and validity of the study by securing a wide exposure interval, a high participation rate, also at follow-up, feasibility of applying sensitive outcome measures, and limited impact of potential confounders. Three major prospective cohort studies on adverse effects of prenatal methylmercury exposure have been published, each conducted in a population with a high average intake of seafood. The first study was carried out in New Zealand. A group of 11,000 new mothers was initially screened by a questionnaire survey at the time their child was born in 1978; of these, about 1000 had consumed at least 3 fish meals per week during pregnancy. Their hair mercury levels were analyzed (7). Seventy-three mothers ‘one of whom had twins’, had hair mercury levels above 6 mg/g and were defined as the “high-exposure group”. High mercury exposure from seafood was mainly due to consumption of sharks, which in New Zealand usually contain methylmercury concentrations of 1–5 mg/g (7). At age 4 years, 31 highexposure children and 31 reference children with lower exposure were matched for potential confounders, i.e., mother’s ethnic group, age, child’s birthplace and birth date. The highexposure group showed lower scores on the Denver Developmental Screening test (7). A follow-up of the original cohort was carried out at age 6 years, now with three control groups with lower prenatal mercury exposure (8). During pregnancy, mothers in two of these control groups had high fish consumption and average hair mercury concentrations of 3–6 mg/g and 0–3 mg/g, respectively. Matching parameters were maternal ethnic group, age, smoking habits, residence, and sex of the child. At this time, 61 of 74 high exposure children were available for examinations (8). Lead levels in cord blood and garden soil were tested to assess potential confounding, but there was no association between lead and methylmercury exposure. Results of the psychological performance tests correlated well. Stepwise robust multiple regression analysis showed that the full (and performance) Wechsler Intelligence Scale for Children (WISC-R), the McCarthy Scales of Children’s Abilities (perceptual and motoric), and the Test of Oral Language Development were most strongly associated with the maternal hair mercury concentration (8). The proportion of the variance in test results due to hair mercury above 6 mg/g was about 2%, which was similar to the influence of social class and home language, two of the main confounders accounted for in the analysis. The robust regression analysis reduced the impact of one extreme outlier (with maternal hair-mercury above 80 mg/g). A reanalysis of the full database of this study (9) replicated the association between high maternal mercury exposure and reduced test performance, but the statistical significance was very much influenced by the extreme outlier. When this subject was excluded some tests became statistically significant. Later on, a study was initiated in the Faroe Islands in the North Atlantic (10). The first birth cohort consisted of 1,022 children born during a 21-month period in 1986–1987.
Methylmercury from Seafood and Freshwater Fish
27
The Faroes constitute a prosperous fishing community where excess exposure to methylmercury is widely prevalent because of the traditional habit of eating meat from the pilot whale. Ingestion of whale blubber causes exposure to lipophilic contaminants, notably polychlorinated biphenyls (PCBs). Assessment of prenatal methylmercury exposure was based on mercury concentrations in cord blood and in maternal hair; they spanned a range of about 1000-fold. Lead levels in cord blood were low. All cohort members were invited for the first detailed examination at school age (7 years), and a total of 917 of eligible children (90.3%) completed the examinations that lasted about 5 hours. The physical examination included a sensory function assessment and a functional neurological examination with emphasis on motor coordination and perceptual-motor performance. Main emphasis was placed on detailed neurophysiological and neuropsychological function tests that had been selected as sensitive indicators of abnormalities thought to be caused by methylmercury. A repeat examination was carried out at age 14 years, again with a high participation rate, and the clinical test battery was very similar to the one previously applied, with proper adjustment for the participants now being adolescents. The main finding at the 7-year follow-up in the Faroes was that decrements in attention, language, verbal memory, and, to a lesser extent, in motor speed and visuospatial function, were associated with prenatal methylmercury exposure; the cord– blood mercury concentration was the best risk indicator (10). These findings were robust in the full Faroes data set in analyses controlled for age, sex and confounders, and they persisted after exclusion of high-exposure subjects. Support for these findings were seen in some of the neurological tests, but particularly in delays in brainstem auditory evoked potentials (11). Likewise, prenatal methylmercury exposure is associated with a decrease in the normal heart rate variability, and this indication of poorer nervous system control of heart function is reflected in a tendency of increased blood pressure (12). Data on the 14-year follow-up are currently being processed, but two recent publications address the neurophysiological outcomes that are unlikely to be affected by socioeconomic confounders (13,14). Mercury-associated delays in brainstem auditory evoked potentials remained at 14 years, as did the decreased heart rate variability. These two functions were associated, perhaps due to their joint involvement of brainstem nuclei, but the association became weaker when adjusted for mercury exposure. These findings suggest that brainstem toxicity may be an important component of developmental methylmercury neurotoxicity. The brainstem auditory evoked potentials also showed a delay in peak V, i.e., the signal elicited by the transmission of the electrical signal to the midbrain, but this delay was associated only with the current methylmercury exposure (Fig. 1) (13). The average hair-mercury concentration in the adolescents examined was about 1 mg/g, i.e., close to the current Reference Dose (RfD) established by the U.S. EPA. This observation suggests that the vulnerability of the brain may extend into the teenage period, and that even exposures similar to the RfD may cause adverse effects. Two birth cohorts were formed in the Seychelles, both involving about 800 children, i.e., about 50% of all children born during the year (15). For exposure assessment, a hair sample was obtained from the mother, about six months after birth. The hair segment that represented the pregnancy period was identified from the assumption that hair grows 1.1 cm per month. The authors have noted that the first pilot study was not as wellcontrolled as the main or longitudinal study: there were fewer covariates, medical records were not reviewed as carefully, and there was less information on socio-economic status. A subset of 217 children from the pilot cohort was evaluated at 66 months (16). Maternal hair mercury was negatively associated with the McCarthy General Cognitive Index and Perceptual Performance subscale, and the Preschool Language Scale Total
28
Grandjean et al.
BAEP III – V 20 Hz (ms)
1.94 1.90 1.86 1.82 1.78 1.74 0.01
0.10 1.00 Child Hair Mercury Concentration (mg/g)
10.00
Figure 1 Latency of peak V of the brainstem auditory evoked potentials recorded in 859 Faroese children at 14 years adjusted for sex and age (27). The association is estimated in a generalized additive model analysis, using the current hair-mercury concentration as an indicator of current exposure. The broken lines indicate the point-wise 95% confidence interval for the doseresponse relationship. Each vertical line above the horizontal axis represents one observation at the exposure level indicated. The average exposure is similar to the U.S. EPA Reference dose (1 mg/g).
Language and Auditory Comprehension subscale. When statistically determined outliers and points considered to be influential were removed from the analyses, statistical significance of the association remained only for auditory comprehension. The main Seychelles study included evaluation of the children at 6.5, 19, 29 and 66 months of age, and again at 8 years. No association with maternal hair mercury was found for most endpoints in these children (16,17). At 29 months there was an association between mercury exposure and decreased activity level in boys only, who also showed a possible mercury-associated delay in age for walking, but the latter was not significant when adjusted for confounders. The authors cautioned that subtle neurological and neurobehavioral effects are more likely to be detected in older rather than younger children. The most detailed examination was carried out at age 8 years using tests that were similar to those applied in New Zealand and the Faroes. In calculating possible effects of prenatal methylmercury exposure, the regression equations included adjustment for postnatal exposure. No association between deficits and maternal hair-mercury concentrations was evident (17). Despite the apparent differences between the three studies of mercury-exposed populations, they may not necessarily be in disagreement. For example, the confidence intervals for the Faroes and Seychelles studies overlap, and the findings therefore do not significantly differ (18). Further, some differences would be anticipated, because these two studies used different methods for assessment of exposures and outcomes (Table 1), and due to different epidemiological settings. The New Zealand study population may be most similar to continental Europe and North America, even though about half of the high-exposure mothers were of Pacific Island descent. Their diet is high in ocean fish, and very few of them smoke, but otherwise their exposures in daily life would not be very different from other New Zealand women or, indeed, women from other Western societies.
Methylmercury from Seafood and Freshwater Fish Table 1
29
Main Differences Between the Prospective Studies of Methylmercury-Exposed Children
Attribute Source of exposure Exposure assessment Concomitant exposures Language Socioeconomic setting Family setting Outcome tests Clinical examiners
New Zealand
Faroes
Shark and other large Whale, ocean fish and ocean fish shellfish Maternal hair Cord blood and maternal hair Lead in house paint PCBs (whale blubber) and air English (and Pacific Faroese (and Danish) languages) Industrialized Industrialized Western Scandinavian Urban, mixed cultures Traditional Omnibus Domain-related and neurophysiological Clinical specialists Clinical specialists
Seychelles Ocean fish Maternal hair Pesticide use in tropics Creole (English and French) Middle-income developing Mainly matriarchal Omnibus and domainrelated Nurse/student
The neurotoxicity of methylmercury should not be judged from a single observational study but needs to be evaluated on the basis of the overall strength of the total evidence available. It is fortunate that three prospective projects have been carried out under different circumstances, and that supplementary information is available from cross-sectional studies. Their strengths and weaknesses need to be considered jointly. Following a review of the cross-sectional studies, we will consider the main issues in this assessment.
CROSS-SECTIONAL STUDIES Due to logistical difficulties in carrying out prospective studies in many exposed communities, most studies were cross-sectional (Table 2). In addition, some research teams have recently embarked on potential prospective studies, but results published so far warrant consideration only as cross-sectional. Again, researchers have chosen populations that include representation of high-level exposures to methylmercury. However, due to the remote setting, e.g., in the Arctic or the Amazon basin, less sophisticated parameters had to be chosen, also taking into account the possible differences in culture, language, and school education. Some of studies are particularly important, because they focus on the impact of methylmercury from freshwater fish. Thus, in the Amazonian region, fish contamination has been increased by local mercury pollution from gold-mining activities. In the Arctic, the traditional diet includes sea mammals and other species high in the food chain, thereby causing an increased risk of high intake of biomagnified methylmercury. The groups of children examined have ranged from tens to a few hundred. Selection bias, especially when studying older children, is possible, and usually no information was available about children who were unavailable for the study. Most likely such selection would result in healthier children being examined, thereby potentially obscuring exposurerelated effects. The studies also differ in regard to the exposure intervals covered. Exposure levels range from an average of about 5 mg/g maternal hair (Cree Indians in Northern Que´bec,
234 children (12–30 mo)
131 infant–mother pairs
21/36 children exposed (3–15 years) 15 non-exposed
149/153 children (7 yr)
354/420 children (7–12 yr)
Peru (20)
Ecuador (21)
Madeira (11)
Brazil (22)
Population (age range)
Canada (19)
Country (ref)
mgZ11.0 mg/g mgZ11.6 mg/g
Child hair Maternal hair (rZ0.80)
Freshwater fish (gold mining area)
Neurological exam Neuropsychological tests: Finger tapping, Hand–eye coordination test Continuous performance test WISC-R: digit spans block designs Stanford–Binet Bead memory test Neurophysiological tests: Brainstem auditory evoked potentials Pattern-reversal visual evoked potentials Neuropsychological tests: Finger-tapping Santa ana dexterity test WISC-R digit span Stanford-Binet tests: Copying Recall Bead memory
mgZ3.8 mg/g mgZ9.6 mg/g
Child hair Maternal hair
Audiological tests Auditory brainstem evoked potentials (10 children exposed)
maZ16.2 mg/L
Child’s blood at time of exam
Freshwater fish (gold mining area)
Marine fish
Growth parameters Developmental milestones
mgZ7 mg/g [1–29]
Growth parameters Neurological exam
Outcomes measured
maZ6 mg/g [0–24]
Level of exposure
Maternal hair during pregnancy
Maternal hair during pregnancy
Exposure biomarker
Marine fish
Freshwater fish
Main source of exposure
pZ0.003 pZ0.02 ns
ns pZ0.001 ns
Correlation I–III (and I–V) interpeak latency with maternal Hg Correlation N145 withmaternal Hg
ns
ns
ns Association with I-III interpeak latency (left ear only)
ns
Abnormalities of tendon reflexes (boys only, no dose-response)
Results
Table 2 Description of Cross-Sectional Studies on the Association Between Prenatal Exposure to Methylmercury and Neurodevelopmental Effects 30 Grandjean et al.
ns (but highly significant when merged with the Madeira data)
Abbreviations: ma, arithmetic mean; mg, geometric mean.
median Z1.63 mg/g median Z1.65 mg/g
Several neurophysiological tests: Brainstem auditory evoked potentials
Child hair Maternal hair
327 children (7 yr)
Akita, Japan (26)
Seafood
Correlation hand-eye coordination test with maternal Hg (pZ0.01)
Neurological exam Neuropsychological tests: Finger tapping Hand-eye coordination test Continuous performance test WISC-R: digit spans block designs Stanford-Binet Bead memory test Neurophysiological tests: Brainstem auditory evoked potentials Pattern-reversal visual evoked potentials
mgZ5.5 mg/g mgZ15.5 mg/g
Marine mam- Child hair mals (arctic Maternal hair traditional food)
43 children (7–12 yr)
Greenland (25)
ns pZ0.006
ns p!0.001 ns
ns
Increased tendon reflexes,
Neurological exam (Amiel-Tison) Neuropsychological tests Finger tapping Stanford-Binet test Block Copying Bead memory McCarthy Digit forward Leg coordination
mgZ10.2 mg/g mgZ12.7 mg/g
Child hair Maternal hair (high exposure area) (rZ0.30)
Freshwater fish (gold mining)
French 248/290 children Guiana (24) neurological ex. (6mo–6 yr) 206/243 children neuropsy. tests (5–12 yr)
pZ0.03
Neurological optimality scale
mgZ20.4 mg/L mgZ4.1 mg/g
Cord blood Maternal hair
182 infants (2 wk)
Maternal seafood diet
Faroe Islands (23)
Methylmercury from Seafood and Freshwater Fish 31
32
Grandjean et al.
Faroes, and two groups in the Amazon Basin) up to 13 mg/g in French Guiana, and even higher in Northern Greenland. Despite the differences in cultural settings and other limitations, these studies show a number of concordant findings when taking into account the different protocols and research strategies. One of the new prospective studies is the Faroese Cohort 2 that included 182 singleton term births. These children were first examined by the Neurological Optimality Score (NOS) at age two weeks (adjusted for gestational age). Detailed information was obtained on exposures both to methylmercury and to lipophilic pollutants. The NOS showed significant decreases at higher cord–blood mercury concentrations, while PCB was not important (23). A small study carried out in the northernmost Greenland included data on prenatal exposure levels on about half of the subjects (25). While anticipating the results from a newly initiated prospective study in Japan (27), a cross-sectional study has analyzed preserved umbilical cords as a measure of the children’s prenatal exposure levels (26). Because the developing brain is considered the main target of methylmercury toxicity, evaluation of these studies must be based on the assumption that exposures measured at the time of the postnatal examination represent causative exposures at the time of the greatest vulnerability of the nervous system. Postnatal exposure may of course add to the overall toxic impact, thereby complicating the evaluation if exposures have not been constant. Overall, these studies tend to confirm that attention, motor coordination and speed, and visuospatial function are sensitive targets of methylmercury toxicity. Language and verbal memory may also be vulnerable, but were not evaluated.
EXPOSURE ASSESSMENT A crucial element in the risk assessment process is a correct measure of exposure in terms of relevant period and accurate level. Because the exposure is not a matter of design, the validity of the exposure assessment depends on the degree to which the exposure parameters reflect the “true” exposure. Exposure biomarkers should be considered only proxy variables, which are always imprecise to some extent. This issue is important, because exposure misclassification is likely to be nondifferential and will therefore cause underestimation of the true effect of the exposure. In the prospective studies, samples for mercury analysis have included maternal hair, cord blood, and cord tissue collected at parturition. In the Seychelles (16), maternal hair was collected at a delay of 6 months after delivery. Some studies have also used maternal dietary questionnaires to obtain information on the origin and approximate magnitude of the methylmercury exposure. Cross-sectional studies, as opposed to cohort studies, rely on surrogate measures of fetal exposure, because the children were enrolled several years after birth. In the populations studied, it seems reasonable to assume that diet has changed little over time due to the preponderant role of fish among available resources. In addition, fish contamination by mercury has most likely remained fairly stable in the years following birth. Such stability was evidenced by the study in Peru, in which peak and average concentrations of mercury in maternal hair during pregnancy are very similar and in French Guiana where hair mercury levels measured five years apart in different villages were remarkably constant. Most studies in Table 2 used maternal hair collected at time of child’s examination. In two studies, the child’s exposure (blood or hair measurement) was used instead due
Methylmercury from Seafood and Freshwater Fish
33
to incomplete data on maternal exposure levels, and because a good correlation was documented between the child’s and the mother’s exposure levels (22). This association is to be expected when older children are examined in communities where they are usually sharing the meals with their parents at home. If the child’s current exposure does not provide a correct ranking between individuals, it could introduce exposure misclassification and thus underestimate the risk. However, if the child’s exposure is lower than the maternal level, an exaggeration of the risk may ensue. The length of maternal hair analyzed is also important for assessment of mercury exposures during pregnancy. Although hair growth rates are known to vary, a 90 mm hair sample obtained at parturition or shortly thereafter would be thought to represent the average mercury exposure during the whole pregnancy. In New Zealand, monthly (10 mm) exposure levels varied by a factor of 2, and on average the peak monthly exposure was about 50% higher than the 9-month average (8). In the Faroes, similar variations were recorded, with coefficients of variation mostly being below 25% (28). Comparison of hair from the Faroes and the Seychelles showed similar short-term variations (29). Until recently, the degree of imprecision has been assumed to be reflected by laboratory imprecisions, although these low levels of imprecision (usually about 5% or less) could not explain why associations between mercury concentrations in hair and blood often show wide scattering. Mercury analyses should always be supported by detailed quality control procedures (e.g., blind comparison with other experienced laboratories and use of certified samples) as was first done in the New Zealand study (8). Although frequently used for feasibility reasons, the maternal hair mercury concentration is likely to be a rather imprecise measure, particularly in regard to fetal exposure. Among sources of variability are hair growth rate, hair type, hair color, external contamination, and leaching due to permanent hair treatments (30). As a contributory reason for differences in study outcomes, temporal variability in exposure has been suggested. The concern is that ‘bolus’ exposures might be more toxic than steady exposures at an average level. This hypothesis is difficult to test, but experimental evidence (31) suggests that fetal brain concentrations change more slowly than maternal blood concentrations. In addition, exposure variability is likely to introduce error in the exposure assessment, and such misclassification would be likely to cause an underestimation of the dose–response relationship. In agreement with this prediction, exclusion of Faroese cohort subjects with variable exposures during gestation tended to increase the associations between the mercury exposure and the deficits (28). In international comparisons, three main types of hair structure are recognized (i.e., African, Caucasian, and Oriental), but good data for calibration with blood concentrations exists only for the latter two hair types. Thus, for the African population in the Seychelles, translation of hair-mercury results to blood concentrations and intake levels must currently be based on data mainly from Caucasian populations. Recent studies have now documented that the coefficient of variation for the hair-mercury imprecision is over 50%, i.e., twice the level found for the blood concentration (32). The overall effect of such non-differential imprecision is that the regression coefficients decrease, the P-values increase, and adjustment for confounders with better precision cause additional bias toward the null hypothesis (33). When calculating an exposure level from the hair mercury concentration, an average hair-to-blood ratio of 250 is generally used (4). This ratio is in accordance with recent evidence on Caucasian and Oriental hair (30), but is known to vary considerably between individuals. The 95th percentile differs from the median by a factor between 2 and 3. It also depends on the concentration level, and it changes with age (32).
34
Grandjean et al.
OUTCOME VARIABLES The validity of outcome variables depends on their sensitivity to the exposure under study and the specificity in this regard, i.e., lack of sensitivity to the influence of other factors, including confounders. The choice of effect parameters must at the same time be feasible and appropriate for the age of the children, and for the setting of the study. Tests that depend only minimally on cooperation of the subject have the advantage of being less likely to be affected by motivation. The more advanced neuropsychological tests are only possible when a child has reached school age. However, such tests may be of uncertain validity, if they have not previously been applied in the same culture. In addition, many tests require special skills of the examiner. All of these issues need to be considered when evaluating the study findings. Most studies employed a battery of neurobehavioral tests, and some appeared to be more sensitive to mercury neurotoxicity than others. Simple comparison of regression coefficients may provide suggestions for the most sensitive parameter, at least within the confines of a particular study. To facilitate such comparisons, the regression coefficient may be expressed as a proportion of the standard deviation of the test result, or as a delay in mental development calculated from the regression coefficient for age. Alternatively, benchmark dose levels may be used as a basis for comparison. Thus, the most sensitive neurological, neuropsychological, and neurophysiological effects parameters all exhibit benchmark dose levels of 5–10 mg/g hair. Despite the great variability of the study settings and the outcome variables, this observation suggests a substantial degree of concordance and that the combined evidence therefore is quite convincing in regard to the dose– response relationship.
Neurological Tests Many of the studies included a neurological exam (11,19,20,23,24). Unfortunately protocols of examination differ between studies: in the Canadian and French Guiana studies, evaluation of sensory functions, cranial signs, muscle tone, stretch reflexes and coordination were conducted in young children. Both studies reported abnormal tendon reflexes in association with maternal hair concentration. However, contrary to the expectation, these signs were mild and isolated, and the reproducibility of the assessment in the French Guiana study was reported to be poor (24). In the study in Peru (20), essential details of the neurological evaluation (items, age of the children examined) were not presented precluding informed expertise of their results. In this study, frequencies of abnormal signs were not associated with maternal mercury levels. In Madeira and the first Faroes cohort, the neurological examination put emphasis on motor coordination and perceptual motor performance (10,11); children who failed the most difficult of the 19 functional neurological tasks tended to have slightly higher exposures than children who performed well. In summary, the clinical neurological tests provide limited evidence linking lowdose methylmercury exposures to detectable abnormalities. It is very likely however that this absence of positive findings partly reflects the lack of sensitivity of this type of evaluation in this range of exposure levels. Thus, performance on a clinical test is rated by the examiner, thereby introducing a potential subjective aspect, and scoring is usually a simple pass-fail or pass-questionable-fail, thereby limiting the sensitivity.
Methylmercury from Seafood and Freshwater Fish
35
Developmental Tests Among the prospective studies, the New Zealand children were examined at 4 years of age using the Denver Developmental Screen Test (DDST). It consists of four major function sectors: gross motor, fine motor, language, and personal–social, where possible scores are abnormal, questionable, or normal. The prevalence for developmental delay in children was 52% for children of high mercury mothers and 17% for those of mothers of the reference group; the delays most frequently affected fine motor and language sectors. The Bayley Scales of Infant Development (BSID) was used in the Seychelles, but no mercuryassociated deficits were reported. Developmental tests may be useful for such studies in small children, they may be less dependent on differences in culture than are tests appropriate for older children, but they may be of limited sensitivity to subtle changes.
Neuropsychological Tests While likely to be more sensitive in revealing early neurotoxic changes, neuropsychological test results may also be affected if the administration is not standardized, and they may show examiner-dependence. Further, they may be sensitive to details in the test situation, such as the use of an interpreter, changes in temperature, and other aspects that may be important when a test is used for the first time in a particular culture. In New Zealand, two blinded psychologists tested the same children with a shortened version of the standard tests used and documented a remarkable agreement (8). In the Faroes and several other studies, tests were administered to all children by the same examiner, thus limiting the possible impact of examiner-related differences. Traditionally, studies in this field have included standard intelligence test batteries, because of the wealth of information available on such tests and the implications of lowlevel performance. The New Zealand study applied the Wechsler Intelligence Scale for Children (WISC) and McCarthy Scale of Children’s Abilities at age 6 years. Likewise, the Seychelles examinations included the McCarthy Scales. These intelligence tests may not be the most appropriate and sensitive for effects of methylmercury. Still, significant effects were found on the WISC and McCarthy in the New Zealand study. The New Zealand study also used the “Test of Oral Language Development” (a standard test widely used in New Zealand school programs), and this test appeared to be the most affected by methylmercury exposure. In the Faroes, the approach taken was to emphasize tests that reflected functional domains, e.g., attention, motor speed, and verbal memory. The functions chosen were those that were most likely to be affected by developmental methylmercury exposure, as judged from location of neuropathological lesions in poisoning cases and as illustrated by studies of other developmental neurotoxicants, especially lead. In the Faroes, the Boston Naming test appeared to be the most sensitive outcome. Similar tests were included when the Seychelles cohort was examined at age 8 years. However, application of the Boston Naming test in a different culture may not be unproblematic. For example, the sequence of stimuli may not necessarily represent an increasing degree of difficulty, e.g., if pictures of an igloo or an acorn are not as familiar to children in a tropical developing country as they are to northern children from the Faroes, or the United States, where the test was developed. In addition, each stimulus was meant to have one correct answer, but since Seychellois is a mixed language, then some stimuli in the Boston Naming test are known to have as many as three correct answers. Thus, even if the same test material and instructions (after translation) are used, the validity of the tests will necessarily differ.
36
Grandjean et al.
A variety of neuropsychological tests, including WISC subtests were used under different circumstances in the cross-sectional studies in Madeira, Greenland, Brazil and French Guiana. In the first two and in an Indian group studied in Brazil, all tests were administered with the use of an interpreter, thereby making the test results less reliable. Likewise, the Continuous Performance test used in the Seychelles was not supervised by an examiner, thereby allowing for possible untoward variability that would be less likely if the examiner was present. Results on such computer-assisted tests will also be affected by the prior computer experience of the child. Due to the type of populations studied, the researchers attempted to avoid culturebiased and language-dependent tests, thereby precluding evaluation of important domains. The functions evaluated focused on motor speed and motor coordination, visuospatial organization, attention, and short-term memory. Several tests were common to these studies and also overlap with the prospective studies, e.g., finger tapping, and Stanford-Binet Bead Memory. At increased exposure levels, reduced scores were evidenced on the Santa-Ana dexterity test in Brazil and the McCarthy leg coordination test in French Guiana. In these two studies, scores on the Stanford-Binet Copying test (that measures visuospatial organization) were negatively associated with mercury exposure with very similar regression coefficients in the two studies. Several types of errors occurred in these tests, and the French Guiana study pointed more specifically at rotation errors among younger children (5–6 years old). Such errors would suggest possible insult in the parietal lobes of the brain resulting in developmental delay in the learning to place objects in space (34). Whether or not this type of test would appear sensitive in other populations living in other cultural environments needs to be established. Neurophysiological Testing As an objective evaluation of brain dysfunction that is probably less sensitive to confounding, neurophysiological tests have been applied in several studies. Their applicability requires advanced instrumentation and depends on skilled examiners. An outcome that has previously been found to be sensitive to lead exposure is brainstem auditory evoked potentials. They are recorded using surface electrodes placed on the skull while the child listens to a stimulus in one ear. The transmission of the electrical signals within the brain is then recorded as peaks that represent the acoustic nerve, an intermediate connection in the pons, and the midbrain. The latency of peak III was significantly increased at higher intrauterine exposure to mercury. Parallel associations were found in 7-year-old children in the Faroes, in Madeira, and in Japan, and these observations were then replicated in the Faroese cohort when examined at 14 years. A smaller study from Ecuador also reported delays in peak III at higher exposure levels. In addition, prolonged latencies of peak V among the 14 years-old were linked to the current mercury exposure only and therefore suggested on effect of postnatal mercury exposure (Fig. 1) and that this effects is different from those caused by mercury exposure during fetal development.
CONFOUNDING VARIABLES Three major reasons for confounding have been noted as to why a mercury effect might have been overestimated: (a) association of mercury intake with exposure to other neurotoxic pollutant(s); (b) other types of residual confounding; and (c) inadequate adjustment for multiple comparisons (35). The best protection against confounding problems is to select a study setting where such concerns are unlikely and, if relevant, may be adjusted for
Methylmercury from Seafood and Freshwater Fish
37
appropriately. Thus, a homogeneous society with limited differences in socioeconomic and cultural factors should be chosen. The existence of residual confounding can never be fully excluded, but there is little reason to invoke “phantom” covariates to explain away a biologically plausible association between methylmercury exposure and neurobehavioral deficits. In addition, most attention is usually paid to confounders that affect the outcomes in the same direction as the exposure under study, but confounders may also have the opposite effect of attenuating the apparent impact of the exposure. Thus the potential for overestimation of a toxic effect should not be raised without paying equal attention to the risk of underestimation. Standard multiple regression methods are often used for controlling for confounding effects. Even in the absence of confounding, adjustment for such established predictors as sex, age, and maternal intelligence should be included to obtain a more precise estimate of the mercury effect. In general, the prudent approach is usually to include all covariates that may be potential confounders. However, in situations were the exposure is measured with some degree of imprecision (as is the case here), this approach may result in biased estimates when covariates are less imprecise. Inclusion of such covariates, which are associated with the exposure but without any explanatory power in regard to the effect, will then increase the underestimation of the effect of the exposure of interest (33). As a main concern in regard to confounding, socioeconomic conditions vary substantially between the study settings. Although mercury neurotoxicity was reported in almost all studies, differences within each study could be important. New Zealand and the Faroes represent relatively wealthy, industrialized populations, where socioeconomic differences are thought to be limited, but most of the other studies were carried out in developing countries, where basic sanitary problems are common, and where nutritional deficiencies may occur, both of which may be difficult to adjust for. In the Seychelles, stunting still occurs in a small percentage of children (36). In New Zealand, ethnic differences appeared to play a role, but the analysis was based on matching of the children in the different exposure groups for ethnicity. An additional factor of possible interest is consanguinity, which is more frequent in island populations and other isolated communities. However, to cause confounding, the degree of consanguinity would have to be associated with mercury exposure and at the same time result in neurobehavioral deficits. Both assumptions seem unlikely, but documentation from an individual study would be a major undertaking. The family structure and home environment are documented as important determinants of childhood development. Within the populations studied, circumstances may vary. For example, only about 25% of the births in the Seychelles are nuptial, while an additional 50% are recognized by a father, but about 25% of children have no known father (37). Accordingly, children of the Seychelles cohort were said to be accompanied by a “care-giver,” often a relative, with whom the child was living (18). The variable family structure, which may be difficult to adjust for in statistical analyses, contrasts with the more uniform circumstances of most other studies with a traditional and stable family structure. In the New Zealand study, low social class and non-English home language reduced the score in some tests (not surprising) and more than 6 months of breastfeeding increased the score in some tests (8). These variables were accounted for in the multiple regression analysis. Among other known developmental neurotoxicants, none is as prevalent as ethanol. Most studies reported that maternal alcohol use during pregnancy was minimal, but in some cases it may be difficult to assess because of the importance of home-brewed beverages, e.g., in the Seychelles (38).
38
Grandjean et al.
In particular the Faroese are exposed to PCBs, in this case from eating whale blubber. Detailed analyses of the Faroes data failed to show any important impact of PCB exposure on the neurotoxicity outcomes (39,40). Inclusion of PCB exposure in a structural equation model attenuated the mercury effect somewhat; mercury remained statistically significant, but PCB was far from significant (41). In New Zealand and the Seychelles, the ocean fish consumed is unlikely to be contaminated by PCB, and the same would be the case with freshwater fish in the Amazon Basin. A reverse effect may occur if subjects who do not eat mercury-containing fish instead consume fruits and vegetables that contain pesticides. Such exposures are more likely in tropical developing countries. The neurotoxicity of many pesticides could then potentially cause neurodevelopmental effects in children with low-level mercury exposures, thus blurring the dose-response relationship. Although pesticide use might be a cofactor in the Seychelles, no information is available to evaluate this possibility. Certain essential nutrients in fish and seafood may provide beneficial effects on brain development, thereby possibly counteracting adverse effects of the contaminants. This possibility has often been mentioned in regard to ocean fish (17). Perhaps, if ocean fish contains higher concentrations of essential n-3 fatty acids than do freshwater fish, then this difference could perhaps explain why the mercury dose–response relationship appears to be steeper in populations that rely on river fish. Chemical analyses of ocean fish from New Zealand show that selenium concentrations do not depend on fish size, while mercury concentrations increased linearly (42). Although selenium has been considered to potentially provide protection against mercury effects, cord–blood selenium concentrations in the Faroes did not impact on mercury-associated deficits. It seems unlikely that essential nutrients would counteract all aspects of mercury neurotoxicity.
PUBLIC HEALTH RELEVANCE Public health authorities have recently begun to issue dietary advisories in regard to the most contaminated types of freshwater fish and seafood. However, some discussions on methylmercury toxicity have erroneously pictured the situation as a conflict between a negative and a positive study. This misleading characteristic may be related to disagreements between regulatory agencies and has been exploited by vested interest groups. In epidemiology, the term “non-positive” is often used in regard to studies that were unable to detect a particular effect. Also, no matter how positive a study is, all observational studies have weaknesses, and a prudent judgment should be based on the total amount of evidence available, no on single studies, whether positive or not. The present chapter has demonstrated that the scientific evidence on methylmercury neurotoxicity is fairly consistent, and that adverse effects may even occur at low-level exposures. There is no dispute about the very serious prenatal effects that occurred in Minamata at maternal hair-mercury concentrations in the range of 10–100 mg/g (1–3). It would seem intuitively logical that less severe effects may occur at the exposure ranges found in the more recent studies. Because of the global significance of methylmercury contamination of food, these scientific findings need to be expressed in terms that may facilitate an evaluation of their public health significance. The Faroes study showed that each doubling in prenatal mercury exposure corresponded to a delay of one or two months in mental development at age 7 years (10). Because rapid development occurs at that age, such delays may be important. Also, even small shifts in a measure of central tendency may be associated with large changes in the tails of the distribution. Such developmental delays are likely to be permanent, at least
Methylmercury from Seafood and Freshwater Fish
39
in part, but the long-term implications are unknown. The experience with lead neurotoxicity suggests that such effects are likely to remain and that they may even become more apparent with time. A shift in IQ levels was documented in the New Zealand study (8). The average WISC-R full-scale IQ for the study population (nZ237) was 93. In the group with maternal hair mercury above 6 mg/g (nZ61) the average was 90. The average exposure in the latter group would be about 4-fold higher than in the study population as a whole. Another way of presenting these shifts in IQ is to estimate the increased number of subjects with very low IQ as methylmercury exposure increases. In New Zealand, an IQ below 70 (Zmental retardation) was twice as common (increase from 5 to 10%) in the highest hair mercury group (O10 mg/g) compared to the group with hair mercury below 6 mg/g (42). For the IQ range 71–85, the increase was from 20 to 25%, but due to the small number of children, this result was not statistically significant. Another approach was used in the Faroes in the absence of formal IQ tests. The regression coefficients were expressed as a proportion of the standard deviation of the test results (22). The most sensitive outcome parameters show a decrement of about 10% of the standard deviation at each doubling of the prenatal methylmercury exposure level. Had an IQ scale been used, with a standard deviation of 15 IQ points, a doubling in the exposure could have caused a deficit of about 1.5 IQ points. More detailed calculations based on the three WISC tests administered are in agreement with this conclusion (43). These findings are also in good agreement with the New Zealand data, and recent calculations of associated diminished lifetime economic productivity suggest that societal expenses may be very substantial (44). Each of these estimations is associated with some degree of uncertainty. Some scientific uncertainties are bound to remain, although new prospective cohort studies on methylmercury neurotoxicity are starting to provide new evidence, e.g., from ongoing research in Japan. However, the documentation is not going to expand substantially or otherwise provide much clearer guidance for regulatory agencies. It should also be recognized that the question as to whether to base decisions either on proof of harm or on precaution cannot be settled from epidemiological evidence. The experience with lead research (6) has amply illustrated that apparent disagreement is likely to occur between studies carried out by different methods in different settings. We therefore should not anticipate complete coherence among all available evidence. Accordingly, decisions on preventive efforts should be justified by the scientific database at large, taking into account its various uncertainties and inconsistencies. The potential costs and other societal consequences of policy decisions—including decisions to do nothing—deserve fair consideration. However, these issues should be addressed in parallel to and separate from the discussion of toxicological and epidemiological concerns. Otherwise, the erroneous impression will be generated that disagreements on preventive measures are solely due to uncertainties in epidemiologic evidence.
ACKNOWLEDGMENTS This work was supported by the U.S. National Institute of Environmental Health Sciences (ES09797 and ES11681) and the Danish Medical Research Council. The contents of this paper are solely the responsibility of the authors and do not represent the official views of the NIEHS, NIH or any other funding agency.
40
Grandjean et al.
REFERENCES 1. United Nations Environment Programme. Global Mercury Assessment. Geneva, 2002. 2. Tsubaki T, Irukayama K. Minamata Disease: Methylmercury Poisoning in Minamata and Niigata, Japan. Amsterdam: Elsevier Scientific Publishing Company, 1977. 3. National Research Council Toxicological Effects of Methylmercury. Washington: National Academy Press, 2000. 4. U.S. Environmental Protection Agency, Office of Science and Technology, Office of Water (2001). Water quality criterion for the protection of human health: methylmercury, Final. EPA823-R-01-001. Washington, 2001. http://www.epa.gov/waterscience/criteria/methylmercury/ document.html. (Accessed 19 December, 2003). 5. JECFA (Joint FAO/WHO Expert Committee on Food Additives). Sixty-first meeting, Rome, 10–19 June 2003. Summary and conclusions. ftp://ftp.fao.org/es/esn/jecfa/jecfa61sc.pdf. (Accessed 19 December, 2003). 6. Needleman HL, Bellinger D. Studies of lead exposure and the developing central nervous system: a reply to Kaufman. Arch Clin Neuropsychol 2001; 16:359–374. 7. Kjellstro¨m T, Kennedy P, Wallis S, Mantell C. Physical and mental development of children with prenatal exposure to mercury from fish. Stage 1: Preliminary tests at age 4. (Report 3080) Stockholm, National Swedish Environmental Protection Board, 1986. 8. Kjellstro¨m T, Kennedy P, Wallis S, et-al. Physical and mental development of children with prenatal exposure to mercury from fish. Stage 2, interviews and psychological tests at age 6. (Report 3642) Stockholm, National Swedish Environmental Protection Board, 1989. 9. Crump KS, Kjellstrom T, Shipp AM, Silvers A, Stewart A. Influence of prenatal mercury exposure upon scholastic and psychological test performance: benchmark analysis of a New Zealand cohort. Risk Anal 1998; 18:701–713. 10. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19:417–428. 11. Murata K, Weihe P, Renzoni A, et al. Delayed evoked potentials in children exposed to methylmercury from seafood. Neurotoxicol Teratol 1999; 21:343–348. 12. Sørensen N, Murata K, Budtz-Jorgensen E, Weihe P, Grandjean P. Prenatal methylmercury exposure as a cardiovascular risk factor at seven years of age. Epidemiology 1999; 10:370–375. 13. Murata K, Weihe P, Budtz-Jørgensen E, Jørgensen PJ, Grandjean P. Delayed brainstem auditory evoked potential latencies in 14-year-old children exposed to methylmercury. J Pediatr 2004; 144:177–183. 14. Grandjean P, Murata K, Budtz-Jorgensen E, Weihe P. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J Pediatr 2004; 144:169–176. 15. Shamlaye CF, Marsh DO, Myers GJ, et al. The Seychelles child development study on neurodevelopmental outcomes in children following in utero exposure to methylmercury from a maternal fish diet: background and demographics. Neurotoxicology 1995; 16:597–612. 16. Myers GJ, Davidson PW, Cox C, et al. Summary of the Seychelles child development study on the relationship of fetal methylmercury exposure to neurodevelopment. Neurotoxicology 1995; 16:711–716. 17. Myers GJ, Davidson PW, Cox C, et al. Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 2003; 361:1686–1692. 18. Keiding N, Budtz-Jørgensen E, Grandjean P. Prenatal methylmercury exposure in the Seychelles [letter]. Lancet 2003; 362:664–665. 19. McKeown-Eyssen G, Ruedy J, Neims A. Methylmercury exposure in northern Quebec. II. Neurologic findings in children. Am J Epidemiol 1983; 118:470–479. 20. Marsh DO, Turner MD, Smith JC, Perez VMH, Allen P, Richdale N. Fetal MeHg study in a Peruvian fish eating population. Neurotoxicology 1995; 16:717–726. 21. Counter SA, Buchanan LH, Laurell G, Ortega F. Blood mercury and auditory neuro-sensory responses in children and adults in the Nambija gold mining area of Ecuador. Neurotoxicology 1998; 19:185–196.
Methylmercury from Seafood and Freshwater Fish
41
22. Grandjean P, White R, Nielsen A, Cleary D, de Oliveira-Santos E. Methylmercury neurotoxicity in Amazonian children downstream from gold mining. Environ Health Perspect 1999; 107:587–591. 23. Steuerwald U, Weihe P, Jørgensen PJ, et al. Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr 2000; 136:599–605. 24. Cordier S, Garel M, Mandereau L, et al. Neurodevelopmental investigations among methylmercury-exposed children in French Guiana. Environ Res 2002; 89:1–11. 25. Weihe P, Hansen JC, Murata K, et al. Neurobehavioral performance of Inuit children with increased prenatal exposure to methylmercury. Int J Circumpolar Health 2002; 61:41–49. 26. Murata K, Sakamoto M, Nakai K, et al. Effects of methylmercury on neurodevelopment in Japanese children in relation to the Madeiran study. Int Arch Occup Environ Health 2004; 77:571–579. 27. Nakai K, Suzuki K, Oka T, et al. The Tohoku Study of Child Development: a Cohort Study of the effects of perinatal exposures to methylmercury and environmentally persistent organic pollutants on neurobehavioral development in Japanese children. Tohoku J Exp Med 2004; 202:227–237. 28. Grandjean P, White RF, Weihe P, Jørgensen PJ. Neurotoxic risk caused by stable and variable exposure to methylmercury from seafood. Ambul Pediatr 2003; 3:18–23. 29. Lanzirotti A, Jones KW, Clarkson TW, Grandjean P. Human health risks from methyl mercury in fish. Science Highlights—National Synchroton Light Source Activity Report. Upton, NY: Brookhaven National Laboratory, 2002 pp. 97–99. 30. Grandjean P, Jørgensen PJ, Weihe P. Validity of mercury exposure biomarkers. In: Wilson SH, Suk WA, eds. Biomarkers of Environmentally Associated Disease. Boca Raton, FL: CRC Press/Lewis Publishers, 2002:235–247. 31. Lewandowski TA, Pierce CH, Pingree SD, Hong S, Faustman EM. Methylmercury distribution in the pregnant rat and embryo during early midbrain organogenesis. Teratology 2002; 66:235–241. 32. Budtz-Jørgensen E, Grandjean P, Jørgensen PJ, Weihe P, Keiding N. Association between mercury concentrations in blood and hair in methylmercury-exposed subjects at different ages. Environ Res 2004; 95:385–393. 33. Budtz-Jørgensen E, Keiding N, Grandjean P, Weihe P, White RF. Consequences of exposure measurement error for confounder identification in environmental epidemiology. Stat Med 2003; 22:3089–3100. 34. Sullivan, K. Neurodevelopmental aspects of methylmercury exposure: neuropsychological consequences and cultural issues. PhD Thesis in Behavioral Neuroscience, Boston University School of Medicine, 1999. 35. NIEHS. Workshop organized by Committee on Environmental and Natural Resources (CENR), Office of Science and Technology Policy (OSTP), The White House: Scientific Issues Relevant to Assessment of Health Effects from Exposure to Methylmercury, November 18–20, 1998. (Accessed December 19, 2003). Available from: http://ntp.niehs.nih.gov/main_pages/ PUBS/MethMercWkshpRpt.html. (Accessed 10 January, 2006). 36. WRI (World Resources Institute) Earth Trends: The Environmental Information Portal, 2003. Variable: Children’s Health: Stunting in Children Under 5. Washington. http://earthtrends.wri. org/text/POP/variables/387.htm. (Accessed 5 March, 2004). 37. MISD (Management & Information Systems Division), Statistics & Database Administration Section (SDAS) of the Ministry of Information Technology & Communication of the Republic of Seychelles, 2003. Statistical Bulletin Quarterly: Population and Vital Statistics 2002. Victoria, Mahe: table 3 (Registered Live Births By Year, Month of Registration, Sex and Status, 1998–2002). 38. Perdrix J, Bovet P, Larue D, Yersin B, Burnand B, Paccaud F. Patterns of alcohol consumption in the Seychelles Islands (Indian Ocean). Alcohol Alcohol 1999; 34:773–785. 39. Budtz-Jørgensen E, Keiding N, Grandjean P, White RF, Weihe P. Methylmercury neurotoxicity independent of PCB exposure [letter]. Environ Health Perspect 1999; 107:A236–A237.
42
Grandjean et al.
40. Grandjean P, Weihe P, Burse VW, et al. Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol 2001; 23:305–317. 41. Budtz-Jørgensen E, Keiding N, Grandjean P, Weihe P. Estimation of health effects of prenatal methylmercury exposure using structural equation models. Environ Health 2002; 1:22. 42. Kjellstro¨m T. Methyl-mercury exposure and intellectual development in vulnerable groups in New Zealand. Proceedings of the US–Japan Workshop, Nov. 2000. Minamata, Japan, National Institute for Minamata Disease, 2000. 43. Budtz-Jørgensen E, Debes F, Weihe P, Grandjean P. Adverse mercury effects in 7-year-old children expressed as loss in “IQ”, 2005. Available from: www.chef-project.dk. 44. Trasande L, Landrigan PJ, Schechter C. Public health and economic consequences of methyl mercury toxicity to the developing brain. Environ Health Perspect 2005; 113:590–596.
3 Effects of Developmental PCB Exposure on Neuropsychological Function in Epidemiological Studies: Issues and Research Needs Deborah C. Rice Environmental and Occupational Health Program, Maine Center for Disease Control and Prevention, Augusta and Center for Integrative and Applied Toxicology, University of Southern Maine, Portland, Maine, U.S.A.
Attention focused on the adverse consequences of PCB exposure on the developing fetus following poisoning episodes in Taiwan (1–4) and Japan (5). Ingestion of rice oil, contaminated with PCBs, dibenzofurans and dibenzodioxins, by women before or during pregnancy resulted in infants with hyperpigmentation, mental retardation, and other overt effects at high exposures, and cognitive impairment and behavior problems at lower exposures. It was clear from these unfortunate incidents that the fetus was much more sensitive to these chemicals than were adults. In the 1980s, investigators in Michigan studied the consequences of developmental exposure to PCBs in women who did or did not consume Lake Michigan fish (6). During the same time period, the effects of in utero exposure were examined in a North Carolina cohort whose exposure was through the general food supply (7). Both studies documented adverse effects during infancy associated with maternal or fetal PCB body burden. The Michigan study found effects on IQ, attention, memory, and reading ability that persisted at least through 11 yr of age (8,9). In the 1990s, several longitudinal prospective studies were implemented to examine the effects of PCBs and other contaminants on neuropsychological development of children. These studies were able to take advantage of more sensitive and accurate chemical analyses of PCBs and related chemicals than were available in earlier studies, as well as to use information from previous studies to choose or develop behavioral outcome measures. A study in Oswego, New York, examined offspring of mothers who did or did not consume Lake Ontario fish (10), whereas studies in Germany (11) and the Netherlands (12) assessed the effects of exposure through the general food supply. All three studies 43
44
Rice
reported deficits associated with developmental PCB exposure. A study in the Faroe Islands, designed to study the effects of methylmercury, also examined the effects of in utero exposure to PCBs (13). A study in the Inuit population in Arctic Canada is in the early stages (14). The epidemiological literature on the effects of PCBs on behavior in children was reviewed most recently and extensively by Schantz et al. (15), as well as in earlier publications (16,17). Congruence between studies in the types of deficits identified is good in most cases; complete agreement in every detail is not to be expected in observational studies such as these (18). This chapter is not intended to be a review of the literature, but rather a discussion of issues that require further study for optimal protection of public health.
IDENTIFICATION OF TYPES OF BEHAVIORAL DEFICITS PRODUCED BY PCB EXPOSURE The evidence that PCBs are neurotoxic is compelling. Studies in monkeys (19–23) and rats (24–32) documented deficits in a variety of neuropsychological functions as a consequence of developmental exposure to PCBs. PCBs also produce effects on neurotransmitter systems and brain metabolic processes (33–39). Comparison of exposure among epidemiological studies is not straightforward for several reasons. The early studies (Michigan, North Carolina) used older, less sensitive analytical methodology that did not determine concentrations of individual congeners. Newer studies analyzed different congeners and different numbers of congeners. In addition, PCBs were assayed in different tissues (cord blood, maternal blood, breast milk, cord tissue), with some studies measuring levels in more than one tissue. Nonetheless, a comparison was performed across studies based on normalization of data to concentrations of congener 153 in maternal serum (40). Results from the five studies designed to assess the effects of PCBs were not dissimilar, with a good deal of overlap in the range of estimated concentrations. North Carolina had the lowest median exposure (80 ng/g lipid) and Germany the highest (140 ng/g lipid). However, the accuracy of the estimates for the Michigan and North Carolina studies are less certain than those from the more recent studies. The population in the Faroe Island study, designed to assess the effects of methylmercury, had much higher PCB exposures than other studies (median 450 ng/g lipid). There is a reasonable degree of consistency in both experimental approach and findings with respect to measures of early psychomotor and cognitive development (Table 1). All the studies designed to assess the effects of PCBs—Michigan, North Carolina, Dutch, German, and Oswego—measured IQ between 3 and 5 yr of age (41–46). The American studies used the McCarthy Scales, whereas the European studies used the Kaufman Assessment Battery for Children (K-ABC). All studies except the North Carolina study reported adverse effects on cognitive performance. The Dutch study was designed to assess the contribution of prenatal exposure and exposure through breastfeeding to any observed effects. Therefore, the cohort was recruited so that half the mothers breast-fed and half did not, with half of each group recruited from Rotterdam or Gro¨ningen. Differential effects on IQ were observed in breast- and formulafed infants; effects were detected in the full cohort and formula-fed infants, but not the breast-fed group. The North Carolina, Dutch, and Oswego studies assessed neurological status during early infancy, and all found associations between prenatal exposure and infant
Vigilance task (55)
np
K-ABC (42)
McCarthy attenuated (61) Tower of London, 9 yr; Rey Complex figure test, negative (53) Vigilance task (54) simple reaction time (53) Reynell language development scale (42)
Negative McCarthy (3–5 yr) (41) np
McCarthy (45,46)
Attention/response inibition/processing speed Language
np
np
Vigilance task (119) freedom from distractibility, WISC-R (8)
Word comprehension, Woodcock Reading mastery test; reading comprehension, verbal comprehension, WISC-R (8)
Cognitive effects in later WISC-R, 11 yr (8) childhood
np
McCarthy attenuated (44) np
K-ABC attenuated (66) np
PDI (51)
MDI (50,92)
Negative (49)
Cognitive effects 4–7 yr np
K-ABC (43)
np
np
(49)
np
np
MDI (11)
np
(Continued)
McCarthy (44)
(52)
Negative (11)
np
Precchtl (12)
Eaters and noneaters of Lake Ontario fish NBAS (94)
Oswego
NBAS (based on fish consumption) (48) NBAS (91)
General population
Germany
Infant neurological status Fagan test of recognition memory Bayley scales of infant development Cognitive effects 3–4 yr
The Netherlands
General population General population, half breast-fed, half not
North Carolina
Eaters and non-eaters of Lake Michgan fish
Michigan
Summary of Identified Associations Between PCB Exposure and Adverse Neuropsychological Effects
Study population
Table 1
PCB Exposure on Neuropsychological Function 45
Vocabulary and information scores, WISC-R (8) np Rating scale (9)
Abbreviations: np, not performed; negative, no effect of PCBs.
Social behavior Activity
Memory
Michigan
np np
np
North Carolina Auditory Verbal Learning Task negative (53) CBCL (59) Rating scale, play behavior (54,60)
The Netherlands
np np
np
Germany
Table 1 Summary of Identified Associations Between PCB Exposure and Adverse Neuropsychological Effects (Continued)
np np
np
Oswego
46 Rice
PCB Exposure on Neuropsychological Function
47
neurological status (7,12,47). The Oswego study found poorer autonomic function and failure to habituate (a measure of learning) associated with increased PCB exposure. The North Carolina and Dutch studies reported hypotonicity associated with increased PCBs; the North Carolina study reported increased abnormal reflexes, for which the Oswego study found a trend. In the Michigan study, maternal fish consumption was associated with motoric immaturity, poorer lability of states, abnormal reflexes, and a greater degree of startle (48). Cord serum levels were not predictive in the Micigan study. However, there were only a limited number of cord blood samples, particularly from highexposure infants. Four of the studies assessed performance on the Bayley Scales of Infant Development, with only the Michigan study failing to find an effect (11,49–51). Three studies used the Fagan test of visual recognition memory: Michigan (49), Oswego (52), and German (11). Effects were observed in the Michigan and Oswego studies, but not the German, possibly as a consequence of poor experimental control (11). Language development was assessed in two studies. The Dutch study found adverse effects of in utero exposure to PCBs in formula-fed infants using the Reynell Language Development Scale (42). The Michigan study found negative effects on verbal IQ, verbal comprehension, and reading ability at 11 yr of age (8). Effects were not observed in the Dutch study on the Auditory Verbal Learning Test (53), which is not a test of language function per se, but assesses short-and longer-term memory for word recall. Performance on a vigilance task was assessed in three studies at various ages between 3.5 and 11 yr. The Dutch (54), Oswego (55), and Michigan studies (56) all found effects related to PCB exposure: in fact, all three studies found increased errors of commission (failure of response inhibition). The Michigan investigators also found a decreased number correct responses and increased errors of commission at four years of age on the Sternberg Memory paradigm, a computerized test of working memory that allows responding to digits not on a sample list (57). The Oswego study also reported an interaction between the size of the corpus collosum (a major brain fiber tract subserving interhemispheric communication) and increased PCB body burden on errors of commission (55). The Dutch investigators found increased response latencies and more variable latencies on a simple reaction time task related to increased PCB exposure at nine years of age (53). This task is similar to the vigilance task, but does not provide the opportunity to respond on incorrect stimuli (errors of commission). No information was provided on failure to respond to the target. The effects observed on the vigilance task are indicative of deficits in “executive function,” the ability to organize behavior in time and space. The Dutch investigators found deficits in spatial executive function on the Tower of London in their cohort at nine years of age (53). No effects of PCB exposure were found on the Rey Complex Fig. Task, which assesses visuospatial organization and memory. The Michigan investigators reported increased perseverative errors on the Wisconsin Card Sort test at 11 yr, as well as deficits in attention on the Digit Cancellation task (57). The Michigan study also reported slower reaction time on a mental rotation task (57), which in the absence of effects on accuracy in this task or reaction time on other tasks, may be considered to be a consequence of a deficit in response organization, again indicative of a problem with executive function. However, no effects were observed in this cohort on the Stroop Color-Word Test, another test of executive function. Observed effects were associated with prenatal and not postnatal exposure. Both the Dutch (54) and the Michigan (58) studies found changes in activity. The Michigan study reported a decrease in activity at 4 yr as assessed by the rating of three adults. The Dutch study reported increased activity as assessed by a parents’ rating scale, but a decrease in free play behavior, at 3.5 yr of age.
48
Rice
The Dutch study also assessed problem behavior using the Child Behavior Check List (CBCL) (59) at 3.5 yr. They reported effects on the internalizing, withdrawn/ depressed and aggressive scales, but not oppositional or overactive scales. Scores on the anxious scale were borderline. Sexually dimorphic play behavior was examined in the Dutch cohort at 7.5 yr using the Pre-School Activity Inventory to test the hypothesis that PCBs and dioxins exert effects on behavior via endocrine disruption (60). Prenatal PCB concentrations were associated with less masculinized play behavior in boys and more masculinized behavior in girls, whereas higher prenatal dioxin levels were associated with more feminized play behavior in both boys and girls. An important issue that has been examined in the Dutch and Michigan studies is the possibility of effect modification: specifically, the salutary effects of an advantaged home environment in reducing the adverse effects of PCBs on children’s development. In the Dutch study, effects were observed on the K-ABC at 3.5 yr in formula-fed but not breast-fed infants (42). These findings were originally attributed to the nutritional benefits of breastfeeding. However, they are more likely the result of the fact that mothers with a higher socio-economic status and education breast-feed their babies longer. The Dutch study found negative effects at 6.5 yr of age on the McCarthy Scales in less- but not moreadvantaged children (61). Analyses revealed that it was because formula-fed infants were from less advantaged homes, and not the formula-versus-breast-fed dichotomy per se, that accounted for the difference in performance on the McCarthy Scales (61). Similarly, the Michigan investigators found that effects on IQ at four and 11 yr were present in infants breast-fed fewer than 6 wk, but not those breast-fed more than 6 wk (62). As in the Dutch study, the Michigan investigators reported that the lack of association between PCB exposure and IQ at 4 or 11 yr of age in breast-fed babies could be accounted for by statistically by quality of parental intellectual input, and that adverse effects were strongest in children of less verbally competent mothers (63,64). The findings in these studies are consistent with studies in lead-exposed children, in which adverse effects were greater in less advantaged children (65). It appears that high-quality parental care may ameliorate, or at least attenuate, the effects of neurotoxic agents. The German investigators studied the effects of home environment and PCB exposure independently. They reported that HOME score was positively associated with mental and motor development on the Bayley Scales at 30 mo and on the K-ABC at 42 mo, whereas increasing milk PCB concentrations were associated with poorer performance, when each variable was adjusted for the other (43). At 72 mo, effects of the HOME score were still a predictor of positive outcome on the K-ABC in this relatively advantaged population (66). The effects of PCBs were no longer significant based on 70 children (less than half the original cohort), although the direction was still negative. The Faroe Islands study, which was designed to study the effects of in utero methylmercury exposure, did not include early development assessment, nor was IQ measured. Instead, a number of domain-specific functions were assessed at seven years of age (67). Only limited effects of PCBs were found prior to control for methylmercury exposure (13) despite the high PCB concentrations (40). A negative association was found between cord tissue PCB levels and performance on the Boston Naming Test, a test of language development. This is consistent with the effects on language in the Dutch and Michigan studies. Effects were also found on a continuous performance test. No effects of PCBs were found on any endpoint in the Faroe Islands study after controlling for methylmercury exposure, although there was some indication of effects on several endpoints in children in the highest tertile with respect to methylmercury. Conclusions. It appears, based on information presently available, that the effects of PCB on IQ, identified at 3–4 yr of age, attenuate or disappear as the child reaches school
PCB Exposure on Neuropsychological Function
49
age in studies begun in the 1990s. It is unknown whether effects will reappear, as was the case for lead in the Cincinnati study (68,69). It also seems, however, that children from less advantaged homes may still be vulnerable to effects of PCBs on IQ at school age. Investigators of the various studies have assessed measures other than IQ in a somewhat individualistic manner, and have identified behavior domains affected by PCBs that require more detailed investigation to characterize effects. One area is that of executive functions: attention, temporal and spatial organization of behavior, and response inhibition. Deficits on spatial tasks have been observed in rats (25,26,29,70), and failure of response inhibition and poor temporal organization of behavior have been observed as a consequence of PCB exposure in monkeys (19,20). Adverse effects in these domains have been observed in the modern PCB studies, but require fuller characterization. Perseverative behavior was observed at 11 yr of age in the Michigan cohort (56). Perseverative behavior as a consequence of PCB exposure in animals was observed in monkeys (21). It is important to assess perseverative behavior in the newer studies in which exposures are lower than those observed in the Michigan study. Another area that requires exploration is social- and antisocial- behavior. Poorer outcome on the CBCL suggests that these children may be at risk for increased criminality in the future, as was the case for lead (71–73). The effects of PCBs and dioxins on masculinization or feminization of play behavior suggests that the potential behavioral consequences of effects on sex hormones should be pursued. Effects of contaminants on social interactions and behavioral consequences of perturbation of sex hormones have been little studied, yet are vitally important to the functioning of the individual in society.
CHOICE OF CONGENERS AND TISSUE COMPARTMENT AS DETERMINANTS OF EXPOSURE PCBs are a mixture of as many as 209 congeners with varying degrees and patterns of toxicity. The fingerprint of PCB congeners in human tissue following environmental exposure is reasonably consistent between populations (74), although there may be differences resulting from sources and recency of exposure (75). It is vitally important to understand the relative potency and pattern of deficits produced by different congeners or congener classes on nervous system function and development to provide the best advice for protection of public health. It is also important to understand in which tissue(s) determination of PCB concentrations provides the best predictor of neurotoxicity. The more recent studies had the opportunity to perform congener-specific analysis using sensitive analytical methodology. Investigators used different strategies regarding which PCB congeners and tissues to analyze. The Oswego study measured 68 congeners or congener pairs in cord blood, with no analysis of maternal blood (10). Breast milk was analyzed from a small subset of women at varying times during the first six months following delivery, thereby essentially obviating the possibility of assessing any effects of postnatal exposure via breast milk. The most highly chlorinated PCB congeners (C 7–9) were predictive of fish consumption, whereas the lower chlorinated homologs (C 1–3 or 4–6) were not. In addition, for most measures the most highly chlorinated congeners were a better predictor of performance than total PCBs or lower chlorinated homologs during infancy (10,47,52) and early childhood (44). The Oswego study did not measure dioxins, and only measured two of the less potent dioxin-like PCB congeners (105 and 118). However, because body burdens of these two congeners may represent a substantial percentage of dioxin-like congeners, they can represent a large proportion of the total toxic equivalency quotient (TEQ) (76).
50
Rice
Only the Dutch study focused on discriminating effects of total PCBs from those of dioxins and dioxin-like PCBs on neuropsychological function. Dioxin-like compounds are those that activate the aryl hydrocarbon (Ah) receptor as a mechanism of action for producing toxic effects. The relative potency compared to 2,3,7,8-tetrachlorinated dibenzo-p-dioxin (TCDD, the most potent dioxin) has been determined by an international committee for the dozen dioxin-like PCB congeners as well as other chemicals that act through Ah receptor activation (77). Individual toxic equivalency factors (TEFs) can be combined into an overall TEQ to estimate the “dioxin-like” potency of a mixture. The Dutch investigators measured, in both maternal and cord blood, the four congeners that typically are found at the highest concentrations in human tissue (congeners 118, 138, 153, and 180) (51). They also measured 17 dioxins and furans, 6 coplanar or mono-ortho coplanar (dioxin-like) PCB congeners, and 20 ortho-substituted congeners in breast milk shortly after birth from the half of the mothers who breast-fed their infants. PCBs and other lipid-soluble chemicals are at higher concentrations in milk than blood, so that sampling of breast milk allowed analysis of more congeners with greater accuracy. The dioxins, furans, and dioxin-like congeners were used to calculate dioxin TEQs separately, or as a total TEQ. This provided the opportunity to determine the association between performance and concentrations of dioxins, dioxin-like- and non-dioxin-like PCBs in breast-fed infants, as well as the sum of the four congeners in maternal and cord blood and breast milk in the full cohort. In general, maternal blood PCB levels were the best predictors of performance measures on the Bayley Scales during infancy (51), and the K-ABC at 3.5 yr of age (42). The sum of PCBs in cord blood was predictive of five outcomes, whereas maternal blood PCB levels were predictive of nine outcomes. This may well be due to the higher levels in maternal compared to cord blood, allowing more accurate measurement of PCB concentrations. PCB levels in milk and milk TEQ were both predictive of only one measure in early assessments: neurological status during infancy (12,51). Similarly, planar, mono-ortho, or dioxin TEQ were not predictive of free play behavior, performance on a vigilance task, or activity according to a parents’ questionnaire at 3.5 yr (54). Total TEQ, dioxin-TEQ, and planar PCB TEQ were each predictive of a more adverse score on the internalizing scale of the CBCL, whereas the sum of the four congeners measured in maternal or cord blood were not (59). All measures were predictive of adverse scores on the withdrawal/depressed scale. In a subsequent study on play behavior, all four measures were predictive of differential behavior in boys and girls: dioxin TEQ in milk predicted more feminized play behavior in both sexes, whereas the sum of the four PCB congeners in cord or maternal blood predicted less masculinized behavior in boys and the sum of the four PCB congeners in milk predicted more masculinized behavior in girls (60). Performance on the Tower of London was assessed at nine years in half the cohort (from Rotterdam but not Gro¨ningen) (53). Higher levels of the four congeners measured in maternal plasma were associated with longer and more variable response times on a simple reaction time task, and lower scores on the Tower of London. Other exposure variables (e.g., cord blood or TEQ) were not compared in this publication. The German study only measured three congeners (153, 138, and 180) in cord plasma. They also measured these congeners in breast milk at 2 and 4 wk postpartum, which were combined to yield a single value. Adverse effects were associated with milk PCB levels on early infant psychomotor and memory tests (11) and performance on the K-ABC at 3.5 yr (43). The authors considered milk PCB concentrations to be a more accurate measure of prenatal exposure than cord blood, since levels are much higher and therefore presumably analyzed more accurately. This contrasts with the Dutch study, however, in which cord (but particularly maternal) blood PCB concentrations predicted
PCB Exposure on Neuropsychological Function
51
cognitive performance at 3.5 yr, but milk levels, taken on the half of the cohort that breast fed, did not. The Faroe Islands study measured five congeners in cord tissue in half the cohort only (118, 138, 153, 170, and 180), but used only 138, 153, and 180 as exposure markers (13), precluding exploration of issues related to optimal markers of exposure. This issue has been little explored in animals. In a series of studies in rats with dioxin (TCDD) and five PCB congeners with or without dioxin-like properties (28, 118, 153, 77, 95), Schantz and colleagues (25,26,70) found all to be neurotoxic, but with different patterns of impairment on the two tasks examined. Rice and colleagues (78–82), on the other hand, reported minimal neurotoxicity following developmental exposure to congener 126, whereas effects were observed in other organ systems. Conclusions. The issue of which congeners are producing toxicity is an important one for public health. It appears from the Dutch study that TEQ in breast milk did not predict performance on most outcome measures early in life, but then neither did non-dioxin-like congeners in breast milk. TEQ was predictive of outcome on non-cognitive endpoints at 3.5 yr of age, and on the masculine/feminine dimension of play behavior at 6.5 yr. The Oswego study measured a reasonable number of congeners, but did not include most dioxin-like PCBs, including the most potent congeners, 126 and 169; therefore, there is not the opportunity to determine whether TEQ is predictive of performance. In the Oswego study, the more highly chlorinated PCBs best predicted performance, but that may be because these congeners are more reliably analyzed than lower-chlorinated congeners because of lack of interference from other chemicals. Both the German and Faroe Islands studies used only three congeners as markers of exposure. The question of whether some congeners are more toxic than others (although this may be assumed), and which those may be, remains largely unaddressed in epidemioloigcal studies. Although only measuring a few congeners may provide a reasonable indication of PCB body burden, such a strategy runs the risk of failing to adequately monitor the congeners or congener classes associated with toxicity. The Oswego study found that total PCBs, even based on 68 congeners, was often not predictive of outcome, whereas highly chlorinated PCBs were. Similarly, the Dutch investigators found that dioxin TEQ predicted some effects that the four congeners used as a surrogate for total PCBs did not. It is also unclear which tissue may be the best to use for PCB determination. The Dutch study suggests that maternal blood in preference to cord blood or milk is a better predictor, at least through early childhood, whereas the German study indicates that milk may be preferable to cord blood. The Oswego study measured only cord blood but multiple congeners, and found effects on numerous endpoints. With current knowledge, it is not possible to recommend one tissue over another; the best strategy is to measure all three compartments.
DETERMINATION OF EFFECTS OF MULTIPLE CHEMICALS IN ADDITION TO PCBS A reality that must be addressed in the evaluation of effects of PCBs on neuropsychological function in children is the fact that all of us are exposed to multiple contaminants, from conception (or pre-conception) onward. Exposures to other chemicals can serve as confounders or effect modifiers. In some instances, the degree of collinearity may be sufficiently high that effects of PCBs cannot be differentiated from those of other chemicals.
52
Rice
No study can measure every chemical believed to possibly be relevant when the study is planned, and the list is constantly expanding. (For example, there is increasing concern about the effects of brominated flame retardants, which are bioaccumulated, bioconcentrated, persistent, and may have many of the same adverse health effects as PCBs. These chemicals were not of concern when the studies under discussion were planned and implemented.) Investigators are forced to choose which co-contaminants may be the most relevant for their study population. Different decisions concerning which and how many chemicals to measure have been made in various studies, making comparison between studies sometimes difficult. Lead is a known neurotoxicant, and exposure is ubiquitous in industrialized countries. All investigators have measured blood lead concentrations in the children. Since lead was not the focus of the study, however, exposure was not necessarily measured as accurately as other contaminants. For example, the Oswego study obtained cord blood lead concentrations from the full cohort, but only a single lead measurement from a subset of the cohort during early childhood. The Michigan study measured blood lead levels in the children at four and 11 yr of age (8). Other studies only measured cord blood, including the German (43), Inuit (14) and Faroe Island (67) studies. The Dutch study measured blood lead and cadmium concentrations of the children at 18 mo of age (83). Blood lead concentrations during early childhood, not cord blood lead, is the best predictor of performance at school age (84,85). Since the correlation between lead and PCBs is presumably low in all recent studies, it is unlikely to be a confounder of the effects of PCBs. However, controlling for lead, particularly childhood lead levels, may have strengthened or revealed effects of PCBs in some studies. Measuring lead concentrations at appropriate ages would have the ancillary benefit of allowing exploration of the effects of lead on the endpoints under study, as was done in additional analyses of the Michigan study (57). In addition, lead and PCBs have similar effects on synaptic plasticity in brain slices (86), suggesting the possibility of interactive effects. Methylmercury is another known developmental neurotoxicant that may be associated with adverse effects in PCB studies. Co-exposure could be particularly important in studies in fish-eating populations. The Michigan study was criticized for not measuring body burdens of methylmercury (or mercury) (87), since Lake Michigan fish are known to be contaminated with methylmercury. The Oswego study, designed as a replicate of the Michigan study, did measure methylmercury in maternal hair sectioned to correspond with the first and second half of pregnancy (52). The Faroe Islands study was designed to study the effects of methylmercury, not PCBs, and analyzed both maternal hair and cord blood for total mercury (67). (In contrast, PCB concentrations were measured in cord tissue in half the cohort.) The Inuit study also measured mercury in cord and maternal blood, as well as hair sectioned to represent each of the three trimesters of pregnancy (14), in recognition of relatively high exposure to methylmercury in the Arctic. Neither the Dutch nor German studies measured methylmercury concentrations. There has been considerable discussion concerning whether blood or hair mercury is a better measure of exposure: the National Academy of Sciences report on the health effects of methylmercury expressed the opinion that both were good (88). However, the Faroe Islands study found cord blood to be a better predictor than maternal hair, at least as assessed by p-values (67). PCB and methylmercury levels are unlikely to be so highly correlated in either fish-eater or general population studies that effects cannot be differentiated. In the Oswego study, which recruited consumers of Lake Ontario fish, the two contaminants were not highly correlated (rZC0.11) (44), probably because fish is the only source of methylmercury exposure, whereas there are of many dietary sources of PCB exposure. In addition, PCB and methylmercury levels are not necessarily highly correlated even
PCB Exposure on Neuropsychological Function
53
in fish. Methylmercury concentrations in fish in Lake Ontario are relatively low, and methylmercury body burdens are also low in the cohort. Methylmercury has not been found to be a predictor of performance on most endpoints, although a mercury-PCB interaction was identified on the McCarthy Scales at 3.5 yr of age (44). A possible influence of methylmercury on the effects of PCBs was reported in the Faroe Islands study, in which PCB and mercury body burdens are both relatively high, with a correlation of about 0.4 based on wet-weight PCB concentrations (89). There was no statistical evidence for an interaction between methylmercury and PCBs when regression analyses for effects of methylmercury were performed separately according to PCB tertiles (89). However, there was some evidence that the effects of PCBs on several measures were only present in children in the highest tertile respect to methylmercury (67). Methylmercury exposure was not measured in the North Carolina, German, or Dutch studies. Because PCB exposure in these populations was through the general food supply, the correlation between PCBs and methylmercury may have been low. However, as with lead, failure to measure methylmercury in these studies is a missed opportunity to assess potential interactions of PCBs and another important neurotoxicant. Of perhaps greatest importance for interpretation of PCB studies is the inclusion (or not) of the measurement of other lipophilic chemicals. The source of PCBs in humans is consumption of fatty animal products, which is also the source of other lipophilic contaminants. These chemicals therefore may be highly correlated within individuals. Of perhaps the most concern is dioxins and the related furans. Dioxins affect behavior in animal models (27,90). It would seem important, therefore, to measure dioxins (and furans) in addition to dioxin-like PCB congeners. The only study to do so thus far has been the Dutch study, in which dioxin TEQ and the sum of PCBs in breast milk, and maternal blood or cord blood were each used as exposure measures (see section on choice of congeners). Differential effects were related to total PCBs, dioxin, and/or PCB TEQ on a number of outcome measures. Pesticides are another class of neurotoxic chemicals that may interact with PCBs in producing adverse health consequences. DDE was not found to be associated with effects in the Oswego study on infant neurological status or performance on the McCarthy Scales at 36 or 54 mo (44). On the Fagan test of infant recognition memory, DDE was significantly associated with performance in the univariate analysis, but not after controlling for PCBs (52). The North Carolina study assessed effects of prenatal exposure to PCBs and DDE without controlling for the other chemical. They reported that both chemicals were associated with adverse outcome on the Brazelton Neonatal Behavioral Assessment Scales (91), whereas on the Bayley Scales, PCBs predicted poorer performance at 6 and 12 mo and DDE predicted better performance at six months (92). The correlation between PCB and DDE in breast milk was 0.23 (93), so that failure to include the alternate chemical in the statistical analyses ignored a potential confounder. The Faroe Islands study is less clear with regard to possible effects of DDE. In a paper reporting the effects of PCBs (13), tissue concentrations of both PCBs and DDE were reported. Univariate analyses of the association of DDE and performance were apparently performed, and the authors stated that “[b]ecause of.collinearity, the regression coefficients of [DDE] were very similar to those for.PCB (data not shown).” Results were not provided. DDE was not included as a covariate in the PCB analyses. One is left with the conclusion that both PCBs and DDE were significant predictors of outcome. It may not have been possible to disentangle the effects of DDE and PCBs, but the paper does not adequately report the findings of the study. In contrast, in a subsequent
54
Rice
cohort study in the Faroe Islands, methylmercury was a significant predictor of poorer infant neurological status, whereas PCBs and DDE were not (94). The Oswego study also measured mirex and hexachlorobenzene, which were not found to be predictive of performance. The Inuit study measured a total of 11 pesticides, including DDT and DDE. The Inuit study failed to find an association between neurological status in early infancy and multiple pesticides, including DDT/DDE, whereas adverse effects were associated with PCBs (95). The Michigan study measured seven organochlorine pesticides, which were unrelated to performance, as were PBBs (9). Other studies have not measured pesticide body burdens, so whether pesticide exposure is producing effects in these cohorts, including possibly interacting with PCBs, is unknown. Conclusions. From the results of studies to date, several inferences may be made. Based on the Dutch study, it appears that the effects of non-dioxin-like PCBs may often be distinguishable from those of dioxins and dioxin-like PCBs as determined by TEQ. However, since this is the only study to examine this issue, definite conclusions cannot be drawn. It also appears that, at the low body burdens of methylmercury present in the Oswego study, there is not usually an interaction between methylmercury and PCBs. However, there may be an interaction when body burdens of both contaminants are high, as in the Faroe Islands cohort. Body burdens of lead have generally been low in recent studies, and not associated with effects. The Oswego study is the only recent study to publish an assessment of the effects of multiple pesticides on neuropsychological function, and no effects related to pesticide body burden have been found. It appears that the contribution of effects from other chemicals has not compromised the ability to interpret the effects of PCBs in these cohorts. It is nonetheless important to continue to measure multiple contaminants in any new studies, and to continue to include measured contaminants in analyses as potential confounders or co-contributors to neurotoxicity. In addition, the relative contribution of PCBs and dioxins to neurotoxicity, and the types of deficits produced by each, is an important issue that requires much more research.
CONTRIBUTION OF POSTNATAL EFFECTS TO NEUROTOXICITY Since PCBs are lipophilic, there are much higher concentrations in breast milk relative to maternal or cord blood. Babies who breast feed for even a few weeks receive much larger amounts of PCBs via nursing than they received in utero (96,97), and blood PCB levels during childhood are largely reflective of exposure through breast milk (98,99). Breast milk PCB concentrations decrease rapidly over several weeks as the infant nurses; the best way for a woman to decrease her own store of PCBs is to breast feed (76,91,100,101). Since developmental processes in the nervous system are ongoing well after birth (102), it seems reasonable that postnatal PCB exposure should have an effect. It was therefore somewhat puzzling that early studies reported effects associated with prenatal but not postnatal exposure on infant and early childhood neuropsychological development (7,8,45,46,49,50,58,92,103). The Dutch study is best suited to examine the contribution of postnatal exposure to behavioral outcome: since it was designed specifically to assess the effects of exposure through breastfeeding versus in utero exposure, half the cohort was breast-fed for at least 6 wk and half was not breast-fed at all. Breast-fed infants performed better on neurological assessments during infancy (51), but this may be the result of the more advantaged social environment of the infants that were breast-fed rather than breastfeeding per se (61). Postnatal TEQ, but not measures of prenatal exposure, was associated with poorer performance on the Bayley PDI at seven months, negating the positive effects of
PCB Exposure on Neuropsychological Function
55
breastfeeding at higher exposures (51). Prenatal exposure was negatively associated with performance on the Bayley PDI at three months, the neurological optimality score at 18 mo, and outcome on a neurological examination at two weeks (12,51). Effects on early neuropsychological function and cognitive performance at 3.5 or 6.5 yr were reported to be related to prenatal exposure but not postnatal exposure (42,61). Significant associations were observed between the concurrent blood level of the child and increased reaction time on a vigilance task, more hyperactive behavior, and poorer attention at 3.5 yr in the breast-fed group (54). PCB blood levels of breast-fed infants were considerably higher than formula-fed infants, and are presumably largely the result of breastfeeding (97,98). An interesting strategy for the determination of pre-versus postnatal effects was adopted by the Dutch investigators in an assessment of performance on domain-specific tasks at 9 yr (53). They divided the Rotterdam half of the cohort into six groups: formula-fed, low or high prenatal exposure as assessed by maternal blood levels; breast-fed for less than 16 wk, low or high prenatal exposure; and breast-fed for more than 16 wk, low or high prenatal exposure. On the Tower of London, there was evidence of prenatal effects (formula-fed high vs. low) as well as a postnatal effect (breast-fed low vs. formula-fed low). There was a marginal effect of breast-fed long versus breast-fed short, and other comparisons were as would be expected (breast-fed short or long vs. formula-fed). On a simple reaction-time task, only prenatal exposure was predictive of performance. The German study measured three congeners in breast milk and cord blood, and recorded weeks of breastfeeding. They reported a negative association between prenatal exposure, as measured by breast milk but not cord blood PCB concentrations, and performance on the Bayley at 30 mo and the K-ABC at 42 mo (43). They also reported a negative effect of postnatal exposure on cognitive performance on the K-ABC at 42 mo of age, measured either by the child’s concurrent blood PCB concentration or breast milk concentration X weeks of breastfeeding. Potential effects of postnatal exposure were apparently not assessed before 42 mo. Based on 70 children (fewer than half the original cohort), effects of neither milk PCB levels (maternal exposure) nor the child’s concurrent blood PCB concentration (postnatal exposure) were significantly associated with the mental processing composite scale of the K-ABC at 72 mo of age, although the trend was negative for both (66). In the Michigan study, prenatal exposure as measured by umbilical cord blood was associated with poorer performance during infancy and at four years of age (45,46,49,62,103). In contrast, exposure via breastfeeding as determined by breast milk PCB concentration X weeks of breastfeeding was not predictive of cognitive performance. However, decreased activity as rated by three adults was associated with postnatal exposure through breastfeeding at four years of age (9). Measures of IQ, attention, and memory were associated with a composite marker of prenatal exposure including cord and maternal blood and breast milk PCB concentrations at 4 and 11 yr (8,57). In a reexamination of the effects at 4 and 11 yr (63), effects were observed on nine of 21 outcome measures in infants breast-fed fewer than six weeks, and on two different measures in infants breast-fed more than six weeks. These latter effects (reaction time on a mental rotation task and errors on the Seashore Rhythm test) may be chance findings, or may reflect an influence of postnatal exposure. In the Michigan study, prenatal exposure was measured by cord blood and/or breast milk PCB concentrations. One breast milk sample was collected within 4.5 mo postpartum, with a median of one month (57). Postnatal exposure was calculated by the measured concentration in breast milk X weeks of breastfeeding. The presumably large variability in time of collection would result in significant exposure misclassification, given that PCB milk concentrations would change dramatically over the first several
56
Rice
months of breastfeeding. Control for prenatal exposure was included in the postnatal analyses, and the child’s blood PCB concentration at four years was used as a control variable in the prenatal analyses in the re-analyses (63). There was no information concerning how many blood samples were above the limit of detection with the old methodology available at the time the study was performed. However, the mean and standard deviations appeared similar to those of cord blood, in which 70% of samples were below the limit of detection. It is therefore likely that the control for concurrent body burden on prenatal effects was relatively poor. In contrast, prenatal exposure was measured by a composite of breast milk, maternal serum, and cord serum levels at 4 and 11 yr, and so was likely a more accurate indicator of prenatal exposure than a child’s blood PCB concentration at 4 yr was an indicator of postnatal exposure (see comments below on over-controlling). No effects were attributed to postnatal exposure as measured by the child’s concurrent blood PCB level, after controlling for prenatal exposure. Conclusions. Several design issues are relevant to the ability of studies performed to date to identify effects of postnatal exposure. Two of the three modern studies (Dutch, German) measured PCB levels in milk taken shortly after birth. The Dutch study collected only one sample, whereas the German study collected milk at two and four weeks postpartum, and averaged them to derive a measure of PCB milk concentration. Both studies multiplied a PCB concentration X weeks of breastfeeding to estimate exposure through breastfeeding. Neither study collected sequential samples beginning within a day or so of birth and ascertained the PCB “wash-out” curve, which is presumably exponential and with an unknown half-time (either in terms of central tendency or on an individual basis). Multiplying one value X weeks of exposure would result in exposure misclassification, which may be substantial if there was a large variability in the length of time of breastfeeding (such that babies stopped exposure at different points on a rather steep wash-out curve). Exposure misclassification of course biases results toward not finding an effect even if there is one. The North Carolina study considered the decline in breast milk concentrations over the duration of breast feeding in the estimation of exposure through breast milk. They sampled milk at birth and several times thereafter. The average percent decrease in milk PCB levels across time based on all women, with linear extrapolation between time points, was used in the estimation of total PCB intake (93). Lack of sufficient data from individual women precluded modeling wash-out curves for individuals (Gladen, personal communication). While not an optimum strategy, this approach is an improvement over other studies in that it incorporated at least an approximation of the decrease in breast milk levels over time. The North Carolina study did not find any effect of PCBs on the McCarthy Scales at 3–5 yr. Further testing was not performed, so that the possibility that postnatal exposure may have predicted effects later in childhood could not be explored. The Dutch and German studies measured blood PCB concentration of the child concurrent with testing at 3.5 yr. Both studies reported effects associated with the child’s concurrent PCB body burden, which is largely the result of exposure through breast milk (97,98). However, this measure too is an imprecise indicator of the child’s exposure during infancy. It is not known whether the child’s body burden at the time of testing (reflecting ongoing effects of exposure to PCBs) or accurate determination of early postnatal exposure would have been the best predictor of performance. The second issue that might result in an underestimation of the effects of breastfeeding is the fact that the effects of breastfeeding were generally assessed controlling for in utero exposure, using blood and/or breast milk concentrations. First, in utero and postnatal exposure via breast milk will be highly correlated, even given that mothers breast feed for different lengths of time, since breast milk is highest following
PCB Exposure on Neuropsychological Function
57
delivery and decreases markedly over a few weeks. Therefore, the early and highest exposure shortly after birth is essentially eliminated from statistical analysis by this procedure, leaving the inaccurate single concentration X weeks of feeding as the measure of postnatal exposure. This analytic strategy is based on the assumption that the primary contribution to any observed deficits will always be in utero exposure. Although it is established that in utero exposure may produce adverse effects (from infants not breast-fed) the strategy of controlling for in utero exposure may represent overcontrolling. The most recent analysis by the Dutch investigators avoided this dilemma by dichotomizing maternal PCB concentration and duration of breastfeeding, eliminating the temptation to control for prenatal exposure when examining the effects of breastfeeding (60). The importance of the contribution of PCBs from breastfeeding to performance is still very much an open question. We do not know how important exposure to PCBs through breastfeeding may be, nor do we understand the interaction of PCB exposure with the benefits of breastfeeding on neuropsychological development. We also do not have much understanding of what kinds of behaviors may be affected by postnatal exposure to PCBs. Although the Dutch study did not find effects of postnatal exposure on cognition at 3.5 yr, the German study did. The Dutch study did find an effect on executive function associated with postnatal exposure at nine years of age, however. Effects on the child’s concurrent blood levels were also associated with other endpoints in the Dutch study. Moreover, the Oswego study did not provide the opportunity to examine postnatal effects, so that the emphasis on prenatal exposure as the important (or only) contributor to adverse outcome may be misleading.
DETERMINATION OF THE RELATIONSHIP BETWEEN EXPOSURE AND EFFECT There is no information published to date on the shape of the relationship between exposure of the infant (or child) to PCBs and performance on any measure. It is unknown whether the relationship is best fit by a linear model, which would suggest that there is no threshold within the range of body burdens studied, or whether it is sublinear (shallower slope at lower body burdens), suggesting that there is a threshold of body burden below which there does not appear to be an adverse effect. This is of vital importance to our understanding of the potential burden for society that ubiquitous exposure to PCBs may produce. Investigators of these studies performed analyses to determine whether there was a statistical association between exposure and performance on one or more measures, which is the standard form of analysis. In contrast to PCBs, the shape of the exposureeffect relationship, and whether there may be a threshold, has been studied for the neurotoxicants lead and methylmercury, both by individual investigators (104–106) and government agencies (88,107–109). For those neurotoxicants, there is evidence that the relationship may be supralinear: i.e. a relatively steeper slope, and therefore greater relative effect, at lower body burdens than higher. Some limited information may be gleaned from graphic representation of data in publications. For example, in the Dutch study, performance on the K-ABC was represented graphically in five categories (42). For all scores (overall cognitive, sequential processing, and simultaneous processing), all four of the higher groups performed more poorly than the lowest group (sum PCB in maternal plasma !1.5 ppb). Information is not available concerning performance in the lowest category, so no conclusions may be drawn concerning possible threshold. Similarly, there appears to be a more-or-less monotonic
58
Rice
relationship in the Oswego study between increased PCB cord blood levels (those with values below the limit of detection, compared to other groups,) for performance on the McCarthy General Cognitive Index, Perceptual and Quantitative Scales (44). In the German study, the second quintile with respect to PCB milk levels appears unimpaired relative to the lowest quintile on the Bayley Scales at 30 or 42 mo (43), suggestive of a threshold. Such ad hoc divination by the reader of course is thoroughly inadequate in determining the association between body burden and effect. The Michigan investigators have performed a Bench Mark Dose (BMD) analysis of four outcomes measured at 11 yr of age (110). This analysis is useful for risk assessment, in that it calculates an exposure (body burden) associated with a defined risk, which can then serve as the starting point for deriving an acceptable intake level. The issue of the shape of the exposure-effect relationship was not explored, however: a linear relationship was apparently assumed. The failure on the part of most investigators to determine the relationship between exposure and effect represents a serious gap in the information required to formulate public health policy.
THYROID HORMONES AS A POTENTIAL MEDIATOR OF NEUROTOXIC EFFECTS Developmental PCB exposure affects circulating thyroid levels in both mother and offspring (111), and effects on thyroid function have been postulated as a mechanism for PCB neurotoxicity. Schantz et al. (112) reported no correlation between degree of thyroid suppression in blood and neurotoxicity following exposure to various congeners in rats. Moreover, the pattern of behavioral effects was different for different congeners, suggesting that even if thyroid suppression is contributing to the behavioral effects, it cannot be the only mechanism. The Dutch study is the only environmental epidemiological study to measure levels of circulating thyroid hormone. They found decreased concentrations of T3 and/or T4 in mothers before and after delivery, and decreased infant T3 and increased TSH at both two weeks and three months of age (113). Effects were associated with TEQ in breast milk. It is unknown whether the effects on circulating thyroid hormones were correlated with performance on any measure. Whereas it is clear that thyroid hormones are important for neurological development (111,114), the degree to which suppression of thyroid hormones by PCBs mediates neurotoxicity, if at all, at environmental exposures is unknown. However, as pointed out by Zoeller (115), the relationship between relevant events in the brain and circulating levels of thyroid hormones in the blood may be weak at best, so that elucidation of this issue is probably best pursued in experimental studies.
SUMMARY AND OVERALL CONCLUSIONS 1. There is good congruence between studies demonstrating that prenatal exposure to PCBs is associated with adverse effects on early neuromotor development and measures of IQ in early childhood. In the Michigan study, effects on IQ were still present at 11 yr of age. In newer studies, effects on IQ attenuated at 4–6 yr of age. However, there is evidence that effects on IQ continue: specifically, that
PCB Exposure on Neuropsychological Function
2.
3.
4.
5.
6.
7.
59
effects are present in children with less advantaged but not more advantaged home environments. In addition, the Dutch investigators reported effects on executive function at nine years of age. Effects have been observed on behavioral domains in addition to cognition. Deficits in attention and failure of response inhibition have been observed in several studies. Differences in activity level, play behavior, and a clinical scale of problem behavior were documented in the Dutch study. Most non-cognitive effects have been studied in early childhood, and whether effects will still be observed as the children age is unknown. However, the Dutch investigators reported differences in sexually dimorphic play behavior at 6.5 yr of age. Measurement of IQ in the studies discussed here should continue, and newer studies (such as the Inuit) should include measures of IQ. It is not yet established that effects on IQ disappear with age. It is also important to assess additional functional domains: attention, impulsivity, language processing, and social and sexually dimorphic behaviors. There is currently some evidence for effects on these domains, but effects need to be fully characterized. This may be especially important since some of the effects associated with PCB exposure are similar to those produced by lead: deficits in attention (116) and impulse control (117), perseveration on the Wisconsin Card Sort Test (118), and abnormal scores on the CBCL (72). Deficits in these functional domains may contribute to increased criminality, suggesting that similar consequences may be associated with PCB exposure as the children get older. The shape of the relationship between exposure (body burden) and effects is unknown. It is not determined whether there is evidence for a threshold within the range of body burdens of individuals in these studies, or conversely, whether effects are actually relatively greater at lower body burdens. This issue is of vital importance for public health policy decisions. The relative potency of specific congeners or congener classes to produce neurotoxic effects is unknown. The epidemiological studies have been unelucidating in this regard, and only a few congeners have been explored in animal models. It might be fruitful to model dose-effect functions for individual congeners or congener classes from current studies that measured a sufficient number of congeners (Dutch, Oswego). The contribution of the effects of other chemicals in addition to PCBs is not well characterized. There is some evidence, particularly for the Faroe Islands study, that PCBs and methylmercury may interact to produce neurotoxicity. There does not appear to be an adverse effect of DDE or other pesticides assessed in the Oswego study. Results from the Inuit study, which measured a number of pesticides, are yet to be published. The issue of the contribution of dioxin, and dioxin-like PCBs, is of considerable importance, and has only been examined in the Dutch study. Results suggest that for some types of outcomes, TEQ, including only planar PCB TEQ, may be predictive of outcome, whereas total PCB concentration is not. The relative importance of postnatal exposure to observed effects is inadequately examined. There have not been accurate data collected on postnatal exposure during infancy. Even so, the two modern studies that have determined PCB blood level of the child have reported effects related to concurrent body burden. In addition, the Dutch investigators observed effects associated with duration of breast feeding at nine years of age. This issue is obviously important with respect to advice regarding breastfeeding.
60
Rice
In summary, there is compelling evidence that developmental exposure to PCBs produces behavioral impairment on a number of domains. However, there are significant gaps in our understanding concerning the effects of PCBs. One of the most important from a public health perspective is the lack of information on the shape of the exposure-effect relationship, including whether there is evidence for a threshold. Another critical area from a public health perspective is the characterization of the effects of postnatal exposure, and at what concentrations adverse effects of PCB exposure potentially negates the positive effects of breastfeeding on neuropsychological function.
REFERENCES 1. Guo YL, Lai TJ, Chen SJ, Hsu CC. Gender-related decrease in Raven’s progressive matrices scores in children prenatally exposed to polychlorinated biphenyls and related contaminants. Bull Environ Contam Toxicol 1995; 55:8–13. 2. Chen YJ, Hsu CC. Effects of prenatal exposure to PCBs on the neurological function of children: a neuropsychological and neurophysiological study. Dev Med Child Neurol 1994; 36:312–320. 3. Chen YC, Yu ML, Rogan WJ, Gladen BC, Hsu CC. A 6-year follow-up of behavior and activity disorders in the Taiwan Yu-cheng children. Am J Public Health 1994; 84:415–421. 4. Chen YCJ, Guo YL, Hsu CC, Rogan WJ. Cognitive development of Yu-Cheng (Oil Disease) children prenatally exposed to heat-degraded PCBs. JAMA 1992; 268:3213–3218. 5. Harada M. Intrauterine poisoning. Bull Inst Constit Med 1976; 25:38–61. 6. Fein G, Jacobson J, Jacobson S, Schwartz P, Dowler J. Prenatal exposure to polychlorinated biphenyls: effects on birth size and gestational age. J Pediatr 1984; 105:315–320. 7. Rogan WJ, Gladen BC, McKinney JD, et al. Neonatal effects of transplacental exposure to PCBs and DDE. J Pediatr 1986; 109:335–341. 8. Jacobson JL, Jacobson SW. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med 1996; 335:783–789. 9. Jacobson JL, Jacobson SW. A 4-year follow-up study of children born to consumers of great lake fish. J Great Lakes Res 1993; 19:776–783. 10. Stewart P, Darvill T, Lonky E, Reihman J, Pagano J, Bush B. Assessment of prenatal exposure to PCBs from maternal consumption of Great Lakes fish: an analysis of PCB pattern and concentration. Environ Res 1999; 80:S87–S96. 11. Winneke G, Bucholski A, Heinzow B, et al. Developmental neurotoxicity of polychlorinated biphenyls (PCBs): cognitive and psychomotor functions in 7-month old children. Toxicol Lett 1998;102–103: 423–428. 12. Huisman M, Koopman-Esseboom C, Fidler V, et al. Perinatal exposure to polychlorinated biphenyls and dioxins and its effect on neonatal neurological development. Early Hum Dev 1995; 41:111–127. 13. Grandjean P, Weihe P, Burse VW, et al. Neurobehavioral deficits associated with PCB in 7-year-old children prenatally exposed to seafood neurotoxicants. Neurotoxicol Teratol 2001; 23:305–317. 14. Muckle G, Ayotte P, Dewailly E, Jacobson SW, Jacobson JL. Prenatal exposure of the Northern Quebec Inuit infants to environmental contaminants. Environ Health Perspect 2001; 109:1291–1299. 15. Schantz SL, Widholm JJ, Rice DC. Effects of PCB Exposure on neuropsychological function in children. Environ Health Perspect 2003; 111:357–376. 16. Schantz SL. Developmental neurotoxicity of PCBs in humans: what do we know and where do we go from here? Neurotoxicol Teratol 1996; 18:217–228. 17. Rice DC. Relationship between measures of exposure to PCBs/dioxins and behavioral effects in recent developmental studies. Hum Ecol Risk Assess 2001; 7:1059–1077.
PCB Exposure on Neuropsychological Function
61
18. Rice DC. PCBs and behavioral impairment: are there lessons we can learn from lead? Open Peer Commentary Neurotoxicol Teratol 1996; 18:229–232. 19. Rice DC. Effects of postnatal exposure of monkeys to a PCB mixture on spatial discrimination reversal and DRL performance. Neurotoxicol Teratol 1998; 20:391–400. 20. Rice DC. Effect of postnatal exposure to a PCB mixture in monkeys on multiple fixed interval-fixed ratio performance. Neurotoxicol Teratol 1997; 19:429–434. 21. Rice DC, Hayward S. Effects of postnatal exposure to a PCB mixture in monkeys on nonspatial discrimination reversal and delayed alternation performance. Neurotoxicology 1997; 18:479–494. 22. Schantz SL, Levin ED, Bowman RE, Heironimus MP, Laughlin NK. Effects of perinatal PCB exposure on discrimination-reversal learning in monkeys. Neurotoxicol Teratol 1989; 11:243–250. 23. Levin ED, Schantz SL, Bowman RE. Delayed spatial alternation deficits resulting from perinatal PCB exposure in monkeys. Arch Toxicol 1988; 62:267–273. 24. Widholm JJ, Clarkson GB, Strupp BJ, Crofton KM, Seegal RF, Schantz SL. Spatial reversal learning in aroclor 1254-exposed rats: sex-specific deficits in associative ability and inhibitory control. Toxicol Appl Pharmacol 2001; 174:188–198. 25. Schantz SL, Seo BW, Moshtaghian J, Peterson RE, Moore RW. Effects of gestational and lactational exposure to TCDD or coplanar PCBs on spatial learning. Neurotoxicol Teratol 1996; 18:305–313. 26. Schantz SL, Seo BW, Wong PW, Pessah IN. Long-term effects of developmental exposure to 2,2 0 ,3,5 0 ,6-pentachlorobiphenyl (PCB 95) on locomotor activity, spatial learning and memory and brain ryanodine binding. Neurotoxicology 1997; 18:457–468. 27. Schantz SL, Widholm JJ. Cognitive effects of endocrine-disrupting chemicals in animals. Environ Health Perspect 2001; 109:1197–1206. 28. Lasky RE, Widholm JJ, Crofton KM, Schantz SL. Perinatal exposure to Aroclor 1254 impairs distortion product otoacoustic emissions (DPOAEs) in rats. Toxicol Sci 2002; 68:458–464. 29. Roegge CS, Seo BW, Crofton KM, Schantz SL. Gestational-lactational exposure to Aroclor 1254 impairs radial-arm maze performance in male rats. Toxicol Sci 2000; 57:121–130. 30. Goldey ES, Crofton KM. Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicol Sci 1998; 45:94–105. 31. Herr DW, Goldey ES, Krofton KM. Developmental exposure to Aroclor 1254 produces lowfrequency alteration in adult rat brainstem auditory evoked responses. Fundam Appl Toxicol 1996; 33:120–128. 32. Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol 1995; 135:77–88. 33. Wong PW, Garcia EF, Pessah IN. Ortho-substituted PCB 95 alters intracellular calcium signaling and causes cellular acidification in PC12 cells by an immunophilin-dependent mechanism. J Neurochem 2001; 76:450–463. 34. Wong PW, Joy RM, Albertson TE, Schantz SL, Pessah IN. Ortho-substituted 2,2 0 ,3,5 0 ,6-pentachlorobiphenyl (PCB 95) alters rat hippocampal ryanodine receptors and neuroplasticity in vitro: evidence for altered hippocampal function. Neurotoxicology 1997; 18:443–456. 35. Kodavanti PR, Tilson HA. Neurochemical effects of environmental chemicals: in vitro and in vivo correlations on second messenger pathways. Ann NY Acad Sci 2000; 919:97–105. 36. Kodavanti PR, Tilson HA. Structure–activity relationships of potentially neurotoxic PCB congeners in the rat. Neurotoxicology 1997; 18:425–441. 37. Richardson JR, Miller GW. Acute exposure to Aroclor 1016 or 1260 differentially affects dopamine transporter and vesicular monoamine transporter 2 levels. Toxicol Lett 2004; 148:29–40.
62
Rice
38. Seegal RF, Bush B, Shain W. Lightly chlorinated ortho-substituted PCB congeners decrease dopamine in nonhuman primate brain and in tissue culture. Toxicol Appl Pharmacol 1990; 106:134–144. 39. Seegal RF, Okoniewski RJ, Brosch KO, Bemis JC. Polychlorinated biphenyls alter extraneuronal but not tissue dopamine concentrations in adult rat striatum: an in vivo microdialysis study. Environ Health Perspect 2002; 110:1113–1117. 40. Longnecker MP, Wolff MS, Gladen BC, et al. Comparison of polychlorinated biphenyl levels across studies of human neurodevelopment. Environ Health Perspect 2003; 111:65–70. 41. Gladen B, Rogan W. Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl dichloroethane on later development. J Pediatr 1991; 119:58–63. 42. Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N. Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age. J Pediatr 1999; 134:7–9. 43. Walkowiak J, Wiener J-A, Fastabend A, et al. Environmental exposure to polychlorinated biphenyls and quality of the home environment: effects on psychodevelopment in early childhood. Lancet 2001; 358:1602–1607. 44. Stewart PW, Reihman J, Lonky EI, Darvill TJ, Pagano J. Cognitive development in preschool children prenatally exposed to PCBs and MeHg. Neurotoxicol Teratol 2003; 25:11–22. 45. Jacobson JL, Jacobson SW, Humphrey HEB. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 1990; 116:38–45. 46. Jacobson JL, Jacobson SW, Padgett R, Brumitt G, Billings R. Effects of prenatal PCB exposure on cognitive processing efficiency and sustained attention. Dev Psychol 1992; 28:297–306. 47. Stewart P, Reihman J, Lonky E, Darvill T, Pagano J. Prenatal PCB exposure and neonatal behavioral assessment scale (NBAS) performance. Neurotoxicol Teratol 2000; 22:21–29. 48. Jacobson JL, Jacobson SW, Fein GG, Schwartz PM, Dowler JK. Prenatal exposure to an environmental toxin: a test of the multiple effects model. Dev Psychol 1984; 20:523–532. 49. Jacobson SW, Jacobson JL, Fein GG. Environmental toxins and infant development. In: Fitzgerald HE, Lester BM, Yogman MW, eds. Theory and Research in Behavioral Pediatrics. New York: Plenum Press, 1986:96–146. 50. Rogan WJ, Gladen BC. PCBs, DDE, and child development at 18 and 24 months. Ann Epidemiol 1991; 1:407–413. 51. Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MAJ, Van der Paauw CG, Tuinstra LGMTh, Sauer PJJ. Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants’ mental and psychomotor development. Pediatrics 1996; 97:700–706. 52. Darvill T, Lonky E, Reihman J, Stewart P, Pagano J. Prenatal exposure to PCBs and infant performance on the Fagan test of infant intelligence. Neurotoxicology 2000; 21:1029–1038. 53. Vreugdenhil HJ, Mulder PG, Emmen HH, Weisglas-Kuperus N. Effects of perinatal exposure to PCBs on neuropsychological functions in the Rotterdam cohort at 9 years of age. Neuropsychology 2004; 18:185–193. 54. Patandin S, Veenstra J, Mulder PGH, Sewnaik A, Sauer PJJ, Weisglas-Kuperus N. Attention and activity in 42-month-old Dutch children with environmental exposure to polychlorinated biphenyls and dioxins. Effects of Environmental Exposure to Polychlorinated Biphenyls and Dioxins on Growth and Development in Young Children. Ph.D. Thesis. Erasmus University, Rotterdam, 1999: 123–142 55. Stewart P, Fitzgerald B, Reihman J, et al. Prenatal PCB exposure, the corpus collosum, and response inhibition. Environ Health Perspect published 2003. 56. Jacobson JL, Jacobson SW. Specific effects of prenatal PCB exposure on attention and behavior in school-age children. XX Int Neurotoxicol Meet, Little Rock AR, Feb. 2003 9–12. 57. Jacobson JL, Jacobson SW. Prenatal exposure to polychlorinated biphenyls and attention at school age. J Pediatr 2003; 143:780–788. 58. Jacobson JL, Jacobson SW, Humphrey HEB. Effects of exposure to PCBs and related compounds on growth and activity in children. Neurotoxicol Teratol 1990; 12:319–326.
PCB Exposure on Neuropsychological Function
63
59. Patantin S, Koot HM, Sauer PJJ, Weisglas-Kuperus N. Problem behavior in Dutch preschool children in relation to background polychlorinated biphenyl and dioxin exposure. Effects of Environmental Exposure to Polycholorinate Biphenyls and Dioxins on Growth and Development in Young Children Ph.D. Thesis. Erasmus University, Rotterdam, 1999: 143–156. 60. Vreugdenhil HJ, Slijper FM, Mulder PG, Weisglas-Kuperus N. Effects of pernatal exposure to PCBs and dioxins on play behavior in Dutch children at school age. Environ Health Perspect 2002; 110:A593–A598. 61. Vreugdenhil HJI, Lanting CI, Mulder PGH, Boersma ER, Weisglas-Kuperus N. Effects of prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children at school age. J Pediatr 2002; 140:48–56. 62. Jacobson SW, Jacobson JL. Breastfeeding and intelligence. Lancet 1992; 339:926. 63. Jacobson JL, Jacobson SW. Breastfeeding and gender as moderators of teratogenic effects on cognitive development. Neurotoxicol Teratol 2002; 24:349–358. 64. Jacobson SW, Chiodo LM, Jacobson JL. Breastfeeding effects on intelligence quotient in 4- and 11-year-old children. Pediatrics 1999; 103:e71–e77. 65. Bellinger DC. Effect modification in epidemiologic studies of low-level neurotoxicant exposures and health outcomes. Neurotoxicol Teratol 2000; 22:133–140. 66. Winneke G, Kraemer U, Walkowiak J, et al. Delay of neurobehavioral development following pre- and postnatal PCB exposure: persistent or reversible? The second PCB workshop— recent advances in the environmental toxicology and health effects of PCBs. Brno, Czech Republic, May 2002. Hedelberg: Springer-Verlag, 2002. Abstract published in NaunynSchmiedeberg’s Archives of Pharmacolgy (2002), Volume 365 supplement. 67. Grandjean P, Weihe P, White RF, et al. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol 1997; 19:417–428. 68. Dietrich KN, Succop PA, Berger OG, Hammond PB, Bornschein RL. Lead exposure and the cognitive development of urban preschool children: the Cincinnati Lead Study cohort at age 4 years. Neurotoxicol Teratol 1991; 13:203–211. 69. Dietrich KN, Succop PA, Bornschein RL, et al. Lead exposure and neurobehavioral development in later infancy. Environ Health Prespect 1990; 89:13–19. 70. Schantz SL, Moshtaghian J, Ness DK. Spatial learning deficits in adult rats exposed to orthosubstituted PCB congeners during gestation and lactation. Fundam Appl Toxicol 1995; 26:117–126. 71. Needleman HL, McFarland C, Ness RB, Fienberg SE, Tobin MJ. Bone lead levels in adjudicated delinquents. A case control study. Neurotoxicol Teratol 2002; 24:711–717. 72. Needleman HL, Riess JA, Tobin MJ, Biesecker GE, Greenhouse JB. Bone lead levels and delinquent behavior. J Am Med Assoc 1996; 275:363–369. 73. Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 2001; 23:511–518. 74. Gladen BC, Doucet J, Hansen LG. Assessing human polychlorinated biphenyl contamination for epidemiologic studies: lessons from patterns of congener concentrations in Canadians in 1992. Environ Health Perspect 2003; 111:437–443. 75. Gerstenberger SL, Dellinger JA, Hansen LG. Concentrations and frequencies of polychlorinated biphenyl congeners in a native American population that consumes great lakes fish. J Toxicol Clin Toxicol 2000; 38:729–746. 76. Hong CS, Xiao J, Casey AC, Bush B, Fitzgerald EF, Hwang SA. Mono-ortho- and non-orthosubstituted polychlorinated biphenyls in human milk from Mohawk and control women: effects of maternal factors and previous lactation. Arch Environ Contam Toxicol 1994; 27:431–437. 77. Van den Berg M, Birnbaum L, Bosveld AT, et al. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. Environ Health Perspect 1998; 106:775–792. 78. Bushnell PJ, Rice DC. Behavioral assessments of learning and attention in rats exposed perinatally to 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126). Neurotoxicol Teratol 1999; 21:381–392.
64
Rice
79. Crofton KM, Rice DC. Low-frequency hearing loss following perinatal exposure to 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126) in rats. Neurotoxicol Teratol 1999; 21:299–301. 80. Geller AM, Bushnell PJ, Rice DC. Behavioral and electrophysiological estimates of visual thresholds in awake rats treated with 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126). Neurotoxicol Teratol 2000; 22:521–531. 81. Rice DC, Hayward S. Effects of exposure to 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126) throughout gestation and lactation on behavior (concurrent random interval-random interval and progressive ratio performance) in rats. Neurotoxicol Teratol 1999; 21:679–687. 82. Rice DC. Effect of exposure to 3,3 0 ,4,4 0 ,5-pentachlorobiphenyl (PCB 126) throughout gestation and lactation on development and spatial delayed alternation performance in rats. Neurotoxicol Teratol 1999; 21:59–69. 83. Weisglas-Kuperus N, Patandin S, Berbers GA, et al. Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in Dutch preschool children. Environ Health Perspect 2000; 108:1203–1207. 84. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 1992; 90:855–861. 85. Dietrich KN, Berger OG, Succop PA, Hammond PB, Bornschein RL. The developmental consequences of low to moderate prenatal and postnatal lead exposure: intellectual attainment in the Cincinnati Lead Study Cohort following school entry. Neurotoxicol Teratol 1993; 15:37–44. 86. Carpenter DO, Hussain RJ, Berger DF, Lombardo JP, Park H-Y. Electrophysiologic and behavioral effects of perinatal and acute exposure of rats to lead and polychlorinated biphenyls. Environ Health Perspect 2002; 110:377–386. 87. NIEHS (National Institute of Environmental Health Sciences). Scientific issues relevant to assessment of health effects from exposure to methylmercury. Workshop organized by Committee on Environmental and Natural Resources (CENR) Office of Science and Technology Policy (OSTP), The White House, Raleigh, NC, November 18–20, 1998. 88. NRC (National Research Council). Committee on the Toxicological effects of Methylmercury, Board on Environmental Studies and Toxicology, Toxicological effects of methylmercury. Committee on the Toxicological Effects of Methylmercury, Board on Environmental Studies and Toxicology, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press, 2000. 89. Budtz-Jørgensen E, Keiding N, Grandjean P, White RF, Weihe P. Methylmercury neurotoxicity independent of PCB exposure. Environ Health Perspect 1999; 107:A236–A237. 90. Schantz SL, Ferguson SA, Bowman RE. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on behavior of monkeys in peer groups. Neurotoxicol Teratol 1992; 14:433–446. 91. Rogan WJ, Gladen BC, McKinney JD, et al. Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethylene (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 1986; 76:172–177. 92. Gladen BC, Rogan WJ, Hardy P, Thullen J, Tingelstad J, Tully M. Development after exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene transplacentally and through human milk. J Pediatr 1988; 113:991–995. 93. Rogan WJ, Gladen BC, McKinney JD, et al. Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects on growth, morbidity, and duration of lactation. Am J Public Health 1987; 77:1294–1297. 94. Steuerwald U, Weihe P, Jørgensen PJ, et al. Maternal seafood diet, methylmercury exposure, and neonatal neurologic function. J Pediatr 2000; 136:599–605. 95. Muckle G, XXI International Neurotoxicology Meeting. Honolulu, HI, Feb 9–12, 2004. 96. Jacobson JL, Humphrey HEB, Jacobson SW, Schantz SL, Mullin MD, Welch R. Determinants of polychlorinated biphenyls (PCBs), polybrominated biphenyls (PBBs), and dichlorodiphenyl trichloroethane (DDT) levels in the sera of young children. Am J Public Health 1989; 79:1401–1404.
PCB Exposure on Neuropsychological Function
65
97. Patandin S, Dagnelie PC, Mulder PG, et al. Dietary exposure to polychlorinated biphenyls and dioxins from infancy until adulthood: A comparison between breastfeeding, toddler, and longterm exposure. Environ Health Perspect 1999; 107:45–51. 98. Patanin S, Weisglas-Kuperus N, de Ridder MAJ, et al. Plasma polychlorinated biphenyl levels in Dutch preschool children either breast-fed or formula-fed during infancy. Am J Public Health 1997; 87:1711–1714. 99. Lanting CI, Fidler V, Huisman M, Boersma ER. Determinants of polychlorinated biphenyl levels in plasma from 42-month-old children. Arch Environ Contam Toxicol 1998; 35:135–139. 100. Schecter A, Ryan JJ, Papke O. Decrease in levels and body burden of dioxins, dibenzofurans, PCBs, DDE, and HCB in blood and milk in a mother nursing twins over a thirty-eight month period. Chemosphere 1998; 37:1807–1816. 101. Abraham K, Papke O, Gross A, et al. Time course of PCDD/PCDF/PDB concentrations in breastfeeding mothers and their infants. Chemosphere 1998; 37:1731–1741. 102. Rice DC, Barone S. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 2000; 3:511–533. 103. Jacobson JL, Jacobson SW. New methodologies for assessing the effects of prenatal toxic exposure on cognitive functioning in humans. In: Evans MS, ed. Toxic Contaminants and Ecosystem Health, a Great Lakes Focus. New York: John Wiley & Sons, Inc., 1988:373–388. 104. Davidson PW, Kost J, Myers GJ, Cox C, Clarkson TW, Shamlaye CF. Methylmercury and neurodevelopment: reanalysis of the Seychelles Child Development Study outcomes at 66 months of age. JAMA 2001; 285:1291–1293. 105. Canfield RL, Henderson CR, Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP. Intellectual impairment in children with blood lead concentrations below 10 micrograms per deciliter. N Engl J Med 2003; 348:1517–1526. 106. Bellinger DC, Needleman HL. Intellectual impairment and blood lead levels. N Engl J Med 2003; 349:500–502. 107. Budtz-Jørgensen E, Keiding N, Grandjean P. Benchmark modeling of the Faroese methylmercury data. Final Report to U.S. EPA. Research Report 99/5. Copenhagen: Department of Biostatistics, University of Copenhagen, 1999. 108. Budtz-Jørgensen E, Grandjean P, Keiding N, et al. Benchmark dose calculations of methylmercury-associated neurobehavioral deficits. Toxicol Lett 2000;112–113: 193–199. 109. Schwartz J. Low-level lead exposure and children’s IQ: a meta-analysis and search for a threshold. Environ Res 1994; 65:42–55. 110. Jacobson JL, Janisse J, Banerjee M, Jester J, Jacobson SW, Ager JW. A benchmark dose analysis of prenatal exposure to polychlorinated biphenyls. Environ Health Perspect 2002; 110:393–398. 111. Zoeller RT, Dowling ALS, Herzig CTA, Iannacone EA, Gauger KJ, Bansal R. Thyroid hormone, brain development, and the environment. Environ Health Perspect 2002; 110:355–361. 112. Schantz SL, Seo BW, Moshtaghian J, Amin S. Developmental exposure to polychlorinated biphenyls or dioxin: do changes in thyroid function mediate effects on spatial learning? Am Zool 1997; 37:399–408. 113. Koopman-Esseboom C, Huisman M, Weisglas-Kuperus N, et al. PCB and dioxin levels in plasma and human milk of 418 Dutch women and their infants. Predictive value of PCB congener levels in maternal plasma for fetal and infant’s exposure to PCBs and dioxins. Chemosphere 1994; 28:1721–1732. 114. Howdeshell KL. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect 2002; 110:337–348. 115. Zoeller RT. Polychlorinated biphenyls as disrupters of thyroid hormone action. In: Robertson LW, Hansen LG, eds. PCBs: Recent Advances in Environmental Toxicology and Health Effects. University of Kentucky Press, Lexington, Kentucky, 2001:265–271.
66
Rice
116. Winneke G, Brockhaus A, Collet W, Kraemer V. Modulation of lead-induced performance deficit in children by varying signal rate in a serial choice reation task. Neurotoxicol Teratol 1989; 11:587–592. 117. Needleman HL, Gunnoe C, Leviton A, et al. Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 1979; 300:689–695. 118. Stiles KM, Bellinger DC. Neuropsychological correlates of low-level lead exposure in school-age children: a prospective study. Neurotoxicol Teratol 1993; 15:27–35. 119. Jacobson, JL, Jacobson, SW, Prospective studies of exposure to an environmental contaminant: the challenge of hypothesis testing in a multivariate correlational context. Psychol Schools 2004; 46: 625–637.
4 Lead Neurotoxicity in Children: Knowledge Gaps and Research Needs David C. Bellinger Department of Neurology, Children’s Hospital Boston, Harvard Medical School and Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts, U.S.A.
INTRODUCTION It was in Australia in the 1890s, two millennia after lead was recognized as an adult neurotoxicant, that childhood lead poisoning was first described (1). For the next halfcentury, it was conceptualized largely as a clinical intoxication that was simply “present” or “absent.” Moreover, the intoxication was thought to have no lasting impact if a child did not become encephalopathic, which tends to occur at blood lead levels greater than 100 mg/dL. The observations of Byers and Lord (2) posed the first major challenge to this view. In this case series, many of the lead poisoned children who presented without signs of encephalopathy nevertheless suffered significant, enduring behavioral and intellectual problems that interfered substantially with their well-being. This suggested that lead poisoning is better characterized as a continuum than as a dichotomy, with subtler forms of neurological deficit occurring among children with lead exposures that do not produce frank toxicity. Progress was slow, however, in identifying milestones on this continuum and characterizing their relationships to lead dose. Textbooks of pediatrics published as recently as the late 1960s identified a blood lead level of 60 mg/dL as the upper limit of the normal range (3). In light of today’s knowledge, this is remarkable. It is somewhat less so, however, if considered in the context of blood lead screening data from that era, which revealed that among young children residing in areas of large, older cities such as Chicago, Philadelphia, and New York, the mean blood lead level differed by only a little more than a factor of two from the levels at which some children become encephalopathic. For instance, in Baltimore in the 1950s, 90% of low-income 7- to 60-month-old children attending well-baby clinics and hospital outpatient departments had a blood lead level above 30 mg/dL and 26% had a level above 60 (4). Other screening data from the 1960s suggested that 20% to 45% of children had a level greater than 40 mg/dL (5). The margin of safety was clearly dangerously slim. It appears that until the final decades of the 20th century, public health recommendations rested, to a large extent, on the erroneous assumption that the blood lead level that was average within the general population of children was also the level that was “physiologically normal” and thus posed no hazard. 67
68
Bellinger
Although population blood lead levels have fallen as a result of the numerous restrictions placed on the uses of lead, as recently as the late 1970s the mean level of U.S. preschool children was 15 mg/dL and 88% had a level greater than 10 mg/dL (6). By the early 1990s, the mean had declined to 4 mg/dL, with 9% of children having a level greater than 10 mg/dL (7). The decline has continued. The current mean among young children, based on NHANES, 1999–2002 data, is 1.9 mg/dL, with 1.6% having a level greater than 10 mg/dL (8). This still represents approximately 310,000 children, and disparities still exist, with poor and non-Hispanic black children suffering the greatest exposures. The economic benefit of the presumed increase in IQ scores associated with the blood lead decline between 1976 and 1999 was estimated to be $110 to $319 billion for each year’s cohort of 2-year-old children (9). The dramatic decline in children’s blood lead levels has prompted some to conclude that because the mean level is now so close to 0 mg/dL, the steps taken in recent decades to abate key sources and pathways of exposure have brought us to the threshold of eliminating lead neurotoxicity in children. This is, however, an artifact of the measurement units used, by convention, to express blood lead level. If blood lead were measured in mg/L instead of mg/dL, the current mean level would be 20 mg/L; in ng/L, it would be 20,000. What was the blood lead level of humans likely to have been before they began to disturb the natural distribution of lead in the earth’s crust by mining and other activities? Two estimates are available. One, based on the relationship between blood and bone lead levels in contemporary animals and humans, is 0.016 mg/d (10). The other, based on a pharmacokinetic model, is 0.06 to 0.12 mg/dL (11). Therefore, the current mean of 2 mg/dL among U.S. children, although a 90% reduction from the mean during the late 1970s, could be as much as two orders of magnitude greater than children’s “natural” blood lead level. One can hope that most of the population distribution of blood lead levels now falls below the level at which lead produces demonstrable neurotoxicities in children, but it is possible that this goal still lies far ahead. The goal of this chapter is to identify some major lacunae in our understanding of the neurotoxicities associated with childhood lead poisoning and the impediments to filling them. The issues discussed bear on the selection of exposure biomarkers; the selection of critical outcomes; the functional form of the concentration–response/effect relationship; the reversibility of effects; and possible bases for individual differences in vulnerability.
SELECTION OF EXPOSURE BIOMARKERS AND SOURCES OF MISCLASSIFICATION ERRORS Given that the central nervous system is considered the critical target organ for childhood lead poisoning, it would be most helpful to be able to measure, in vivo, the concentration of lead at the cellular site(s) of action in the brain. Because such measurements are not currently feasible, investigators must rely on measurements of lead in more readily accessible but peripheral tissues, most commonly blood and bone. The relationship between brain lead and lead in each of these surrogate tissues is poorly understood, although the pharmacokinetics clearly differ among these compartments. In both rodents (12) and non-human primates (13), brain lead level falls much more slowly than blood lead level following chelation with succimer and, in the rodent, in non-chelated animals after cessation of exposure. These observations suggest that using blood lead as an index of lead in the brain will result in exposure misclassification, although the magnitude of this bias in any specific
Lead Neurotoxicity in Children
69
setting will be difficult to characterize. The most likely direction, however, would be underestimation of the amount of lead in the brain. As an exposure biomarker, blood lead level has other limitations. Only about 5% of an individual’s total body lead burden resides in blood. Furthermore, blood consists of several sub-compartments. More than 90% of lead in whole blood is bound to red cell proteins such as hemoglobin, with the balance in plasma. From a toxicological perspective, this unbound fraction is likely to be the most important sub-compartment of blood lead because of the ease with which it diffuses into soft tissues. The concentration of lead is plasma is much lower than in whole blood, however. For example, in a group of pregnant women with blood lead levels below 10 mg/dL, plasma lead levels were less than 0.3% of the whole blood lead level (14). The use of whole blood lead as a surrogate for plasma lead could be justified if the ratio of whole blood lead:plasma lead were well characterized, but this is not so. At least some studies suggest that it varies several-fold among individuals with the same blood lead level (14–17). Moreover, the ability of red cells to bind lead is limited, so the ratio of blood lead: plasma lead would be expected to be non-linear. Thus, interpreting whole blood lead level as a proxy for plasma lead level, which, itself, is a proxy for brain lead level, will likely result in some exposure misclassification. The greater relative abundance of lead in whole blood makes its measurement much easier (and cheaper) than the measurement of lead in plasma. With the number of toxicokinetic steps separating brain lead level from the exposure biomarkers usually measured, it is remarkable that we have made as much progress as we have in characterizing the concentration-response/effect relationships. Another limitation in the use of blood lead as the exposure biomarker is that its residence time in blood is closely linked to red cell lifetime, with a half-time on the order of 30 days, although it can be somewhat longer in individuals with higher total body burdens because of re-equilibration of lead stored in deeper and shallower pools. In nonchelated children, the time for blood lead to decline to a value less than 10 mg/dL was linearly related to baseline blood lead level. In children with starting levels of 25–29 mg/dL, the mean duration was 24 months, compared to 9 months in children with starting levels of 10–14 mg/dL (18). A single blood lead measurement might therefore provide limited information about an individual’s lead exposure history, a difficulty frequently cited regarding the interpretation of cross-sectional studies, in which blood lead is often measured only once, and sometimes only well after the period when children’s blood lead levels peak (18–30 mo). If it is exposures to lead in the early postnatal years that are most detrimental to children’s development (19), categorizing a child’s exposure status based on the blood lead level that is contemporaneous with the measurement of neurodevelopment at school-age could result in exposure misclassification. Unless intraindividual stability of serial blood lead levels is very high within a study cohort, misclassification would probably be non-differential, resulting in bias towards the null. This concern must be qualified by recent data from some longitudinal studies indicating that concurrent blood lead level, even at ages well beyond 18 to 30 mo, is sometimes the strongest predictor of late outcomes (20). Age-related changes in vulnerability, and the reasons why it might differ across studies, remain uncertain. It might be that among children with chronically elevated exposure, but not in children with relatively low lifetime exposure, blood lead level measured at school-age is a reasonably good marker of cumulative exposure. That concurrent blood lead level is a stronger predictor of schoolage outcomes than is blood lead level in the early postnatal years does not necessarily imply greater vulnerability of the brain to ongoing than to past exposure. The development of X-ray-fluorescence (XRF) methods for measuring lead in mineralized tissues engendered the hope that they would allow better characterization and
70
Bellinger
reconstruction of exposure history. Such tissues are a long-term lead storage site, with a half-life measured in decades, containing approximately 90% of the total body lead burden in adults and 70% in children. Thus, bone lead is an index with a long exposure averaging time (21). Moreover, some data suggest that bone lead, which can be mobilized by many physiologic and pathophysiologic processes, is a major contributor to plasma lead. XRF methods have proven useful in studying individuals with occupational lead exposure (22,23), those living in highly polluted environments (24), and those who grew up when community lead exposures were relatively high (25). In a relatively highly exposed cohort of pregnant women in Mexico City, higher bone lead levels at one month post-partum were associated with reduced birth weight (26), less infant weight gain (27), smaller head circumference and birth length (28), and slower infant development (29). Among children living near a large lead smelter in Yugoslavia, IQ at age 10–12 yr was more strongly associated, inversely, with tibia lead level than with blood lead level (30). Current XRF methods for measuring bone lead levels have limitations, however. Temporal features of exposure history cannot easily be discerned. Some progress has been made toward this goal by examining the spatial distribution of lead in teeth in relation to the relative abundance of stable lead isotopes (31), but the specialized technologies needed to carry out these analyses are unlikely ever to be widely available, and the unpredictability of tooth exfoliation makes this tissue difficult to collect unless the study design involves contact with (and the cooperation of) participants at the appropriate ages. Current XRF methods might not be sufficiently sensitive for studies of the health effects of low-dose community exposures. The bone lead levels of a large percentage of subjects might be below the detection limit, for example, 80% in a case-control study of bone lead levels and juvenile delinquency (32). Efforts continue to modify the instrumentation or measurement protocols to reduce the detection limit. Lead appears to be deposited at sites of most active calcification (33). In children, this is trabecular bone, in which the rate of fractional resorption in early childhood is high. Depending on the amount of a child’s ongoing exposure, lead might not permanently remain in bone, making bone lead level an inaccurate index of lifetime lead exposure. Finally, it is difficult to compare the performance of different laboratories using XRF methods to measure bone lead because of the absence of standard reference materials. A major research need is the development and validation of biomarkers of critical dose that, compared to blood lead or bone lead, are fewer toxicokinetic steps removed from the sites of lead’s actions in the brain. One promising front in the effort to deduce the contents of the “black box” separating external dose and clinical disease is the measurement of processes and products that potentially mediate the association between them. For example, magnetic resonance spectroscopy (MRS) has been used in small case series to measure the ratio of N-acetylaspartate (NAA) to creatine, which is a marker of neuronal and axonal damage, and thus an early biological effect rather than a biomarker of exposure. In children, higher lead exposures are associated with lower NAA:creatine ratios in the frontal gray matter and, to a lesser extent, in frontal white matter (34,35). Similarly, an adult who had higher bone and blood lead levels than did his monozygotic twin had both greater neuropsychological deficits and lower NAA:creatine ratios in the hippocampus, frontal lobe, and midbrain (36). While much remains uncertain about the interpretation of MRS, the use of this and other biochemical imaging methods, in combination with more conventional structural and functional imaging methods, might bring us closer to understanding the mechanisms of lead neurotoxicity. Imprecision in exposure classification can result in estimates of critical dose that are insufficiently protective (37). All other things being equal, exposure misclassification will result in the greatest reduction of statistical power in studies that focus on the lower end of
Lead Neurotoxicity in Children
71
the exposure range. Exposure-related outcome differences would be expected to be smaller at lower than at higher blood lead levels (excepting a supralinear functional form; see “Functional Form of the Concentration–Response/Concentration–Effect Relationship”), so the size of the error introduced by misclassification will be greater in relation to mean blood lead level, representing a greater proportion of the coefficient of variation.
SELECTION OF CRITICAL OUTCOMES The functions measured as indicators of lead’s developmental neurotoxicity have, overwhelmingly, been neurocognitive deficits. Because of the intense controversy that attended proposals to impose significant restrictions on lead’s uses, many study publications focused entirely on analyses of the association between children’s lead levels and their scores on apical tests, such as IQ, that integrate performance over diverse domains. This is understandable in light of the risk assessor’s need to base exposure standards on endpoints for which consensus is firm with regard to individual and societal importance and for which deficits can be readily valued (i.e., monetized). Because individuals with the same IQ can present with markedly different patterns of strengths and weaknesses, however, IQ is perhaps the least useful piece of data collected in a clinical evaluation. A low score suggests the magnitude of a child’s struggles, but relatively little about their nature and, thus, about strategies for amelioration. In most studies, assessment batteries include, in addition to IQ, age-appropriate standardized tests of specific aspects of neurodevelopmental function, administered in hopes that the pattern of test scores will help to identify the neuropsychological mechanisms that underlie the inverse associations between lead and apical test scores. Lead-associated deficits on diverse domain-focused tests have been reported, involving attention, language, executive functions, visual-motor integration, and fine motor skills. Some have suggested that the findings provide a sufficient basis for inferring a “behavioral signature” for lead neurotoxicity (38,39). Any particular study has tended to identify leadassociated deficits in only a subset of these domains, however, and not all children within a study sample display all of the deficits noted at the group level. This is true even among children who suffer clinical lead poisoning (J. Rosen, personal communication). The limited consistency across studies in the domains identified as lead-sensitive provides relatively weak evidence for a true behavioral signature that can, with good sensitivity and specificity, identify the child whose impairments are related to lead and not to some other chemical, biological, or psychosocial factor (40). Some argue that behavioral signatures, in this strict diagnostic sense, have been identified only for Rett Syndrome, Prader–Willi Syndrome, and Lesch–Nyhan Syndrome (41). Furthermore, the deficits that have been proposed as contributing to a behavioral signature for lead are, themselves, vague, referring to broad abstract constructs (e.g., attention) rather than to specific processes. The processes within these broad domains that are lead-sensitive would have to be specified and defined operationally before any purported behavioral signature would be useful. Some of the difficulties encountered in drawing strong inferences about a behavioral signature, and weaker inferences about the more common relative deficits of lead-exposed children, stem from psychometric limitations of the tests that are used to assess different domains. These limitations have potentially serious implications for any effort to use batteries of such tests to draw inferences about relative deficits, a first step in determining whether a behavioral signature can be identified. The key data needed to identify a relative
72
Bellinger
deficit is a lead-associated decrement on the test used to assess one domain but not on the test used to assess another domain (in neuropsychological terms, a “double dissociation”). To support the inference that this does